CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: terpenoid indole alkaloid
Accession: CHEBI:65321
browse the term
Definition: An indole alkaloid which is biosynthesised from L-tryptophan and isoprenoid building blocks.
Synonyms: related_synonym: terpenoid indole alkaloids
G
Casp3
caspase 3
increases expression multiple interactions
ISO
raubasine results in increased expression of CASP3 protein CASP3 protein affects the reaction [raubasine results in increased secretion of IL1B protein]; CASP3 protein affects the reaction [raubasine results in increased secretion of IL6 protein]; CASP3 protein affects the reaction [raubasine results in increased secretion of TNF protein]
CTD
PMID:38064316
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases activity multiple interactions
ISO
raubasine results in decreased activity of CYP2D6 protein raubasine inhibits the reaction [CYP2D6 protein affects the metabolism of Dextromethorphan]
CTD
PMID:15930738
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
raubasine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
CTD
PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Gsdme
gasdermin E
increases cleavage
ISO
raubasine results in increased cleavage of GSDME protein
CTD
PMID:38064316
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
G
Il1b
interleukin 1 beta
increases expression increases secretion multiple interactions
ISO
raubasine results in increased expression of IL1B protein raubasine results in increased secretion of IL1B protein [Acetylcysteine co-treated with raubasine] results in increased secretion of IL1B protein; CASP3 protein affects the reaction [raubasine results in increased secretion of IL1B protein]
CTD
PMID:38064316
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression increases secretion multiple interactions
ISO
raubasine results in increased expression of IL6 protein raubasine results in increased secretion of IL6 protein [Acetylcysteine co-treated with raubasine] results in increased secretion of IL6 protein; CASP3 protein affects the reaction [raubasine results in increased secretion of IL6 protein]
CTD
PMID:38064316
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Tnf
tumor necrosis factor
increases secretion multiple interactions increases expression
ISO
raubasine results in increased secretion of TNF protein [Acetylcysteine co-treated with raubasine] results in increased secretion of TNF protein; CASP3 protein affects the reaction [raubasine results in increased secretion of TNF protein] raubasine results in increased expression of TNF protein
CTD
PMID:38064316
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
Ajmaline inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
CTD
PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Ajmaline results in decreased activity of KCNH2 protein
CTD
PMID:15599706 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Scn5a
sodium voltage-gated channel alpha subunit 5
decreases activity affects response to substance
ISO
Ajmaline results in decreased activity of SCN5A protein SCN5A protein affects the susceptibility to Ajmaline
CTD
PMID:10662748 PMID:15520322 PMID:20174578
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Casp3
caspase 3
increases activity
ISO
ergocryptine results in increased activity of CASP3 protein
CTD
PMID:21295106
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Afp
alpha-fetoprotein
multiple interactions
EXP
brucine inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]
CTD
PMID:24060683
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
brucine results in increased expression of BAX protein
CTD
PMID:16443926 PMID:21684292
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
brucine results in decreased expression of BCL2 protein
CTD
PMID:16443926
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity increases expression multiple interactions
ISO
[brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein; brucine results in increased activity of CASP3 protein brucine results in increased expression of CASP3 protein brucine results in increased expression of and results in increased activity of CASP3 protein; Cyclosporine inhibits the reaction [[brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein]
CTD
PMID:16442763 PMID:16443926 PMID:17449162 PMID:21684292
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions increases activity
ISO
brucine results in increased activity of and results in increased cleavage of CASP9 protein; Cyclosporine inhibits the reaction [[brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein]; Cyclosporine inhibits the reaction [brucine results in increased activity of and results in increased cleavage of CASP9 protein] [brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein; brucine results in increased activity of CASP9 protein
CTD
PMID:16443926 PMID:21684292
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; brucine inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]
CTD
PMID:24060683 PMID:30027798
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Chrm1
cholinergic receptor, muscarinic 1
multiple interactions
ISO
brucine affects the reaction [muscarinic toxin 7 binds to CHRM1 protein]; brucine affects the reaction [Pirenzepine analog binds to CHRM1 protein]; brucine analog affects the reaction [Acetylcholine binds to CHRM1 protein]; brucine analog affects the reaction [N-Methylscopolamine binds to CHRM1 protein]; brucine promotes the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM1 protein]; brucine promotes the reaction [5-methylfurtrethonium binds to CHRM1 protein]; brucine promotes the reaction [Acetylcholine binds to CHRM1 protein]; brucine promotes the reaction [Acetylcholine results in increased activity of CHRM1 protein]; brucine promotes the reaction [Bethanechol binds to CHRM1 protein]; brucine promotes the reaction [Carbachol binds to CHRM1 protein]; brucine promotes the reaction [furtrethonium binds to CHRM1 protein]; brucine promotes the reaction [oxotremorine M binds to CHRM1 protein]; brucine promotes the reaction [Pilocarpine binds to CHRM1 protein]; Quinuclidinyl Benzilate inhibits the reaction [brucine promotes the reaction [Acetylcholine results in increased activity of CHRM1 protein]]
CTD
PMID:9224827 PMID:9495826 PMID:10069518 PMID:10101037 PMID:15294002 PMID:16439611 More...
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Chrm2
cholinergic receptor, muscarinic 2
multiple interactions affects binding
ISO
brucine analog affects the reaction [Acetylcholine binds to CHRM2 protein]; brucine analog affects the reaction [N-Methylscopolamine binds to CHRM2 protein]; brucine promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] brucine binds to CHRM2 protein
CTD
PMID:9495826 PMID:10069518 PMID:15647330
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chrm3
cholinergic receptor, muscarinic 3
multiple interactions affects binding
ISO
brucine analog affects the reaction [Acetylcholine binds to CHRM3 protein]; brucine analog affects the reaction [N-Methylscopolamine binds to CHRM3 protein]; brucine binds to and results in increased activity of CHRM3 protein mutant form; brucine promotes the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM3 protein]; brucine promotes the reaction [5-methylfurtrethonium binds to CHRM3 protein]; brucine promotes the reaction [Acetylcholine binds to CHRM3 protein]; brucine promotes the reaction [Arecoline binds to CHRM3 protein]; brucine promotes the reaction [Bethanechol binds to CHRM3 protein]; brucine promotes the reaction [Carbachol binds to CHRM3 protein]; brucine promotes the reaction [Carbachol results in increased activity of CHRM3 protein mutant form]; brucine promotes the reaction [furtrethonium binds to CHRM3 protein]; brucine promotes the reaction [oxotremorine M binds to CHRM3 protein]; brucine promotes the reaction [Pilocarpine binds to CHRM3 protein] brucine binds to CHRM3 protein
CTD
PMID:9224827 PMID:10069518 PMID:15647330 PMID:20466821
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Chrm4
cholinergic receptor, muscarinic 4
multiple interactions affects binding
ISO
brucine analog affects the reaction [Acetylcholine binds to CHRM4 protein]; brucine analog affects the reaction [N-Methylscopolamine binds to CHRM4 protein]; brucine promotes the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM4 protein]; brucine promotes the reaction [5-methylfurtrethonium binds to CHRM4 protein]; brucine promotes the reaction [Bethanechol binds to CHRM4 protein]; brucine promotes the reaction [Carbachol binds to CHRM4 protein]; brucine promotes the reaction [furtrethonium binds to CHRM4 protein]; brucine promotes the reaction [oxotremorine M binds to CHRM4 protein]; brucine promotes the reaction [Pilocarpine binds to CHRM4 protein]; WIN 62577 inhibits the reaction [brucine binds to CHRM4 protein]
CTD
PMID:9224827 PMID:10069518 PMID:16709648
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Ctsd
cathepsin D
decreases expression
ISO
brucine results in decreased expression of CTSD mRNA brucine results in decreased expression of CTSD mRNA; brucine results in decreased expression of CTSD protein
CTD
PMID:23933019
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein
CTD
PMID:21800547
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
brucine results in increased expression of CYP2B1 protein
CTD
PMID:7906730
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
brucine results in increased expression of CYP2B2 protein
CTD
PMID:7906730
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression
EXP
brucine results in increased expression of CYP2B3 protein
CTD
PMID:8850324
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions increases activity
EXP
[brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP2E1 protein; [brucine co-treated with liquiritin] results in decreased activity of CYP2E1 protein brucine results in increased activity of CYP2E1 protein
CTD
PMID:21800547
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Fn1
fibronectin 1
decreases expression
ISO
brucine results in decreased expression of FN1 mRNA brucine results in decreased expression of FN1 mRNA; brucine results in decreased expression of FN1 protein
CTD
PMID:23933019
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Glra1
glycine receptor, alpha 1
multiple interactions
ISO
brucine analog binds to and results in decreased activity of GLRA1 protein; brucine binds to and results in decreased activity of GLRA1 protein
CTD
PMID:15081878 PMID:16687139
NCBI chr10:39,625,853...39,727,897
Ensembl chr10:39,629,459...39,727,162
G
Gpt
glutamic--pyruvic transaminase
increases expression
ISO
brucine results in increased expression of GPT protein
CTD
PMID:31284022
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GPX1 protein]
CTD
PMID:30027798
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]
CTD
PMID:30027798
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
multiple interactions
EXP
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSTA1 protein]
CTD
PMID:30027798
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Lox
lysyl oxidase
decreases expression
ISO
brucine results in decreased expression of LOX mRNA brucine results in decreased expression of LOX mRNA; brucine results in decreased expression of LOX protein
CTD
PMID:23933019
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Mbp
myelin basic protein
affects expression
EXP
brucine affects the expression of MBP mRNA
CTD
PMID:22954530
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
brucine results in decreased expression of MMP2 mRNA brucine results in decreased expression of MMP2 mRNA; brucine results in decreased expression of MMP2 protein
CTD
PMID:23933019
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Npas2
neuronal PAS domain protein 2
multiple interactions
ISO
NPAS2 protein affects the metabolism of and affects the susceptibility to brucine
CTD
PMID:31284022
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
brucine inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein]
CTD
PMID:24060683
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
brucine results in decreased expression of PTGS2 protein
CTD
PMID:16442763 PMID:17449162
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Sod1
superoxide dismutase 1
multiple interactions
EXP
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of SOD1 protein]
CTD
PMID:30027798
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Tnf
tumor necrosis factor
decreases secretion
ISO
brucine results in decreased secretion of TNF protein
CTD
PMID:21684292
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Chrm2
cholinergic receptor, muscarinic 2
affects binding
ISO
caracurine binds to CHRM2 protein
CTD
PMID:15647330
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chrm3
cholinergic receptor, muscarinic 3
affects binding
ISO
caracurine binds to CHRM3 protein
CTD
PMID:15647330
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Dihydroergotamine results in decreased activity of ABCB11 protein
CTD
PMID:28437613
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Dihydroergotamine results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity increases activity
ISO EXP
Dihydroergotamine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Dihydroergotamine results in decreased activity of CYP1A1 protein Dihydroergotamine results in increased activity of CYP1A1 protein
CTD
PMID:18420780 PMID:18493746 PMID:33814510
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP1B1 protein
CTD
PMID:18420780
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2A4 protein
CTD
PMID:18420780
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2B10 protein
CTD
PMID:18420780
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2C29 protein
CTD
PMID:18420780
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP2D6 protein Dihydroergotamine results in decreased activity of CYP2D22 protein
CTD
PMID:18420780
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
Dihydroergotamine results in decreased activity of CYP3A4 protein
CTD
PMID:18420780
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
dihydroergotamine binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Il24
interleukin 24
increases expression
ISO
Dihydroergotamine results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Dihydroergotamine results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
ergocristine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] ergocristine results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Casp3
caspase 3
increases activity
ISO
ergocristine results in increased activity of CASP3 protein
CTD
PMID:21295106
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp3
caspase 3
increases activity
ISO
ergosine results in increased activity of CASP3 protein
CTD
PMID:21295106
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
EXP
Ergotamine inhibits the reaction [Nitroglycerin results in increased expression of CALCA protein]
CTD
PMID:19121572
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
increases activity
ISO
Ergotamine results in increased activity of CASP3 protein
CTD
PMID:21295106
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
Ergotamine inhibits the reaction [Nitroglycerin results in increased expression of FOS protein]
CTD
PMID:19121572
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Ergotamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
Ergotamine binds to and results in increased activity of HTR2B protein
CTD
PMID:11104741
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Ifng
interferon gamma
decreases expression
ISO
fumigaclavine C results in decreased expression of IFNG mRNA; fumigaclavine C results in decreased expression of IFNG protein
CTD
PMID:16023606
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il12a
interleukin 12A
decreases expression
ISO
fumigaclavine C results in decreased expression of IL12A mRNA
CTD
PMID:16023606
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il1b
interleukin 1 beta
decreases expression
ISO
fumigaclavine C results in decreased expression of IL1B mRNA
CTD
PMID:16023606
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
decreases expression
ISO
fumigaclavine C results in decreased expression of IL2 mRNA; fumigaclavine C results in decreased expression of IL2 protein
CTD
PMID:16023606
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Mmp9
matrix metallopeptidase 9
decreases activity decreases expression
ISO
fumigaclavine C results in decreased activity of MMP9 protein fumigaclavine C results in decreased expression of MMP9 mRNA
CTD
PMID:16023606
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Tnf
tumor necrosis factor
decreases expression
ISO
fumigaclavine C results in decreased expression of TNF mRNA
CTD
PMID:16023606
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Ibogaine results in decreased activity of KCNH2 protein
CTD
PMID:23707769 PMID:24307198
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Scn5a
sodium voltage-gated channel alpha subunit 5
decreases activity
ISO
Ibogaine results in decreased activity of SCN5A protein
CTD
PMID:23707769
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases response to substance
ISO
SEC24D protein results in increased susceptibility to Ibogaine
CTD
PMID:27555326
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Slc6a3
solute carrier family 6 member 3
multiple interactions increases expression
ISO
Ibogaine inhibits the reaction [SLC6A3 protein mutant form results in decreased import of Dopamine]; Ibogaine promotes the reaction [SLC6A3 protein results in increased import of Dopamine] Ibogaine results in increased expression of SLC6A3 protein
CTD
PMID:27555326
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Scn5a
sodium voltage-gated channel alpha subunit 5
multiple interactions
ISO
icajine binds to and results in decreased activity of SCN5A protein
CTD
PMID:21616062
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Htr2b
5-hydroxytryptamine receptor 2B
affects binding multiple interactions
ISO
mesulergine binds to HTR2B protein Fluoxetine promotes the reaction [mesulergine binds to HTR2B protein]
CTD
PMID:11930908
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding multiple interactions
ISO EXP
mesulergine binds to HTR2C protein N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [mesulergine binds to HTR2C protein] Carbamazepine inhibits the reaction [Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]]; Carbamazepine inhibits the reaction [Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]; Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]; Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]; Plant Extracts inhibits the reaction [Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]]; Plant Extracts inhibits the reaction [Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]
CTD
PMID:18083778 PMID:19439326 PMID:19700373 PMID:29458138
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr7
5-hydroxytryptamine receptor 7
affects binding multiple interactions
ISO
mesulergine binds to HTR7 protein [mesulergine binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]; mesulergine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]
CTD
PMID:14578406 PMID:20827463
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Prl
prolactin
multiple interactions
EXP
mesulergine inhibits the reaction [Diethylstilbestrol results in increased secretion of PRL protein]
CTD
PMID:1421203
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Methysergide results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Methysergide promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Calca
calcitonin-related polypeptide alpha
affects activity
EXP
Methysergide affects the activity of CALCA protein
CTD
PMID:10075105
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Methysergide binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
methysergide binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Abcg2
ATP binding cassette subfamily G member 2
affects activity
ISO
mitragynine affects the activity of ABCG2 protein
CTD
PMID:30083819
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ces1d
carboxylesterase 1D
increases hydrolysis decreases activity multiple interactions
ISO
CES1 protein results in increased hydrolysis of mitragynine mitragynine results in decreased activity of CES1 protein [mitragynine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir
CTD
PMID:25445008 PMID:37716419
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity increases expression
ISO
mitragynine results in increased activity of CYP1A2 protein mitragynine results in increased expression of CYP1A2 mRNA; mitragynine results in increased expression of CYP1A2 protein
CTD
PMID:23274770
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
mitragynine results in decreased activity of CYP2C19 protein
CTD
PMID:31707106
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases expression decreases activity
ISO
mitragynine results in increased expression of CYP2D6 protein mitragynine results in decreased activity of CYP2D6 protein
CTD
PMID:23274770 PMID:31707106
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases activity increases expression
ISO
mitragynine results in increased activity of CYP3A4 protein mitragynine results in increased expression of CYP3A4 mRNA; mitragynine results in increased expression of CYP3A4 protein
CTD
PMID:23274770
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases expression multiple interactions
ISO
mitragynine results in decreased expression of KCNH2 protein mitragynine binds to and results in decreased activity of KCNH2 protein
CTD
PMID:27260674
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Oprd1
opioid receptor, delta 1
affects binding
ISO
mitragynine binds to OPRD1 protein
CTD
PMID:27192616
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
affects binding multiple interactions
ISO
mitragynine binds to OPRK1 protein mitragynine inhibits the reaction [3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer binds to and results in increased activity of OPRK1 protein]
CTD
PMID:27192616
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
multiple interactions increases activity affects binding
ISO
mitragynine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]; mitragynine binds to and results in increased activity of OPRM1 protein; mitragynine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA] mitragynine results in increased activity of OPRM1 protein mitragynine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] mitragynine binds to OPRM1 protein
CTD
PMID:23608241 PMID:27192616 PMID:32734307
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
ISO
mitragynine promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of PTGS1 protein]
CTD
PMID:21513785
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
mitragynine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; mitragynine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]
CTD
PMID:21513785
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of AKT1 protein]]
CTD
PMID:12807996
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of CREB1 protein]]
CTD
PMID:12807996
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Fasn
fatty acid synthase
multiple interactions increases expression
ISO
[Bexarotene co-treated with paxilline] results in increased expression of FASN mRNA; [CD 3254 co-treated with paxilline] results in increased expression of FASN mRNA paxilline results in increased expression of FASN mRNA
CTD
PMID:32123961
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Flt1
Fms related receptor tyrosine kinase 1
multiple interactions
ISO
paxilline inhibits the reaction [NS 1619 inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]
CTD
PMID:25371888
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
affects response to substance
EXP
KCNMA1 protein affects the susceptibility to paxilline
CTD
PMID:22226998
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Mlxipl
MLX interacting protein-like
increases expression
ISO
paxilline results in increased expression of MLXIPL mRNA
CTD
PMID:32123961
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions increases expression
ISO
[Bexarotene co-treated with paxilline] results in increased expression of NR0B2 mRNA; [CD 3254 co-treated with paxilline] results in increased expression of NR0B2 mRNA paxilline results in increased expression of NR0B2 mRNA
CTD
PMID:32123961
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions increases expression
ISO
[Bexarotene co-treated with paxilline] results in increased expression of NR1H3 mRNA; [CD 3254 co-treated with paxilline] results in increased expression of NR1H3 mRNA; NR1H3 protein promotes the reaction [paxilline results in increased abundance of Lipids] paxilline results in increased expression of NR1H3 mRNA
CTD
PMID:20079722 PMID:32123961
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nrip1
nuclear receptor interacting protein 1
multiple interactions increases expression
ISO
[CD 3254 co-treated with paxilline] results in increased expression of NRIP1 mRNA paxilline results in increased expression of NRIP1 mRNA
CTD
PMID:32123961
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in increased phosphorylation of PTEN protein]]
CTD
PMID:12807996
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression
ISO
[CD 3254 co-treated with paxilline] results in increased expression of SCD mRNA paxilline results in increased expression of SCD mRNA
CTD
PMID:32123961
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
ISO
[Bexarotene co-treated with paxilline] results in increased expression of SREBF1 mRNA; [CD 3254 co-treated with paxilline] results in increased expression of SREBF1 mRNA paxilline results in increased expression of SREBF1 mRNA
CTD
PMID:32123961
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tnf
tumor necrosis factor
multiple interactions
ISO
paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of AKT1 protein]]; paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of CREB1 protein]]; paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in increased phosphorylation of PTEN protein]]
CTD
PMID:12807996
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
rescinnamine results in increased expression of ABCB1 mRNA
CTD
PMID:7476894
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
rescinnamine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
reserpic acid inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
CTD
PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Reserpine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Reserpine results in decreased activity of ABCB11 protein
CTD
PMID:20829430 PMID:23956101 PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression decreases activity
ISO
Cycloheximide promotes the reaction [Reserpine results in increased expression of ABCB1 mRNA]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine] Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] Reserpine results in increased expression of ABCB1 mRNA; Reserpine results in increased expression of ABCB1 protein Reserpine results in decreased activity of ABCB1 protein
CTD
PMID:7476894 PMID:8632764 PMID:10617675 PMID:12235267 PMID:19528478
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Reserpine inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]; Reserpine inhibits the reaction [ABCG2 protein results in increased transport of Irinotecan]
CTD
PMID:12869632
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ache
acetylcholinesterase
multiple interactions affects activity
EXP
[Plant Extracts results in increased abundance of Dronabinol] inhibits the reaction [Reserpine affects the activity of ACHE protein]
CTD
PMID:28212939
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Adra1d
adrenoceptor alpha 1D
increases response to substance increases expression
EXP
ADRA1D protein results in increased susceptibility to Reserpine Reserpine results in increased expression of ADRA1D mRNA
CTD
PMID:15159276 PMID:17676312
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Adra2a
adrenoceptor alpha 2A
increases expression
EXP
Reserpine results in increased expression of ADRA2A mRNA
CTD
PMID:11264240
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Adrb1
adrenoceptor beta 1
increases expression increases stability
EXP
Reserpine results in increased expression of ADRB1 mRNA; Reserpine results in increased expression of ADRB1 protein Reserpine results in increased stability of ADRB1 mRNA
CTD
PMID:1336118
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
increases expression
EXP
Reserpine results in increased expression of ADRB2 mRNA
CTD
PMID:1664493
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agtr2
angiotensin II receptor, type 2
increases expression
EXP
Reserpine results in increased expression of AGTR2 mRNA; Reserpine results in increased expression of AGTR2 protein
CTD
PMID:20964730
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Reserpine results in increased expression of AKR1B10 mRNA
CTD
PMID:26198647
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
Reserpine results in decreased phosphorylation of AKT1 protein arsenic trioxide promotes the reaction [Reserpine results in decreased phosphorylation of AKT1 protein]
CTD
PMID:26114099
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Amd1
adenosylmethionine decarboxylase 1
multiple interactions
ISO
Reserpine inhibits the reaction [Folic Acid results in increased activity of AMD1 protein]
CTD
PMID:17371283
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Ar
androgen receptor
multiple interactions
ISO
Reserpine inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
CTD
PMID:29162470
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arc
activity-regulated cytoskeleton-associated protein
multiple interactions
EXP
Reserpine inhibits the reaction [Cocaine results in increased expression of ARC mRNA]
CTD
PMID:7722525
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein]
CTD
PMID:19463876
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]
CTD
PMID:19463876
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
decreases expression multiple interactions
ISO EXP
Reserpine results in decreased expression of BDNF protein cerebrolysin inhibits the reaction [Reserpine results in decreased expression of BDNF protein]; Fluoxetine inhibits the reaction [Reserpine results in decreased expression of BDNF protein] arsenic trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein]
CTD
PMID:26114099 PMID:33279466
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Birc5
baculoviral IAP repeat-containing 5
affects binding
ISO
Reserpine binds to BIRC5 promoter
CTD
PMID:17968851
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
C3
complement C3
affects expression
EXP
Reserpine affects the expression of C3 mRNA
CTD
PMID:18363858
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp3
caspase 3
multiple interactions increases activity
EXP
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein]
CTD
PMID:19463876
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases activity
EXP
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein]
CTD
PMID:19463876
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
multiple interactions decreases expression increases expression
EXP
Plant Extracts inhibits the reaction [Reserpine results in decreased expression of CAT protein]; Quercetin inhibits the reaction [Reserpine results in decreased expression of CAT protein] Reserpine results in increased expression of CAT protein
CTD
PMID:14685008 PMID:16444668 PMID:19109989 PMID:19761039 PMID:20628966
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
decreases expression
ISO
Reserpine results in decreased expression of CCND1 mRNA; Reserpine results in decreased expression of CCND1 protein
CTD
PMID:19607803
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein
CTD
PMID:11318962
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
multiple interactions
EXP
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA]
CTD
PMID:18504326
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Chga
chromogranin A
multiple interactions increases expression increases activity
ISO EXP
CHGA protein alternative form inhibits the reaction [Reserpine results in increased activity of CHGA promoter]; Chlorisondamine inhibits the reaction [Reserpine results in increased activity of CHGA promoter] Reserpine results in increased expression of CHGA mRNA
CTD
PMID:1907749 PMID:8189248 PMID:12799369
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chgb
chromogranin B
increases expression
EXP
Reserpine results in increased expression of CHGB mRNA; Reserpine results in increased expression of CHGB protein
CTD
PMID:1907749 PMID:8189248 PMID:8361347
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chrm1
cholinergic receptor, muscarinic 1
increases expression decreases expression
EXP
Reserpine results in increased expression of CHRM1 mRNA Reserpine results in decreased expression of CHRM1 protein
CTD
PMID:1506860
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Cnr1
cannabinoid receptor 1
decreases expression
EXP
Reserpine results in decreased expression of CNR1 mRNA
CTD
PMID:11358453
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cpe
carboxypeptidase E
increases expression
EXP
Reserpine results in increased expression of CPE mRNA
CTD
PMID:8189248
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Crem
cAMP responsive element modulator
multiple interactions increases expression
EXP
Reserpine promotes the reaction [CREM protein binds to TH promoter] Reserpine results in increased expression of CREM mRNA alternative form; Reserpine results in increased expression of CREM protein; Reserpine results in increased expression of CREM protein alternative form
CTD
PMID:8810303 PMID:11438978
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Crh
corticotropin releasing hormone
increases expression
EXP
Reserpine results in increased expression of CRH mRNA; Reserpine results in increased expression of CRH protein
CTD
PMID:1850078
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Reserpine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
CTD
PMID:15627480 PMID:18493746
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]
CTD
PMID:16510159
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA
CTD
PMID:17041008
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression multiple interactions
ISO
Reserpine results in increased expression of CYP3A4 mRNA; Reserpine results in increased expression of CYP3A4 protein [Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Reserpine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
CTD
PMID:8632764 PMID:16837568 PMID:17041008 PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
ISO
Reserpine results in increased expression of CYP3A5 protein
CTD
PMID:8632764
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyss
cystatin S
multiple interactions
EXP
Reserpine inhibits the reaction [Isoproterenol results in increased expression of CYSS mRNA]
CTD
PMID:9447264
NCBI chr 3:137,432,049...137,436,654
Ensembl chr 3:137,432,049...137,436,610
G
Dbh
dopamine beta-hydroxylase
decreases activity increases expression increases stability increases activity
EXP
Reserpine results in decreased activity of DBH protein Reserpine results in increased expression of DBH mRNA Reserpine results in increased stability of DBH protein Reserpine results in increased activity of DBH protein
CTD
PMID:1359376 PMID:2325165 PMID:7984052 PMID:8189248
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Ddc
dopa decarboxylase
increases expression
EXP
Reserpine results in increased expression of DDC mRNA
CTD
PMID:1359376
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Drd1
dopamine receptor D1
increases expression
EXP
Reserpine results in increased expression of DRD1 mRNA
CTD
PMID:8419537
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions increases expression
ISO EXP
DRD2 protein affects the susceptibility to [8-(3-chlorostyryl)caffeine co-treated with Reserpine] Reserpine results in increased expression of DRD2 mRNA; Reserpine results in increased expression of DRD2 mRNA alternative form
CTD
PMID:1331675 PMID:8419537 PMID:11172060
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Egr1
early growth response 1
multiple interactions increases expression
EXP
[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA; eticlopride inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA]; Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]] Reserpine results in increased expression of EGR1 mRNA; Reserpine results in increased expression of EGR1 protein
CTD
PMID:1347779 PMID:8063705 PMID:9729266 PMID:9890435
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Erbb2
erb-b2 receptor tyrosine kinase 2
increases response to substance
EXP
ERBB2 protein results in increased susceptibility to Reserpine
CTD
PMID:8093862
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Fabp7
fatty acid binding protein 7
affects expression
EXP
Reserpine affects the expression of FABP7 mRNA
CTD
PMID:18363858
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression increases phosphorylation
EXP
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine promotes the reaction [Reserpine results in increased expression of FOS protein]; 3,7-dimethyl-1-propargylxanthine inhibits the reaction [Reserpine results in increased expression of FOS protein]; 8-(3-chlorostyryl)caffeine promotes the reaction [Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]]; Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]; Quinpirole promotes the reaction [Reserpine results in increased expression of FOS protein]; Reserpine inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] results in increased expression of FOS protein]; Reserpine inhibits the reaction [Cocaine results in increased expression of FOS protein]; Reserpine promotes the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of FOS protein]; Reserpine promotes the reaction [Amphetamine results in increased expression of FOS protein]; Reserpine promotes the reaction [Quinpirole results in increased expression of FOS protein]; Theophylline inhibits the reaction [Reserpine results in increased expression of FOS protein] Reserpine results in increased expression of FOS mRNA; Reserpine results in increased expression of FOS protein Reserpine results in increased phosphorylation of FOS protein
CTD
PMID:1359376 PMID:1686849 PMID:2118661 PMID:7845612 PMID:7914358 PMID:8100600 PMID:8102797 PMID:8577368 PMID:8864302 PMID:9210518 More...
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gad1
glutamate decarboxylase 1
increases expression multiple interactions
EXP
Reserpine results in increased expression of GAD1 mRNA Clenbuterol inhibits the reaction [Reserpine results in increased expression of GAD1 mRNA]
CTD
PMID:8774452
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gal
galanin and GMAP prepropeptide
decreases expression increases expression multiple interactions
EXP
Reserpine results in decreased expression of GAL mRNA Reserpine results in increased expression of GAL mRNA Desipramine inhibits the reaction [Reserpine results in increased expression of GAL mRNA]
CTD
PMID:1279347 PMID:1698642 PMID:1705056 PMID:1717808 PMID:9512271 PMID:19598284 More...
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gast
gastrin
multiple interactions
EXP
Reserpine inhibits the reaction [Levodopa results in decreased cleavage of GAST protein]
CTD
PMID:10332097
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
G
Gch1
GTP cyclohydrolase 1
increases expression
EXP
Reserpine results in increased expression of GCH1 mRNA; Reserpine results in increased expression of GCH1 mRNA alternative form
CTD
PMID:8103077
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
Reserpine results in increased expression of GCNT3 mRNA
CTD
PMID:26198647
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gnai1
G protein subunit alpha i1
increases expression
EXP
Reserpine results in increased expression of GNAI1 protein
CTD
PMID:11264240
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
increases expression
EXP
Reserpine results in increased expression of GNAI2 mRNA; Reserpine results in increased expression of GNAI2 protein
CTD
PMID:8419537 PMID:11264240
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
increases expression
EXP
Reserpine results in increased expression of GNAI3 protein
CTD
PMID:11264240
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gnao1
G protein subunit alpha o1
increases expression
EXP
Reserpine results in increased expression of GNAO1 mRNA; Reserpine results in increased expression of GNAO1 protein
CTD
PMID:8419537 PMID:11264240
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
G
Gnas
GNAS complex locus
increases expression decreases expression
EXP
Reserpine results in increased expression of GNAS mRNA; Reserpine results in increased expression of GNAS protein Reserpine results in decreased expression of GNAS protein alternative form
CTD
PMID:1336118 PMID:8419537 PMID:11264240
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Grm5
glutamate metabotropic receptor 5
decreases expression increases expression
EXP
Reserpine results in decreased expression of GRM5 mRNA Reserpine results in increased expression of GRM5 protein
CTD
PMID:16890937
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
G
Hgf
hepatocyte growth factor
increases expression
EXP
Reserpine results in increased expression of HGF protein
CTD
PMID:16081063
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hspg2
heparan sulfate proteoglycan 2
multiple interactions
ISO
HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine]
CTD
PMID:20072119
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
G
Htr1a
5-hydroxytryptamine receptor 1A
decreases expression
ISO
Reserpine results in decreased expression of HTR1A protein
CTD
PMID:26114099
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Iapp
islet amyloid polypeptide
multiple interactions
EXP
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein]
CTD
PMID:19463876
NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
G
Il10
interleukin 10
decreases expression multiple interactions
ISO
Reserpine results in decreased expression of IL10 mRNA; Reserpine results in decreased expression of IL10 protein SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 mRNA]; SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 protein]
CTD
PMID:16985181
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
increases expression
EXP
Reserpine results in increased expression of IL18 mRNA
CTD
PMID:8999896
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Reserpine results in increased expression of JUN mRNA
CTD
PMID:1359376
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]]
CTD
PMID:1347779
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcna3
potassium voltage-gated channel subfamily A member 3
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of KCNA3 protein [Reserpine results in decreased activity of KCNA3 protein] which results in decreased import of Thallium
CTD
PMID:21362439
NCBI chr 2:194,632,106...194,634,059
Ensembl chr 2:194,632,196...194,650,138
G
Kcna5
potassium voltage-gated channel subfamily A member 5
increases expression
EXP
Reserpine results in increased expression of KCNA5 mRNA
CTD
PMID:12606256
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcnd2
potassium voltage-gated channel subfamily D member 2
decreases expression
EXP
Reserpine results in decreased expression of KCND2 mRNA
CTD
PMID:12606256
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
G
Kcnd3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
Reserpine results in decreased expression of KCND3 mRNA
CTD
PMID:12606256
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of KCNH2 protein [Reserpine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium
CTD
PMID:21362439 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lep
leptin
increases expression
ISO
Reserpine results in increased expression of LEP mRNA
CTD
PMID:10050748
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases response to substance decreases expression
ISO
MYC protein results in increased susceptibility to Reserpine Reserpine results in decreased expression of MYC protein
CTD
PMID:8093862 PMID:19607803
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncf1
neutrophil cytosolic factor 1
increases expression
EXP
Reserpine results in increased expression of NCF1 mRNA; Reserpine results in increased expression of NCF1 protein
CTD
PMID:20964730
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Reserpine results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ngf
nerve growth factor
increases expression
EXP
Reserpine results in increased expression of NGF mRNA; Reserpine results in increased expression of NGF protein
CTD
PMID:1996081 PMID:8593794
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nos1
nitric oxide synthase 1
increases expression
EXP
Reserpine results in increased expression of NOS1 mRNA; Reserpine results in increased expression of NOS1 protein
CTD
PMID:7533141
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Npy
neuropeptide Y
multiple interactions increases expression decreases expression
EXP
Chlorisondamine inhibits the reaction [Reserpine results in increased expression of NPY mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of NPY mRNA]; Dexamethasone inhibits the reaction [Reserpine results in increased expression of NPY mRNA] Reserpine results in increased expression of NPY mRNA; Reserpine results in increased expression of NPY protein Reserpine results in decreased expression of NPY mRNA; Reserpine results in decreased expression of NPY protein
CTD
PMID:1671012 PMID:1676830 PMID:1687976 PMID:1698642 PMID:1713314 PMID:1714554 PMID:1878751 PMID:1907749 PMID:2233698 PMID:2897091 PMID:2903502 PMID:3215285 PMID:3805164 PMID:7644023 PMID:7911764 PMID:8189248 PMID:20504635 More...
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:17041008
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions decreases activity
ISO
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA Reserpine results in decreased activity of NR1I3 protein
CTD
PMID:17041008 PMID:30203046
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
EXP
Reserpine results in increased expression of NR3C1 mRNA
CTD
PMID:7984052
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
arsenic trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein]
CTD
PMID:26114099
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Nts
neurotensin
increases expression
EXP
Reserpine results in increased expression of NTS mRNA
CTD
PMID:1850078
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Odc1
ornithine decarboxylase 1
decreases expression multiple interactions
EXP ISO
Reserpine results in decreased expression of ODC1 protein Reserpine inhibits the reaction [CB 3717 results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [CB 3717 results in increased expression of ODC1 mRNA]; Reserpine inhibits the reaction [Testosterone results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [Testosterone results in increased expression of ODC1 mRNA]
CTD
PMID:6519379 PMID:9194572 PMID:10354516 PMID:17371283
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Pam
peptidylglycine alpha-amidating monooxygenase
increases expression
EXP
Reserpine results in increased expression of PAM mRNA
CTD
PMID:8189248
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein
CTD
PMID:11318962
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
increases expression
EXP
Reserpine results in increased expression of PCSK2 mRNA
CTD
PMID:8189248
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Penk
proenkephalin
multiple interactions increases expression decreases expression
EXP
Apomorphine inhibits the reaction [Reserpine results in increased expression of PENK mRNA] Reserpine results in increased expression of PENK mRNA; Reserpine results in increased expression of PENK protein Reserpine results in decreased expression of PENK mRNA
CTD
PMID:1331675 PMID:1850078 PMID:3188958 PMID:3838946 PMID:4078631 PMID:7494455 PMID:17719177 More...
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Pnmt
phenylethanolamine-N-methyltransferase
multiple interactions increases expression decreases expression
EXP
Chlorisondamine inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Dexamethasone inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Reserpine results in increased expression of and results in increased activity of PNMT protein Reserpine results in increased expression of PNMT mRNA
CTD
PMID:1359376 PMID:1687976 PMID:1714554 PMID:2903502 PMID:8063705 PMID:8479280 PMID:20504635 More...
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
G
Pomc
proopiomelanocortin
increases expression multiple interactions
EXP
Reserpine results in increased expression of POMC mRNA; Reserpine results in increased expression of POMC protein alternative form POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]
CTD
PMID:8479280 PMID:20504635
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
ISO
Reserpine results in decreased expression of PRKACA protein
CTD
PMID:26114099
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prl
prolactin
increases expression
EXP
Reserpine results in increased expression of PRL protein
CTD
PMID:11071396
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prss1
serine protease 1
decreases expression increases expression
EXP
Reserpine results in decreased expression of PRSS1 protein Reserpine results in increased expression of PRSS1 protein
CTD
PMID:8625754
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Reserpine results in increased expression of PTGS2 protein
CTD
PMID:16081063
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pts
6-pyruvoyl-tetrahydropterin synthase
increases expression
EXP
Reserpine results in increased expression of PTS mRNA
CTD
PMID:7545485
NCBI chr 8:50,870,838...50,877,869
Ensembl chr 8:50,870,841...50,877,869
G
Rasd2
RASD family, member 2
decreases expression
EXP
Reserpine results in decreased expression of RASD2 mRNA
CTD
PMID:16352400
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
G
Rgs10
regulator of G-protein signaling 10
decreases expression
EXP
Reserpine results in decreased expression of RGS10 mRNA
CTD
PMID:14505795
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
decreases expression
EXP
Reserpine results in decreased expression of RGS2 mRNA
CTD
PMID:14505795
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs4
regulator of G-protein signaling 4
decreases expression
EXP
Reserpine results in decreased expression of RGS4 mRNA
CTD
PMID:14505795
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs5
regulator of G-protein signaling 5
decreases expression
EXP
Reserpine results in decreased expression of RGS5 mRNA
CTD
PMID:14505795
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
G
Rgs8
regulator of G-protein signaling 8
decreases expression
EXP
Reserpine results in decreased expression of RGS8 mRNA
CTD
PMID:14505795
NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807
G
Rgs9
regulator of G-protein signaling 9
affects response to substance decreases expression
ISO EXP
RGS9 affects the susceptibility to Reserpine Reserpine results in decreased expression of RGS9 mRNA
CTD
PMID:14505795 PMID:15728856
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
G
Scg2
secretogranin II
increases expression
EXP
Reserpine results in increased expression of SCG2 mRNA
CTD
PMID:1907749 PMID:8189248 PMID:8361347
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
G
Serpine1
serpin family E member 1
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein
CTD
PMID:11318962
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Siah1
siah E3 ubiquitin protein ligase 1
increases expression
ISO
Reserpine results in increased expression of SIAH1 mRNA
CTD
PMID:19607803
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Slc18a1
solute carrier family 18 member A1
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of SLC18A1 protein Reserpine inhibits the reaction [SLC18A1 protein results in increased uptake of Serotonin]
CTD
PMID:8245983 PMID:21712771
NCBI chr16:20,653,268...20,687,051
Ensembl chr16:20,653,508...20,687,051
G
Slc18a2
solute carrier family 18 member A2
affects binding multiple interactions decreases activity increases expression affects response to substance decreases response to substance
ISO EXP
Reserpine binds to SLC18A2 protein Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] Reserpine results in decreased activity of SLC18A2 protein SLC18A2 protein binds to Reserpine Reserpine results in increased expression of SLC18A2 mRNA SLC18A2 affects the susceptibility to Reserpine Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin]; Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] SLC18A2 gene SNP results in decreased susceptibility to Reserpine
CTD
PMID:1438304 PMID:7912402 PMID:8189248 PMID:9038139 PMID:15475732 PMID:17664021 PMID:18287335 PMID:29908239 PMID:33378168 More...
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc6a2
solute carrier family 6 member 2
decreases expression
EXP
Reserpine results in decreased expression of SLC6A2 mRNA
CTD
PMID:7478180 PMID:7616203
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
G
Slc6a3
solute carrier family 6 member 3
decreases activity affects response to substance
ISO
Reserpine results in decreased activity of SLC6A3 protein SLC6A3 gene mutant form affects the susceptibility to Reserpine
CTD
PMID:17664021 PMID:19615345
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
decreases expression
EXP
Reserpine results in decreased expression of SLC6A4 mRNA
CTD
PMID:10027743
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Snca
synuclein alpha
affects response to substance increases expression multiple interactions
ISO EXP
SNCA protein mutant form affects the susceptibility to Reserpine Reserpine results in increased expression of SNCA protein [Levodopa co-treated with Carbidopa] inhibits the reaction [Reserpine results in increased expression of SNCA protein]; Dextromethorphan promotes the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; Glutamic Acid inhibits the reaction [zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]]; zolmitriptan inhibits the reaction [Reserpine results in increased expression of SNCA protein]
CTD
PMID:18622040 PMID:38229316
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sqstm1
sequestosome 1
increases expression
ISO
Reserpine results in increased expression of SQSTM1 mRNA
CTD
PMID:26198647
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Syt7
synaptotagmin 7
multiple interactions
EXP
[Reserpine co-treated with Apomorphine] results in increased expression of SYT7 mRNA
CTD
PMID:17719177
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Tac1
tachykinin, precursor 1
multiple interactions increases expression
EXP
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine co-treated with Quinpirole] results in increased expression of TAC1 mRNA; [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine] results in increased expression of TAC1 mRNA; Apomorphine promotes the reaction [Reserpine results in increased expression of TAC1 mRNA]
CTD
PMID:9751140 PMID:17719177
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tff1
trefoil factor 1
increases expression
ISO
Reserpine results in increased expression of TFF1 mRNA
CTD
PMID:35307500
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Th
tyrosine hydroxylase
increases expression increases activity decreases expression affects activity increases stability multiple interactions
ISO EXP
Reserpine results in increased expression of TH mRNA Reserpine results in increased activity of TH protein Reserpine results in increased expression of TH mRNA; Reserpine results in increased expression of TH protein Reserpine results in decreased expression of TH mRNA Reserpine affects the activity of TH protein Reserpine results in increased stability of TH mRNA Bicuculline promotes the reaction [Reserpine affects the activity of TH protein]; Bicuculline promotes the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of TH mRNA]; Desipramine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Reserpine promotes the reaction [CREM protein binds to TH promoter]; Reserpine results in increased expression of and results in increased activity of TH protein
CTD
PMID:1350653 PMID:1359376 PMID:1676830 PMID:1687822 PMID:1687976 PMID:1698642 PMID:1705056 PMID:1714554 PMID:1717808 PMID:1970845 PMID:1976760 PMID:1978789 PMID:1981253 PMID:2568627 PMID:2862954 PMID:2863328 PMID:2872048 PMID:2881815 PMID:2882513 PMID:2883324 PMID:2903502 PMID:7478180 PMID:7532593 PMID:7545485 PMID:7616203 PMID:7911764 PMID:8369965 PMID:8666980 PMID:9210518 PMID:9691425 PMID:11161478 PMID:11438978 PMID:20504635 More...
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
increases expression multiple interactions
EXP
Reserpine results in increased expression of TNF protein cerebrolysin inhibits the reaction [Reserpine results in increased expression of TNF protein]; Fluoxetine inhibits the reaction [Reserpine results in increased expression of TNF protein]
CTD
PMID:33279466
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions increases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein]
CTD
PMID:19463876
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tph1
tryptophan hydroxylase 1
increases activity decreases activity
EXP
Reserpine results in increased activity of TPH1 protein Reserpine results in decreased activity of TPH1 protein
CTD
PMID:8369965
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Vgf
VGF nerve growth factor inducible
increases expression
EXP
Reserpine results in increased expression of VGF mRNA
CTD
PMID:8189248
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
G
Vip
vasoactive intestinal peptide
increases expression
EXP
Reserpine results in increased expression of VIP mRNA
CTD
PMID:1850078
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Casp3
caspase 3
increases expression
EXP
Strychnine results in increased expression of CASP3 mRNA
CTD
PMID:19815060
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Chrm2
cholinergic receptor, muscarinic 2
affects binding multiple interactions
ISO
Strychnine binds to CHRM2 protein Strychnine promotes the reaction [N-Methylscopolamine binds to CHRM2 protein]
CTD
PMID:9495826 PMID:15647330
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chrm3
cholinergic receptor, muscarinic 3
affects binding
EXP ISO
Strychnine binds to CHRM3 protein
CTD
PMID:12435818 PMID:15647330
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Chrm4
cholinergic receptor, muscarinic 4
multiple interactions
ISO
Strychnine promotes the reaction [N-Methylscopolamine binds to CHRM4 protein]
CTD
PMID:9495826
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions
EXP
Strychnine results in increased expression of and results in increased degradation of CYP2B1 protein
CTD
PMID:7906730
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
Strychnine results in increased expression of CYP2B2 protein
CTD
PMID:7906730
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
multiple interactions
EXP
[Strychnine co-treated with Ketoconazole] results in decreased expression of CYP3A23-3A1 protein; [Strychnine co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:35358606
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Gfap
glial fibrillary acidic protein
increases expression
EXP
Strychnine results in increased expression of GFAP mRNA
CTD
PMID:22954530
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Glra1
glycine receptor, alpha 1
multiple interactions decreases activity
ISO EXP
Strychnine analog binds to and results in decreased activity of GLRA1 protein; Strychnine binds to and results in decreased activity of GLRA1 protein; Strychnine promotes the reaction [Genistein results in decreased activity of GLRA1 protein]; Strychnine promotes the reaction [Quercetin results in decreased activity of GLRA1 protein] Strychnine results in decreased activity of GLRA1 protein Genistein promotes the reaction [Strychnine results in decreased activity of GLRA1 protein]; Quercetin promotes the reaction [Strychnine results in decreased activity of GLRA1 protein]
CTD
PMID:7752562 PMID:15081878 PMID:16687139 PMID:20719748
NCBI chr10:39,625,853...39,727,897
Ensembl chr10:39,629,459...39,727,162
G
Glra2
glycine receptor, alpha 2
decreases activity
EXP
Strychnine results in decreased activity of GLRA2 protein
CTD
PMID:7752562
NCBI chr X:29,020,377...29,241,666
Ensembl chr X:29,020,557...29,241,666
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Strychnine inhibits the reaction [NAD inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased secretion of IL1B protein]]
CTD
PMID:29642561
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Strychnine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Scn5a
sodium voltage-gated channel alpha subunit 5
multiple interactions
ISO
Strychnine binds to and results in decreased activity of SCN5A protein
CTD
PMID:21616062
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Strychnine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
syrosingopine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Abca2
ATP binding cassette subfamily A member 2
decreases response to substance increases expression
ISO
ABCA2 mRNA results in decreased susceptibility to Vinblastine Vinblastine results in increased expression of ABCA2 mRNA
CTD
PMID:16928819
NCBI chr 3:8,244,515...8,264,545
Ensembl chr 3:8,244,639...8,264,537
G
Abca3
ATP binding cassette subfamily A member 3
decreases response to substance increases expression
ISO
ABCA3 mRNA results in decreased susceptibility to Vinblastine Vinblastine results in increased expression of ABCA3 mRNA
CTD
PMID:16928819
NCBI chr10:13,382,439...13,439,748
Ensembl chr10:13,382,540...13,439,745
G
Abcb11
ATP binding cassette subfamily B member 11
decreases uptake decreases activity multiple interactions increases export
ISO
ABCB11 protein results in decreased uptake of Vinblastine Vinblastine results in decreased activity of ABCB11 protein Vinblastine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] ABCB11 protein results in increased export of Vinblastine
CTD
PMID:10617675 PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases response to substance increases secretion increases activity increases expression affects binding multiple interactions affects uptake increases transport
ISO EXP
ABCB1 protein results in decreased susceptibility to Vinblastine ABCB1A protein results in increased secretion of Vinblastine Vinblastine results in increased activity of ABCB1 protein mutant form Vinblastine results in increased expression of ABCB1 protein Vinblastine binds to ABCB1 protein [Carvedilol inhibits the reaction [ABCB1 protein results in increased transport of Vinblastine]] which results in decreased susceptibility to Vinblastine; [Elacridar binds to and results in decreased activity of ABCB1 protein] which results in decreased export of Vinblastine; [Glycyrrhetinic Acid affects the activity of ABCB1 protein] which affects the susceptibility to Vinblastine; [sodium arsenite results in increased expression of ABCB1 protein] which results in decreased susceptibility to Vinblastine; [Vinblastine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; Amiodarone inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Carvedilol inhibits the reaction [ABCB1 protein results in increased transport of Vinblastine]; Clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; cnidiadin inhibits the reaction [ABCB1 protein results in increased export of Vinblastine]; Curcumin analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vinblastine]; Curcumin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vinblastine]; Cyclosporine inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Diazinon affects the reaction [ABCB1 protein results in increased transport of Vinblastine]; Erythromycin inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Ketoconazole inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Miconazole inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; NR1I2 protein promotes the reaction [Vinblastine results in increased expression of ABCB1 protein]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Sesquiterpenes analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vinblastine]; Troleandomycin inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein affects the uptake of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Vinblastine]; Vinblastine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]
CTD
PMID:1967174 PMID:8917702 PMID:9148857 PMID:11355955 PMID:11455017 PMID:12235267 PMID:12708479 PMID:12711602 PMID:15466210 PMID:15640379 PMID:15725475 PMID:15824923 PMID:16221533 PMID:17284363 PMID:18204840 PMID:20041327 PMID:23976943 PMID:26689174 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases secretion
EXP
ABCB1B protein results in increased secretion of Vinblastine
CTD
PMID:12235267
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc1
ATP binding cassette subfamily C member 1
affects response to substance decreases response to substance
ISO EXP
ABCC1 protein affects the susceptibility to Vinblastine ABCC1 protein results in decreased susceptibility to Vinblastine
CTD
PMID:9334814 PMID:11455017 PMID:16156793
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
affects transport decreases response to substance multiple interactions
ISO EXP
ABCC2 protein affects the transport of Vinblastine ABCC2 protein results in decreased susceptibility to Vinblastine [isopropyl 5,12-hydroxypentadeca-8,10-dien-6,14-diynoate results in decreased activity of ABCC2 protein] which results in increased uptake of Vinblastine; [verlukast results in decreased activity of ABCC2 protein] which results in increased uptake of Vinblastine; Probenecid promotes the reaction [ABCC2 protein affects the transport of Vinblastine]
CTD
PMID:9525973 PMID:11455017 PMID:15849751 PMID:25844889
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Ablim1
actin-binding LIM protein 1
affects response to substance
ISO
ABLIM1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969
G
Acat2
acetyl-CoA acetyltransferase 2
affects response to substance
ISO
ACAT2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acot13
acyl-CoA thioesterase 13
affects response to substance
ISO
ACOT13 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
G
Acp1
acid phosphatase 1
affects response to substance
ISO
ACP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
G
Add3
adducin 3
affects response to substance
ISO
ADD3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Aif1
allograft inflammatory factor 1
decreases expression
EXP
Vinblastine results in decreased expression of AIF1 mRNA
CTD
PMID:20624997
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Ak1
adenylate kinase 1
decreases expression
EXP
Vinblastine results in decreased expression of AK1 mRNA
CTD
PMID:20624997
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Aox1
aldehyde oxidase 1
affects response to substance
ISO
AOX1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Apln
apelin
decreases expression
EXP
Vinblastine results in decreased expression of APLN mRNA
CTD
PMID:20624997
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Atp5me
ATP synthase membrane subunit e
affects response to substance
ISO
ATP5ME protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
G
Atp5mf
ATP synthase membrane subunit f
affects response to substance
ISO
ATP5MF protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
G
Aurkb
aurora kinase B
affects response to substance
ISO
AURKB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Axl
Axl receptor tyrosine kinase
affects response to substance
ISO
AXL protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
Birc2
baculoviral IAP repeat-containing 2
affects response to substance
ISO
BIRC2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
affects response to substance
ISO
BIRC3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc7
baculoviral IAP repeat-containing 7
decreases response to substance
ISO
BIRC7 protein results in decreased susceptibility to Vinblastine
CTD
PMID:17437058
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
affects response to substance
ISO
BUB1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
C10h5orf15
similar to human chromosome 5 open reading frame 15
affects response to substance
ISO
C5ORF15 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:36,563,989...36,576,593
Ensembl chr10:36,563,958...36,576,590
G
Casp3
caspase 3
increases cleavage multiple interactions
EXP ISO
Vinblastine results in increased cleavage of CASP3 protein CD40LG protein inhibits the reaction [Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]
CTD
PMID:16545138 PMID:20624997
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
affects response to substance
ISO
CAT protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
increases expression
EXP
Vinblastine results in increased expression of CCL2 mRNA
CTD
PMID:20624997
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccn2
cellular communication network factor 2
affects response to substance
ISO
CCN2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnb1
cyclin B1
affects response to substance increases response to substance
ISO
CCNB1 protein affects the susceptibility to Vinblastine CCNB1 protein results in increased susceptibility to Vinblastine
CTD
PMID:16217747 PMID:16849574
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
affects response to substance
ISO
CCNB2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Cd14
CD14 molecule
increases expression
EXP
Vinblastine results in increased expression of CD14 mRNA
CTD
PMID:20624997
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40lg
CD40 ligand
decreases response to substance multiple interactions
ISO
CD40LG protein results in decreased susceptibility to Vinblastine CD40LG protein inhibits the reaction [Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]
CTD
PMID:16545138
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd44
CD44 molecule
increases expression
EXP
Vinblastine results in increased expression of CD44 mRNA
CTD
PMID:20624997
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdca8
cell division cycle associated 8
affects response to substance
ISO
CDCA8 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdk1
cyclin-dependent kinase 1
affects response to substance
ISO
CDK1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
affects response to substance
ISO
CDK2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
Vinblastine results in increased expression of CDKN1A mRNA
CTD
PMID:20624997
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
affects response to substance
ISO
CDKN2C protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
Vinblastine results in decreased expression of CDKN3 mRNA
CTD
PMID:20624997
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cenpa
centromere protein A
affects response to substance
ISO
CENPA protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Ckap2
cytoskeleton associated protein 2
affects response to substance
ISO
CKAP2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Cox17
cytochrome c oxidase copper chaperone COX17
affects response to substance
ISO
COX17 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr11:62,400,733...62,406,507
G
Cox5a
cytochrome c oxidase subunit 5A
affects response to substance
ISO
COX5A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
G
Cox6b1
cytochrome c oxidase subunit 6B1
affects response to substance
ISO
COX6B1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001
G
Cp
ceruloplasmin
increases expression
EXP
Vinblastine results in increased expression of CP mRNA
CTD
PMID:20624997
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Creg1
cellular repressor of E1A-stimulated genes 1
affects response to substance
ISO
CREG1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
G
Cript
CXXC repeat containing interactor of PDZ3 domain
affects response to substance
ISO
CRIPT protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:7,581,428...7,589,384
Ensembl chr 6:7,580,703...7,589,399
G
Ctss
cathepsin S
increases expression
EXP
Vinblastine results in increased expression of CTSS mRNA
CTD
PMID:20624997
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Vinblastine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:11602686
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dcps
decapping enzyme, scavenger
affects response to substance
ISO
DCPS protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:33,468,669...33,524,407
Ensembl chr 8:33,415,671...33,524,389
G
Ddx23
DEAD-box helicase 23
affects response to substance
ISO
DDX23 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
G
Dera
deoxyribose-phosphate aldolase
affects response to substance
ISO
DERA protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865
G
Dffb
DNA fragmentation factor subunit beta
affects response to substance
ISO
DFFB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dipk1a
divergent protein kinase domain 1A
affects response to substance
ISO
DIPK1A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
affects response to substance
ISO
DKK1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dkk3
dickkopf WNT signaling pathway inhibitor 3
affects response to substance
ISO
DKK3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:166,237,969...166,281,271
Ensembl chr 1:166,238,238...166,280,590
G
Donson
DNA replication fork stabilization factor DONSON
affects response to substance
ISO
DONSON protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dscc1
DNA replication and sister chromatid cohesion 1
affects response to substance
ISO
DSCC1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
E2f1
E2F transcription factor 1
increases response to substance
ISO
E2F1 protein results in increased susceptibility to Vinblastine
CTD
PMID:16849574
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Ednrb
endothelin receptor type B
increases expression
EXP
Vinblastine results in increased expression of EDNRB mRNA
CTD
PMID:20624997
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Efcab7
EF-hand calcium binding domain 7
affects response to substance
ISO
EFCAB7 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:114,525,403...114,576,130
Ensembl chr 5:114,525,167...114,576,129
G
Emp2
epithelial membrane protein 2
affects response to substance
ISO
EMP2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
G
Epcam
epithelial cell adhesion molecule
affects response to substance
ISO
EPCAM protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
EXP
Vinblastine results in increased expression of EPRS1 mRNA
CTD
PMID:20624997
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Erbb2
erb-b2 receptor tyrosine kinase 2
affects response to substance
ISO
ERBB2 protein affects the susceptibility to Vinblastine
CTD
PMID:10327070
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Ereg
epiregulin
affects response to substance
ISO
EREG protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Esm1
endothelial cell-specific molecule 1
decreases expression
EXP
Vinblastine results in decreased expression of ESM1 mRNA
CTD
PMID:20624997
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Etfb
electron transfer flavoprotein subunit beta
affects response to substance
ISO
ETFB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
G
Exosc9
exosome component 9
affects response to substance
ISO
EXOSC9 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:119,416,028...119,426,981
Ensembl chr 2:119,388,715...119,427,051
G
F3
coagulation factor III, tissue factor
increases expression
EXP
Vinblastine results in increased expression of F3 mRNA
CTD
PMID:20624997
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fam3c
FAM3 metabolism regulating signaling molecule C
affects response to substance
ISO
FAM3C protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
G
Fancl
FA complementation group L
affects response to substance
ISO
FANCL protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:100,249,733...100,317,958
Ensembl chr14:100,248,875...100,314,255
G
Faslg
Fas ligand
increases expression
ISO
Vinblastine results in increased expression of FASLG protein
CTD
PMID:11716366
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Vinblastine results in increased expression of FCGR2B mRNA
CTD
PMID:20624997
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fen1
flap structure-specific endonuclease 1
affects response to substance
ISO
FEN1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fkbp1a
FKBP prolyl isomerase 1A
affects response to substance
ISO
FKBP1A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Fli1
Fli-1 proto-oncogene, ETS transcription factor
affects response to substance
ISO
FLI1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
G
Fn1
fibronectin 1
affects response to substance
ISO
FN1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
affects response to substance
ISO
FOSL1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
G0s2
G0/G1switch 2
affects response to substance
ISO
G0S2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
Vinblastine results in increased expression of GADD45A mRNA
CTD
PMID:20624997
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
EXP
Vinblastine results in increased expression of GADD45B mRNA
CTD
PMID:20624997
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
EXP
Vinblastine results in increased expression of GADD45G mRNA
CTD
PMID:20624997
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Gas7
growth arrest specific 7
decreases expression
EXP
Vinblastine results in decreased expression of GAS7 mRNA
CTD
PMID:20624997
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
G
Ggct
gamma-glutamyl cyclotransferase
affects response to substance
ISO
GGCT protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:84,122,921...84,129,327
Ensembl chr 4:84,123,118...84,129,277
G
Ggcx
gamma-glutamyl carboxylase
affects response to substance
ISO
GGCX protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
G
Gmnn
geminin, DNA replication inhibitor
affects response to substance
ISO
GMNN protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gnptab
N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
affects response to substance
ISO
GNPTAB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:22,800,502...22,866,336
Ensembl chr 7:22,800,485...22,866,933
G
Gpr176
G protein-coupled receptor 176
affects response to substance
ISO
GPR176 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
G
Gpsm2
G-protein signaling modulator 2
affects response to substance
ISO
GPSM2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
G
Gstp1
glutathione S-transferase pi 1
decreases response to substance
EXP
GSTP1 protein results in decreased susceptibility to Vinblastine
CTD
PMID:11455017
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf2i
general transcription factor II I
affects response to substance
ISO
GTF2I protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Gtf3a
general transcription factor III A
affects response to substance
ISO
GTF3A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
G
Gtse1
G-2 and S-phase expressed 1
affects response to substance
ISO
GTSE1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
G
Gusb
glucuronidase, beta
affects response to substance
ISO
GUSB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
H1f2
H1.2 linker histone, cluster member
affects response to substance
ISO
H1-2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
Hadh
hydroxyacyl-CoA dehydrogenase
affects response to substance
ISO
HADH protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hcls1
hematopoietic cell specific Lyn substrate 1
affects response to substance
ISO
HCLS1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
G
Hmgb1
high mobility group box 1
affects response to substance
ISO
HMGB1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgb2
high mobility group box 2
affects response to substance
ISO
HMGB2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgn3
high mobility group nucleosomal binding domain 3
affects response to substance
ISO
HMGN3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hmmr
hyaluronan-mediated motility receptor
affects response to substance
ISO
HMMR protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
increases expression
EXP
Vinblastine results in increased expression of HMOX1 mRNA
CTD
PMID:20624997
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Homer1
homer scaffold protein 1
affects response to substance
ISO
HOMER1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Icam1
intercellular adhesion molecule 1
increases expression decreases expression
EXP ISO
Vinblastine results in increased expression of ICAM1 mRNA Vinblastine results in decreased expression of ICAM1 mRNA; Vinblastine results in decreased expression of ICAM1 protein
CTD
PMID:12649748 PMID:20624997
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id2
inhibitor of DNA binding 2
affects response to substance
ISO
ID2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
affects response to substance
ISO
IDH2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
affects response to substance
ISO
IGF2BP3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
increases phosphorylation multiple interactions
ISO
Vinblastine results in increased phosphorylation of IKBKB protein Vinblastine results in decreased localization of [IKBKB protein binds to NFKBIA protein]
CTD
PMID:17029595
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il13ra2
interleukin 13 receptor subunit alpha 2
affects response to substance
ISO
IL13RA2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il1b
interleukin 1 beta
affects response to substance increases expression
ISO EXP
IL1B protein affects the susceptibility to Vinblastine Vinblastine results in increased expression of IL1B mRNA
CTD
PMID:16217747 PMID:20624997
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases chemical synthesis increases stability
ISO
Vinblastine results in decreased chemical synthesis of IL6 protein Vinblastine results in increased stability of IL6 mRNA
CTD
PMID:16499908
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inha
inhibin subunit alpha
decreases expression
EXP
Vinblastine results in decreased expression of INHA mRNA
CTD
PMID:20624997
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhba
inhibin subunit beta A
affects response to substance
ISO
INHBA protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Itgal
integrin subunit alpha L
decreases expression
ISO
Vinblastine results in decreased expression of ITGAL mRNA; Vinblastine results in decreased expression of ITGAL protein
CTD
PMID:12649748
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgb1bp1
integrin subunit beta 1 binding protein 1
affects response to substance
ISO
ITGB1BP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases phosphorylation
ISO
TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of JUN protein]
CTD
PMID:12221076
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kank1
KN motif and ankyrin repeat domains 1
affects response to substance
ISO
KANK1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kazn
kazrin, periplakin interacting protein
affects response to substance
ISO
KAZN protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074
G
Kif11
kinesin family member 11
affects response to substance
ISO
KIF11 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Kif15
kinesin family member 15
affects response to substance
ISO
KIF15 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif1b
kinesin family member 1B
affects response to substance
ISO
KIF1B protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
G
Kif20a
kinesin family member 20A
affects response to substance
ISO
KIF20A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif23
kinesin family member 23
affects response to substance
ISO
KIF23 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif4a
kinesin family member 4A
affects response to substance
ISO
KIF4A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kpna2
karyopherin subunit alpha 2
affects response to substance
ISO
KPNA2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Lmnb1
lamin B1
affects response to substance
ISO
LMNB1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lpar1
lysophosphatidic acid receptor 1
affects response to substance
ISO
LPAR1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Lrrc1
leucine rich repeat containing 1
affects response to substance
ISO
LRRC1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
G
Lsm7
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
affects response to substance
ISO
LSM7 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:8,856,698...8,859,113
Ensembl chr 7:8,856,489...8,859,119
G
Ltbp2
latent transforming growth factor beta binding protein 2
affects response to substance
ISO
LTBP2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Mad2l1
mitotic arrest deficient 2 like 1
affects response to substance
ISO
MAD2L1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
Vinblastine results in increased phosphorylation of MAPK8 protein TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK8 protein]
CTD
PMID:12221076
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO
TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein]
CTD
PMID:12221076
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapkapk5
MAPK activated protein kinase 5
affects response to substance
ISO
MAPKAPK5 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052
G
Melk
maternal embryonic leucine zipper kinase
affects response to substance
ISO
MELK protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
G
Mme
membrane metallo-endopeptidase
affects response to substance
ISO
MME protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp1
matrix metallopeptidase 1
affects response to substance
ISO
MMP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mok
MOK protein kinase
affects response to substance
ISO
MOK protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mrpl57
mitochondrial ribosomal protein L57
affects response to substance
ISO
MRPL57 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:31,970,904...31,971,766
Ensembl chr15:31,970,860...31,973,993
G
Myc
MYC proto-oncogene, bHLH transcription factor
affects response to substance increases expression
ISO EXP
MYC protein affects the susceptibility to Vinblastine Vinblastine results in increased expression of MYC mRNA
CTD
PMID:18802399 PMID:20624997
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycbp
Myc binding protein
affects response to substance
ISO
MYCBP protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
G
Nbn
nibrin
increases expression
EXP
Vinblastine results in increased expression of NBN mRNA
CTD
PMID:20624997
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Ncapg
non-SMC condensin I complex, subunit G
affects response to substance
ISO
NCAPG protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncaph
non-SMC condensin I complex, subunit H
affects response to substance
ISO
NCAPH protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ndc80
NDC80 kinetochore complex component
affects response to substance
ISO
NDC80 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndufa1
NADH:ubiquinone oxidoreductase subunit A1
affects response to substance
ISO
NDUFA1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:116,424,223...116,427,875
Ensembl chr X:116,424,223...116,428,633
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
affects response to substance
ISO
NDUFA13 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
affects response to substance
ISO
NDUFA3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
affects response to substance
ISO
NDUFA7 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
affects response to substance
ISO
NDUFB2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
G
Ndufc1
NADH:ubiquinone oxidoreductase subunit C1
affects response to substance
ISO
NDUFC1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
G
Ndufc2
NADH:ubiquinone oxidoreductase subunit C2
affects response to substance
ISO
NDUFC2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:151,711,965...151,718,188
Ensembl chr 1:151,711,901...151,718,189
G
Ndufs6
NADH:ubiquinone oxidoreductase subunit S6
affects response to substance
ISO
NDUFS6 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
affects response to substance
ISO
NDUFV2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
G
Nfatc4
nuclear factor of activated T-cells 4
decreases localization
ISO
Vinblastine results in decreased localization of NFATC4 protein
CTD
PMID:17044076
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nfkbia
NFKB inhibitor alpha
increases phosphorylation multiple interactions
ISO
Vinblastine results in increased phosphorylation of NFKBIA protein Vinblastine results in decreased localization of [IKBKB protein binds to NFKBIA protein]
CTD
PMID:17029595
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Ngf
nerve growth factor
decreases response to substance
EXP
Vinblastine results in decreased susceptibility to NGF protein
CTD
PMID:9524088
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Npy
neuropeptide Y
decreases expression
EXP
Vinblastine results in decreased expression of NPY mRNA
CTD
PMID:1671012
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
Vinblastine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases activity
ISO
[Vinblastine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; NR1I2 protein promotes the reaction [Vinblastine results in increased expression of ABCB1 protein]
CTD
PMID:20041327
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nsmaf
neutral sphingomyelinase activation associated factor
affects response to substance
ISO
NSMAF protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 5:19,517,795...19,578,773
Ensembl chr 5:19,518,348...19,577,627
G
Nudt15
nudix hydrolase 15
affects response to substance
ISO
NUDT15 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:48,707,776...48,713,847
Ensembl chr15:48,709,700...48,747,363
G
Nudt4
nudix hydrolase 4
affects response to substance
ISO
NUDT4 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615
G
Nusap1
nucleolar and spindle associated protein 1
affects response to substance
ISO
NUSAP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Oaz1
ornithine decarboxylase antizyme 1
affects response to substance
ISO
OAZ1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310
G
Odc1
ornithine decarboxylase 1
multiple interactions
ISO
Vinblastine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]
CTD
PMID:9270009
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Oip5
Opa interacting protein 5
affects response to substance
ISO
OIP5 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Or1i2
olfactory receptor family 1 subfamily I member 2
affects response to substance
ISO
OR1I1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:10,985,938...10,986,879
Ensembl chr 7:10,980,344...10,987,036
G
Orc6
origin recognition complex, subunit 6
affects response to substance
ISO
ORC6 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662
G
Osbpl10
oxysterol binding protein-like 10
affects response to substance
ISO
OSBPL10 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
CD40LG protein inhibits the reaction [Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]
CTD
PMID:16545138
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdhb
pyruvate dehydrogenase E1 subunit beta
affects response to substance
ISO
PDHB protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
G
Pelo
pelota mRNA surveillance and ribosome rescue factor
affects response to substance
ISO
PELO protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:46,797,853...46,799,621
Ensembl chr 2:46,797,853...46,799,746
G
Pgrmc1
progesterone receptor membrane component 1
affects response to substance
ISO
PGRMC1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
G
Pir
pirin
affects response to substance
ISO
PIR protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Plagl1
PLAG1 like zinc finger 1
increases expression
EXP
Vinblastine results in increased expression of PLAGL1 mRNA
CTD
PMID:20624997
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
G
Plat
plasminogen activator, tissue type
increases expression
EXP
Vinblastine results in increased expression of PLAT mRNA
CTD
PMID:20624997
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
affects response to substance
ISO
PLAU protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Vinblastine results in increased expression of PLAUR mRNA
CTD
PMID:20624997
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
EXP
Vinblastine results in increased expression of PPP1R15A mRNA
CTD
PMID:20624997
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prc1
protein regulator of cytokinesis 1
affects response to substance
ISO
PRC1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prkcd
protein kinase C, delta
affects localization
ISO
Vinblastine affects the localization of PRKCD protein
CTD
PMID:9852137
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Psmb1
proteasome 20S subunit beta 1
affects response to substance
ISO
PSMB1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560
G
Psme4
proteasome activator subunit 4
affects response to substance
ISO
PSME4 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Ptges3
prostaglandin E synthase 3
affects response to substance
ISO
PTGES3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
affects response to substance
ISO
PTTG1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Ptx3
pentraxin 3
affects response to substance
ISO
PTX3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Qrich1
glutamine-rich 1
increases phosphorylation
ISO
Vinblastine results in increased phosphorylation of QRICH1 protein
CTD
PMID:17510977
NCBI chr 8:109,216,900...109,256,472
Ensembl chr 8:109,217,376...109,261,359
G
Rab11fip1
RAB11 family interacting protein 1
affects response to substance
ISO
RAB11FIP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr16:64,886,902...64,917,491
Ensembl chr16:64,884,676...64,917,491
G
Racgap1
Rac GTPase-activating protein 1
affects response to substance
ISO
RACGAP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
G
Ranbp1
RAN binding protein 1
affects response to substance
ISO
RANBP1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
G
Rassf1
Ras association domain family member 1
increases expression
EXP
Vinblastine results in increased expression of RASSF1 mRNA
CTD
PMID:20624997
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rev3l
REV3 like, DNA directed polymerase zeta catalytic subunit
affects response to substance
ISO
REV3L protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
G
Rfc5
replication factor C subunit 5
affects response to substance
ISO
RFC5 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
G
Rpa3
replication protein A3
affects response to substance
ISO
RPA3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
G
Rrm2
ribonucleotide reductase regulatory subunit M2
affects response to substance
ISO
RRM2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
Vinblastine results in increased expression of S100A8 mRNA
CTD
PMID:20624997
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Vinblastine results in increased expression of S100A9 mRNA
CTD
PMID:20624997
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sele
selectin E
increases expression
EXP
Vinblastine results in increased expression of SELE mRNA
CTD
PMID:20624997
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Serpinb2
serpin family B member 2
affects response to substance
ISO
SERPINB2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Serpine1
serpin family E member 1
increases expression affects response to substance
EXP ISO
Vinblastine results in increased expression of SERPINE1 mRNA SERPINE1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747 PMID:20624997
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sfxn1
sideroflexin 1
affects response to substance
ISO
SFXN1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Shtn1
shootin 1
affects response to substance
ISO
SHTN1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:258,121,966...258,225,861
Ensembl chr 1:258,121,968...258,228,265
G
Skic8
SKI8 subunit of superkiller complex
affects response to substance
ISO
SKIC8 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:55,103,542...55,120,837
Ensembl chr 8:55,103,545...55,120,813
G
Skp2
S-phase kinase associated protein 2
affects response to substance
ISO
SKP2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slc22a3
solute carrier family 22 member 3
affects response to substance
ISO
SLC22A3 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Snrnp25
small nuclear ribonucleoprotein U11/U12 subunit 25
affects response to substance
ISO
SNRNP25 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:15,420,482...15,423,806
Ensembl chr10:15,420,486...15,423,804
G
Snx10
sorting nexin 10
affects response to substance
ISO
SNX10 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
G
Sod1
superoxide dismutase 1
affects response to substance
ISO
SOD1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
bisindolylmaleimide I inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]; calphostin C inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]; Cycloheximide promotes the reaction [Vinblastine results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]
CTD
PMID:9852137
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sort1
sortilin 1
affects response to substance
ISO
SORT1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:195,924,099...196,002,354
G
Spon1
spondin 1
increases expression
EXP
Vinblastine results in increased expression of SPON1 mRNA
CTD
PMID:20624997
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Srd5a1
steroid 5 alpha-reductase 1
affects response to substance
ISO
SRD5A1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srgn
serglycin
affects response to substance
ISO
SRGN protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
Vinblastine deficiency results in decreased activity of and affects the localization of STAT1 protein
CTD
PMID:28086195
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
Vinblastine deficiency results in decreased activity of and affects the localization of STAT3 protein
CTD
PMID:28086195
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stc2
stanniocalcin 2
affects response to substance
ISO
STC2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stk26
serine/threonine kinase 26
affects response to substance
ISO
STK26 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr X:130,325,064...130,375,674
Ensembl chr X:130,310,885...130,374,291
G
Strn
striatin
affects response to substance
ISO
STRN protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:16,335,265...16,422,159
Ensembl chr 6:16,335,358...16,417,083
G
Sucla2
succinate-CoA ligase ADP-forming subunit beta
affects response to substance
ISO
SUCLA2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138
G
Suclg1
succinate-CoA ligase GDP/ADP-forming subunit alpha
affects response to substance
ISO
SUCLG1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
G
Sult1a1
sulfotransferase family 1A member 1
affects response to substance
ISO
SULT1A1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Syde1
synapse defective Rho GTPase homolog 1
affects response to substance
ISO
SYDE1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:11,032,931...11,038,917
Ensembl chr 7:11,032,898...11,039,869
G
Tbc1d4
TBC1 domain family, member 4
affects response to substance
ISO
TBC1D4 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tdg
thymine-DNA glycosylase
affects response to substance
ISO
TDG protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Tfpi2
tissue factor pathway inhibitor 2
affects response to substance increases expression
ISO EXP
TFPI2 protein affects the susceptibility to Vinblastine Vinblastine results in increased expression of TFPI2 mRNA
CTD
PMID:16217747 PMID:20624997
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Thbd
thrombomodulin
increases expression
EXP
Vinblastine results in increased expression of THBD mRNA
CTD
PMID:20624997
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
EXP
Vinblastine results in increased expression of THBS1 mRNA
CTD
PMID:20624997
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Vinblastine results in increased expression of TIMP1 mRNA
CTD
PMID:20624997
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tmem134
transmembrane protein 134
affects response to substance
ISO
TMEM134 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:201,419,225...201,424,778
Ensembl chr 1:201,419,264...201,431,411
G
Tmem14a
transmembrane protein 14A
affects response to substance
ISO
TMEM14A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 9:23,640,594...23,652,379
Ensembl chr 9:23,733,039...23,734,463 Ensembl chr 9:23,733,039...23,734,463
G
Tmem156
transmembrane protein 156
affects response to substance
ISO
TMEM156 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,223,381...43,252,449
G
Tmem97
transmembrane protein 97
affects response to substance
ISO
TMEM97 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmpo
thymopoietin
affects response to substance
ISO
TMPO protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Top2a
DNA topoisomerase II alpha
affects response to substance
ISO
TOP2A protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
multiple interactions
ISO
TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of JUN protein]; TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK8 protein]; TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein]
CTD
PMID:12221076
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpd52l1
TPD52 like 1
increases expression affects response to substance
EXP ISO
Vinblastine results in increased expression of TPD52L1 mRNA TPD52L1 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747 PMID:20624997
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Trim2
tripartite motif-containing 2
affects response to substance
ISO
TRIM2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trmt5
tRNA methyltransferase 5
affects response to substance
ISO
TRMT5 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:91,963,558...91,987,660
Ensembl chr 6:91,943,724...91,987,555
G
Tspan13
tetraspanin 13
affects response to substance
ISO
TSPAN13 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:52,738,748...52,765,503
Ensembl chr 6:52,738,758...52,765,547
G
Ttf2
transcription termination factor 2
affects response to substance
ISO
TTF2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 2:188,366,321...188,397,750
Ensembl chr 2:188,366,331...188,397,689
G
Ttk
Ttk protein kinase
affects response to substance
ISO
TTK protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Tuba1b
tubulin, alpha 1B
decreases expression
EXP
Vinblastine results in decreased expression of TUBA1B mRNA
CTD
PMID:20624997
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP
Vinblastine results in decreased expression of TUBA4A mRNA
CTD
PMID:20624997
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
EXP
Vinblastine results in decreased expression of TUBB4B mRNA
CTD
PMID:20624997
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
Vinblastine results in decreased expression of TUBB5 mRNA
CTD
PMID:20624997
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubg1
tubulin, gamma 1
decreases expression
EXP
Vinblastine results in decreased expression of TUBG1 mRNA
CTD
PMID:20624997
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Uqcr10
ubiquinol-cytochrome c reductase, complex III subunit X
affects response to substance
ISO
UQCR10 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr14:79,566,151...79,569,017
Ensembl chr14:79,566,157...79,569,003
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Vinblastine results in increased expression of VCAM1 mRNA
CTD
PMID:20624997
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
decreases expression
EXP
Vinblastine results in decreased expression of VEGFA mRNA
CTD
PMID:20624997
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
affects response to substance
ISO
VEGFC protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vwf
von Willebrand factor
increases expression
EXP
Vinblastine results in increased expression of VWF mRNA
CTD
PMID:20624997
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wsb2
WD repeat and SOCS box-containing 2
affects response to substance
ISO
WSB2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr12:39,217,645...39,238,634
Ensembl chr12:39,217,648...39,238,640
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
affects response to substance
ISO
YWHAQ protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273
G
Zdhhc11
zinc finger, DHHC-type containing 11
affects response to substance
ISO
ZDHHC11 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 1:29,296,334...29,327,227
Ensembl chr 1:29,296,334...29,326,898
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
affects response to substance
ISO
ZFP36L2 protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
G
Zwint
ZW10 interacting kinetochore protein
affects response to substance
ISO
ZWINT protein affects the susceptibility to Vinblastine
CTD
PMID:16217747
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
G
Aif1
allograft inflammatory factor 1
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IBA1 protein]
CTD
PMID:38629493
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Gfap
glial fibrillary acidic protein
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein]
CTD
PMID:38629493
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HMOX1 protein]
CTD
PMID:38629493
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B mRNA]; Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]
CTD
PMID:38629493
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 mRNA]; Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 protein]
CTD
PMID:38629493
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Vincamine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]
CTD
PMID:38629493
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of NFKBIA protein]
CTD
PMID:38629493
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of RELA protein]
CTD
PMID:38629493
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF mRNA]; Vincamine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]
CTD
PMID:38629493
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Aamdc
adipogenesis associated, Mth938 domain containing
increases expression
ISO
Vincristine results in increased expression of AAMDC mRNA
CTD
PMID:23649840
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA1 mRNA
CTD
PMID:19944135
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abca12
ATP binding cassette subfamily A member 12
increases expression multiple interactions
ISO
Vincristine results in increased expression of ABCA12 mRNA [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA12 mRNA
CTD
PMID:19944135 PMID:23649840
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
G
Abca4
ATP binding cassette subfamily A member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA4 mRNA
CTD
PMID:19944135
NCBI chr 2:210,164,813...210,302,069
Ensembl chr 2:210,164,813...210,302,069
G
Abca5
ATP binding cassette subfamily A member 5
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCA5 mRNA
CTD
PMID:19944135
NCBI chr10:95,240,159...95,309,195
Ensembl chr10:95,240,154...95,308,976
G
Abca8
ATP binding cassette subfamily A member 8
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCA8 mRNA
CTD
PMID:19944135
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects response to substance increases expression multiple interactions increases transport decreases uptake decreases response to substance affects uptake
ISO EXP
ABCB1 protein affects the susceptibility to Vincristine Vincristine results in increased expression of ABCB1A mRNA Vincristine results in increased expression of ABCB1 protein [Estradiol results in decreased expression of ABCB1 protein] which results in increased uptake of and results in increased susceptibility to Vincristine; [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Vincristine; [Paclitaxel results in increased expression of ABCB1] which results in decreased susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB1 mRNA; [Vincristine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; CEP 33779 inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Cyclosporine inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Fenofibrate inhibits the reaction [ABCB1 protein results in increased transport of Vincristine]; Flupenthixol analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; NR1I2 protein promotes the reaction [Vincristine results in increased expression of ABCB1 protein]; pinostrobin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; tectochrysin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; zosuquidar trihydrochloride inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine] ABCB1 protein results in decreased uptake of Vincristine ABCB1 protein affects the uptake of Vincristine
CTD
PMID:7905786 PMID:10617675 PMID:11792417 PMID:11934808 PMID:15239124 PMID:15645438 PMID:16038730 PMID:16221289 PMID:16316932 PMID:16925584 PMID:19944135 PMID:20041327 PMID:21344920 PMID:21833476 PMID:25058526 PMID:32497533 PMID:37259354 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects uptake
EXP
ABCB1B protein affects the uptake of Vincristine
CTD
PMID:11934808
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB4 mRNA
CTD
PMID:19944135
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcb6
ATP binding cassette subfamily B member 6
multiple interactions decreases response to substance
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB6 mRNA ABCB6 protein results in decreased susceptibility to Vincristine
CTD
PMID:19944135 PMID:25202056
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
G
Abcc1
ATP binding cassette subfamily C member 1
increases response to substance increases expression multiple interactions decreases response to substance affects transport affects response to substance affects export
ISO EXP
ABCC1 gene SNP results in increased susceptibility to Vincristine Vincristine results in increased expression of ABCC1 mRNA [Genistein results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Indomethacin results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Probenecid results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Sulfinpyrazone results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine ABCC1 protein results in decreased susceptibility to Vincristine; ABCC1 results in decreased susceptibility to Vincristine [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC1 mRNA; ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine; Buthionine Sulfoximine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Cyclosporine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Doxorubicin inhibits the reaction [ABCC1 protein affects the transport of Vincristine]; GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC1 protein affects the export of Vincristine]; myricetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Quercetin promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon]; Vincristine inhibits the reaction [Glutathione promotes the reaction [ABCC1 results in increased transport of methylarsine analog]]; zafirlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] ABCC1 protein affects the transport of Vincristine; ABCC1 protein mutant form affects the transport of Vincristine ABCC1 protein affects the susceptibility to Vincristine
CTD
PMID:7954421 PMID:8649356 PMID:8968083 PMID:10348353 PMID:10685512 PMID:10900222 PMID:11278867 PMID:11306701 PMID:11778547 PMID:12067707 PMID:12731862 PMID:12893836 PMID:15044619 PMID:15180633 PMID:15581632 PMID:15896345 PMID:16042792 PMID:16221289 PMID:19232821 PMID:19944135 PMID:20864405 PMID:21918036 PMID:22095822 More...
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc10
ATP binding cassette subfamily C member 10
multiple interactions decreases response to substance
ISO
Imatinib Mesylate inhibits the reaction [ABCC10 protein results in decreased susceptibility to Vincristine]; nilotinib inhibits the reaction [ABCC10 protein results in decreased susceptibility to Vincristine]
CTD
PMID:19841739
NCBI chr 9:14,657,242...14,677,178
Ensembl chr 9:14,657,264...14,677,178
G
Abcc2
ATP binding cassette subfamily C member 2
affects export multiple interactions decreases response to substance
ISO
ABCC2 protein affects the export of Vincristine [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC2 mRNA; ABCC2 protein affects the export of and results in decreased susceptibility to Vincristine; myricetin inhibits the reaction [ABCC2 protein affects the export of and results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC2 protein affects the export of Vincristine]; myricetin inhibits the reaction [ABCC2 protein results in decreased susceptibility to Vincristine]
CTD
PMID:15896345 PMID:19944135 PMID:22095822
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC3 mRNA
CTD
PMID:19944135
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCC4 mRNA
CTD
PMID:19944135
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcc5
ATP binding cassette subfamily C member 5
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCC5 mRNA
CTD
PMID:19944135
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcc6
ATP binding cassette subfamily C member 6
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCC6 mRNA
CTD
PMID:19944135
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Abcd3
ATP binding cassette subfamily D member 3
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCD3 mRNA
CTD
PMID:19944135
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG1 mRNA
CTD
PMID:19944135
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Paclitaxel results in decreased expression of ABCG2] which results in decreased susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCG2 mRNA
CTD
PMID:19944135 PMID:21833476
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg4
ATP binding cassette subfamily G member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG4 mRNA
CTD
PMID:19944135
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
G
Abhd11
abhydrolase domain containing 11
decreases expression
ISO
Vincristine results in decreased expression of ABHD11 mRNA
CTD
PMID:23649840
NCBI chr12:21,682,206...21,685,331
Ensembl chr12:21,682,202...21,685,398
G
Abtb2
ankyrin repeat and BTB domain containing 2
increases expression
ISO
Vincristine results in increased expression of ABTB2 mRNA
CTD
PMID:23649840
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
G
Acad9
acyl-CoA dehydrogenase family, member 9
decreases expression
ISO
Vincristine results in decreased expression of ACAD9 mRNA
CTD
PMID:23649840
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
G
Ache
acetylcholinesterase
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of ACHE protein xaliproden inhibits the reaction [Vincristine results in decreased expression of ACHE protein]
CTD
PMID:8413926
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ackr3
atypical chemokine receptor 3
increases expression
ISO
Vincristine results in increased expression of ACKR3 mRNA
CTD
PMID:23649840
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Actr2
actin related protein 2
increases expression
ISO
Vincristine results in increased expression of ACTR2 mRNA
CTD
PMID:23649840
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Adat2
adenosine deaminase, tRNA-specific 2
decreases expression
ISO
Vincristine results in decreased expression of ADAT2 mRNA
CTD
PMID:23649840
NCBI chr 1:7,954,520...7,975,254
Ensembl chr 1:7,954,631...7,975,251
G
Adgrf4
adhesion G protein-coupled receptor F4
increases expression
ISO
Vincristine results in increased expression of ADGRF4 mRNA
CTD
PMID:23649840
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
G
Adrb1
adrenoceptor beta 1
decreases expression
ISO
Vincristine results in decreased expression of ADRB1 mRNA
CTD
PMID:23649840
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
increases response to substance
ISO
ADRB2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agbl3
AGBL carboxypeptidase 3
decreases expression
ISO
Vincristine results in decreased expression of AGBL3 mRNA
CTD
PMID:23649840
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
G
Ahsa2
activator of HSP90 ATPase homolog 2
decreases expression
ISO
Vincristine results in decreased expression of AHSA2P mRNA
CTD
PMID:23649840
NCBI chr14:97,476,304...97,485,725
Ensembl chr14:97,476,817...97,485,657
G
Aim2
absent in melanoma 2
increases expression
ISO
Vincristine results in increased expression of AIM2 mRNA
CTD
PMID:23649840
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
G
Ak1
adenylate kinase 1
decreases expression
EXP
Vincristine results in decreased expression of AK1 mRNA
CTD
PMID:20624997
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Ak3
adenylate kinase 3
decreases expression
ISO
Vincristine results in decreased expression of AK3 mRNA
CTD
PMID:23649840
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
G
Akap10
A-kinase anchoring protein 10
increases expression
ISO
Vincristine results in increased expression of AKAP10 mRNA
CTD
PMID:23649840
NCBI chr10:46,545,371...46,608,730
Ensembl chr10:46,551,532...46,608,769
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression
ISO EXP
Vincristine inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] Vincristine results in decreased expression of AKT1 mRNA Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT1 mRNA] Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]]
CTD
PMID:16740780 PMID:18590705 PMID:33038355
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of AKT2 mRNA Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA]
CTD
PMID:33038355
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression
ISO
Vincristine results in decreased expression of ALDOC mRNA
CTD
PMID:23649840
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alms1
ALMS1, centrosome and basal body associated protein
decreases expression
ISO
Vincristine results in decreased expression of ALMS1 mRNA
CTD
PMID:23649840
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
G
Alpk2
alpha-kinase 2
increases expression
ISO
Vincristine results in increased expression of ALPK2 mRNA
CTD
PMID:23649840
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
G
Amh
anti-Mullerian hormone
decreases secretion
ISO
Vincristine results in decreased secretion of AMH protein
CTD
PMID:30657998
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
G
Anapc5
anaphase-promoting complex subunit 5
increases expression
ISO
Vincristine results in increased expression of ANAPC5 mRNA
CTD
PMID:23649840
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Ankdd1a
ankyrin repeat and death domain containing 1A
decreases expression
ISO
Vincristine results in decreased expression of ANKDD1A mRNA
CTD
PMID:23649840
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
G
Ankhd1
ankyrin repeat and KH domain containing 1
increases expression
ISO
Vincristine results in increased expression of ANKHD1 mRNA
CTD
PMID:23649840
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
G
Ankra2
ankyrin repeat family A member 2
increases expression
ISO
Vincristine results in increased expression of ANKRA2 mRNA
CTD
PMID:23649840
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd13c
ankyrin repeat domain 13C
decreases expression
ISO
Vincristine results in decreased expression of ANKRD13C mRNA
CTD
PMID:23649840
NCBI chr 2:247,023,040...247,070,433
Ensembl chr 2:247,022,286...247,070,433
G
Ankrd33b
ankyrin repeat domain 33B
increases expression
ISO
Vincristine results in increased expression of ANKRD33B mRNA
CTD
PMID:23649840
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
G
Ankrd37
ankyrin repeat domain 37
decreases expression
ISO
Vincristine results in decreased expression of ANKRD37 mRNA
CTD
PMID:23649840
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Anp32e
acidic nuclear phosphoprotein 32 family member E
decreases expression
ISO
Vincristine results in decreased expression of ANP32E mRNA
CTD
PMID:23649840
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
G
Anxa1
annexin A1
increases expression
ISO
Vincristine results in increased expression of ANXA1 mRNA
CTD
PMID:23649840
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
increases expression
ISO
Vincristine results in increased expression of ANXA2 mRNA
CTD
PMID:23649840
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Ap1s2
adaptor related protein complex 1 subunit sigma 2
decreases expression
ISO
Vincristine results in decreased expression of AP1S2 mRNA
CTD
PMID:23649840
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
decreases expression
ISO
Vincristine results in decreased expression of APEX2 mRNA
CTD
PMID:23649840
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
G
Apln
apelin
decreases expression
EXP
Vincristine results in decreased expression of APLN mRNA
CTD
PMID:20624997
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apod
apolipoprotein D
increases expression
ISO
Vincristine results in increased expression of APOD mRNA
CTD
PMID:23649840
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Apold1
apolipoprotein L domain containing 1
increases expression
ISO
Vincristine results in increased expression of APOLD1 mRNA
CTD
PMID:23649840
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
Aqp9
aquaporin 9
increases expression
ISO
Vincristine results in increased expression of AQP9 mRNA
CTD
PMID:23649840
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Arap2
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
decreases expression
ISO
Vincristine results in decreased expression of ARAP2 mRNA
CTD
PMID:23649840
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
G
Arf1
ARF GTPase 1
increases expression
ISO
Vincristine results in increased expression of ARF1 mRNA
CTD
PMID:23649840
NCBI chr10:43,997,983...44,014,461
Ensembl chr10:43,997,986...44,014,434
G
Arhgap15
Rho GTPase activating protein 15
increases expression
ISO
Vincristine results in increased expression of ARHGAP15 mRNA
CTD
PMID:23649840
NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:27,989,633...28,600,265
G
Arhgap18
Rho GTPase activating protein 18
decreases expression
ISO
Vincristine results in decreased expression of ARHGAP18 mRNA
CTD
PMID:23649840
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgap5
Rho GTPase activating protein 5
decreases expression
ISO
Vincristine results in decreased expression of ARHGAP5 mRNA
CTD
PMID:23649840
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Arhgef6
Rac/Cdc42 guanine nucleotide exchange factor 6
increases expression
ISO
Vincristine results in increased expression of ARHGEF6 mRNA
CTD
PMID:23649840
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
G
Arhgef7
Rho guanine nucleotide exchange factor 7
increases expression
ISO
Vincristine results in increased expression of ARHGEF7 mRNA
CTD
PMID:23649840
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
G
Arid2
AT-rich interaction domain 2
increases expression
ISO
Vincristine results in increased expression of ARID2 mRNA
CTD
PMID:23649840
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
G
Arid4b
AT-rich interaction domain 4B
increases expression
ISO
Vincristine results in increased expression of ARID4B mRNA
CTD
PMID:23649840
NCBI chr17:51,138,419...51,262,894
Ensembl chr17:51,138,535...51,262,906
G
Arl5a
ARF like GTPase 5A
decreases expression
ISO
Vincristine results in decreased expression of ARL5A mRNA
CTD
PMID:23649840
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
G
Arl5b
ARF like GTPase 5B
increases expression
ISO
Vincristine results in increased expression of ARL5B mRNA
CTD
PMID:23649840
NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
ISO
Vincristine results in decreased expression of ARL6IP1 mRNA
CTD
PMID:23649840
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Armc8
armadillo repeat containing 8
decreases expression
ISO
Vincristine results in decreased expression of ARMC8 mRNA
CTD
PMID:23649840
NCBI chr 8:100,036,946...100,131,544
Ensembl chr 8:100,036,946...100,131,520
G
Aspm
assembly factor for spindle microtubules
increases expression
ISO
Vincristine results in increased expression of ASPM mRNA
CTD
PMID:17374387
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Asxl1
ASXL transcriptional regulator 1
increases expression
ISO
Vincristine results in increased expression of ASXL1 mRNA
CTD
PMID:23649840
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atad2
ATPase family, AAA domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of ATAD2 mRNA
CTD
PMID:23649840
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
increases expression
ISO
Vincristine results in increased expression of ATF3 mRNA
CTD
PMID:23649840
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf5
activating transcription factor 5
increases expression
ISO
Vincristine results in increased expression of ATF5 mRNA
CTD
PMID:23649840
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
multiple interactions increases expression
EXP
Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]
CTD
PMID:33038355
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atp2b4
ATPase plasma membrane Ca2+ transporting 4
increases expression
ISO
Vincristine results in increased expression of ATP2B4 mRNA
CTD
PMID:23649840
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
G
Atp5f1c
ATP synthase F1 subunit gamma
decreases expression
ISO
Vincristine results in decreased expression of ATP5F1C mRNA
CTD
PMID:23649840
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
ISO
Vincristine results in increased expression of ATP6V0E1 mRNA
CTD
PMID:23649840
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
G
Atp7a
ATPase copper transporting alpha
decreases response to substance
ISO
ATP7A protein results in decreased susceptibility to Vincristine
CTD
PMID:17510416
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp8a1
ATPase phospholipid transporting 8A1
decreases expression
ISO
Vincristine results in decreased expression of ATP8A1 mRNA
CTD
PMID:23649840
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Aurka
aurora kinase A
increases response to substance increases expression
ISO
AURKA gene SNP results in increased susceptibility to Vincristine Vincristine results in increased expression of AURKA mRNA
CTD
PMID:17374387 PMID:20864405
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression
ISO
Vincristine results in decreased expression of AURKB mRNA
CTD
PMID:23649840
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Avp
arginine vasopressin
increases expression
ISO
Vincristine results in increased expression of AVP protein
CTD
PMID:4356234
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
B3galt6
Beta-1,3-galactosyltransferase 6
decreases expression
ISO
Vincristine results in decreased expression of B3GALT6 mRNA
CTD
PMID:23649840
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
G
B3gnt5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
increases expression
ISO
Vincristine results in increased expression of B3GNT5 mRNA
CTD
PMID:23649840
NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166
G
Bak1
BCL2-antagonist/killer 1
affects response to substance
ISO
BAK1 protein affects the susceptibility to Vincristine
CTD
PMID:22178383
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Vincristine results in increased expression of BAMBI mRNA
CTD
PMID:23649840
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
Vincristine results in decreased expression of BARD1 mRNA
CTD
PMID:23649840
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Basp1
brain abundant, membrane attached signal protein 1
increases expression
ISO
Vincristine results in increased expression of BASP1 mRNA
CTD
PMID:23649840
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
ISO
Vincristine results in increased expression of BATF mRNA
CTD
PMID:23649840
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression multiple interactions increases expression affects response to substance
ISO EXP
Vincristine results in decreased expression of BAX mRNA KN 93 inhibits the reaction [Vincristine results in increased expression of BAX mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of BAX protein] Vincristine results in increased expression of BAX mRNA; Vincristine results in increased expression of BAX protein Quercetin inhibits the reaction [Vincristine results in increased expression of BAX mRNA] BAX protein affects the susceptibility to Vincristine [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BAX protein; Vincristine results in increased cleavage of and results in increased expression of BAX protein
CTD
PMID:9815696 PMID:15131059 PMID:16001973 PMID:22178383 PMID:33038355 PMID:34286406 PMID:36808657 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcat1
branched chain amino acid transaminase 1
increases expression
ISO
Vincristine results in increased expression of BCAT1 mRNA
CTD
PMID:23649840
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bcl2
BCL2, apoptosis regulator
decreases response to substance multiple interactions decreases expression increases phosphorylation
ISO EXP
BCL2 protein results in decreased susceptibility to Vincristine KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA]; KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 protein] Vincristine results in decreased expression of BCL2 mRNA; Vincristine results in decreased expression of BCL2 protein Quercetin inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA] Vincristine results in increased phosphorylation of BCL2 protein [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein; [MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Vincristine; TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]
CTD
PMID:9815696 PMID:15907805 PMID:20162574 PMID:21182165 PMID:21258880 PMID:33038355 PMID:34286406 PMID:36808657 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
increases expression
ISO
Vincristine results in increased expression of BCL2A1 mRNA
CTD
PMID:23649840
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
increases expression affects response to substance
ISO
Vincristine results in increased expression of BCL2L1 mRNA BCL2L1 protein affects the susceptibility to Vincristine
CTD
PMID:22178383 PMID:23649840
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
Vincristine results in decreased expression of BCLAF1 mRNA
CTD
PMID:23649840
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bcor
BCL6 co-repressor
increases expression
ISO
Vincristine results in increased expression of BCOR mRNA
CTD
PMID:23649840
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
G
Bdkrb1
bradykinin receptor B1
multiple interactions
EXP
[HOE 140, desArg(10)- binds to and results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:17989505
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
multiple interactions
EXP
[icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:17989505
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Birc2
baculoviral IAP repeat-containing 2
increases expression
ISO
Vincristine results in increased expression of BIRC2 mRNA
CTD
PMID:23649840
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
Vincristine results in increased expression of BIRC3 mRNA
CTD
PMID:23649840
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blm
BLM RecQ like helicase
decreases expression
ISO
Vincristine results in decreased expression of BLM mRNA
CTD
PMID:23649840
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
Vincristine results in increased expression of BMP2 mRNA
CTD
PMID:23649840
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Bnip3
BCL2 interacting protein 3
decreases expression multiple interactions
ISO
Vincristine results in decreased expression of BNIP3 mRNA Vincristine affects the reaction [Valproic Acid affects the localization of BNIP3 protein]
CTD
PMID:23649840 PMID:25446377
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
decreases expression
ISO
Vincristine results in decreased expression of BNIP3L mRNA
CTD
PMID:23649840
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Borcs7
BLOC-1 related complex subunit 7
increases expression
ISO
Vincristine results in increased expression of BORCS7 mRNA
CTD
PMID:23649840
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
G
Brip1
BRCA1 interacting DNA helicase 1
decreases expression
ISO
Vincristine results in decreased expression of BRIP1 mRNA
CTD
PMID:23649840
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
G
Brwd1
bromodomain and WD repeat domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of BRWD1 mRNA
CTD
PMID:23649840
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
G
Btg1
BTG anti-proliferation factor 1
increases expression
ISO
Vincristine results in increased expression of BTG1 mRNA
CTD
PMID:23649840
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Vincristine results in increased expression of BTG2 mRNA
CTD
PMID:23649840
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg4
BTG anti-proliferation factor 4
increases expression
ISO
Vincristine results in increased expression of BTG4 mRNA
CTD
PMID:23649840
NCBI chr 8:51,410,774...51,425,802
Ensembl chr 8:51,422,061...51,425,796
G
Bub3
BUB3 mitotic checkpoint protein
decreases expression
ISO
Vincristine results in decreased expression of BUB3 mRNA
CTD
PMID:23649840
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:186,327,931...186,395,036
G
C13h1orf74
similar to human chromosome 1 open reading frame 74
decreases expression
ISO
Vincristine results in decreased expression of C1ORF74 mRNA
CTD
PMID:23649840
NCBI chr13:104,692,769...104,695,368
Ensembl chr13:104,692,824...104,695,470
G
C1galt1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
decreases expression
ISO
Vincristine results in decreased expression of C1GALT1 mRNA
CTD
PMID:23649840
NCBI chr 4:35,930,981...35,966,100
Ensembl chr 4:35,928,104...35,961,831
G
C7h12orf54
similar to human chromosome 12 open reading frame 54
increases expression
ISO
Vincristine results in increased expression of C12ORF54 mRNA
CTD
PMID:23649840
NCBI chr 7:129,529,811...129,548,676
G
C8h15orf39
similar to human chromosome 15 open reading frame 39
decreases expression
ISO
Vincristine results in decreased expression of C15ORF39 mRNA
CTD
PMID:23649840
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
G
Cables2
Cdk5 and Abl enzyme substrate 2
decreases expression
ISO
Vincristine results in decreased expression of CABLES2 mRNA
CTD
PMID:23649840
NCBI chr 3:167,347,527...167,362,274
Ensembl chr 3:167,347,461...167,362,279
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression multiple interactions
ISO
Vincristine results in increased expression of CACNA1H mRNA; Vincristine results in increased expression of CACNA1H protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of CACNA1H mRNA]; Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; KN 62 inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; zinc chloride inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]
CTD
PMID:34286406
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
increases expression
ISO
Vincristine results in increased expression of CACNB2 mRNA
CTD
PMID:23649840
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Cald1
caldesmon 1
increases expression
ISO
Vincristine results in increased expression of CALD1 mRNA
CTD
PMID:23649840
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Calm2
calmodulin 2
decreases expression
ISO
Vincristine results in decreased expression of CALM2 mRNA
CTD
PMID:23649840
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Calu
calumenin
increases expression
ISO
Vincristine results in increased expression of CALU mRNA
CTD
PMID:23649840
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
ISO
Vincristine results in decreased expression of CAMK2D mRNA
CTD
PMID:23649840
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1
increases response to substance
ISO
CAMKK1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
G
Capg
capping actin protein, gelsolin like
increases expression
ISO
Vincristine results in increased expression of CAPG mRNA
CTD
PMID:23649840
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
Vincristine results in decreased expression of CARHSP1 mRNA
CTD
PMID:23649840
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Casp1
caspase 1
increases expression
ISO
Vincristine results in increased expression of CASP1 mRNA
CTD
PMID:23649840
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases cleavage multiple interactions increases expression
EXP ISO
Vincristine results in increased cleavage of CASP3 protein KN 93 inhibits the reaction [Vincristine results in increased cleavage of CASP3 protein] coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Vincristine results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Vincristine results in increased expression of CASP3 protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 mRNA]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 protein] Vincristine results in increased expression of CASP3 mRNA; Vincristine results in increased expression of CASP3 protein
CTD
PMID:20624997 PMID:29958920 PMID:33038355 PMID:34286406 PMID:34939713 PMID:36808657 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
Vincristine results in increased expression of CASP6 mRNA
CTD
PMID:16001973
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
increases expression increases response to substance multiple interactions
ISO
Vincristine results in increased expression of CASP8 mRNA CASP8 protein results in increased susceptibility to Vincristine Vincristine results in increased expression of and results in increased cleavage of CASP8 protein
CTD
PMID:16001973 PMID:22010212
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
affects response to substance decreases activity decreases expression multiple interactions
ISO EXP
CAT protein affects the susceptibility to Vincristine Vincristine results in decreased activity of CAT protein Vincristine results in decreased expression of CAT protein Quercetin inhibits the reaction [Vincristine results in decreased activity of CAT protein]; tetrahydrocurcumin inhibits the reaction [Vincristine results in decreased expression of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]
CTD
PMID:11178967 PMID:24201307 PMID:25537132 PMID:26102012 PMID:36808657
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbx3
chromobox 3
decreases expression
ISO
Vincristine results in decreased expression of CBX3 mRNA
CTD
PMID:23649840
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
G
Cbx5
chromobox 5
decreases expression
ISO
Vincristine results in decreased expression of CBX5 mRNA
CTD
PMID:23649840
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
G
Ccar1
cell division cycle and apoptosis regulator 1
decreases expression
ISO
Vincristine results in decreased expression of CCAR1 mRNA
CTD
PMID:23649840
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
G
Ccdc12
coiled-coil domain containing 12
decreases expression
ISO
Vincristine results in decreased expression of CCDC12 mRNA
CTD
PMID:23649840
NCBI chr 8:110,635,276...110,686,417
Ensembl chr 8:110,635,710...110,686,417
G
Ccdc186
coiled-coil domain containing 186
decreases expression
ISO
Vincristine results in decreased expression of CCDC186 mRNA
CTD
PMID:23649840
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
G
Ccdc198
coiled-coil domain containing 198
decreases expression
ISO
Vincristine results in decreased expression of CCDC198 mRNA
CTD
PMID:23649840
NCBI chr15:22,500,181...22,527,011
Ensembl chr15:22,502,687...22,526,992
G
Ccdc32
coiled-coil domain containing 32
decreases expression
ISO
Vincristine results in decreased expression of CCDC32 mRNA
CTD
PMID:23649840
NCBI chr 3:105,998,429...106,010,985
Ensembl chr 3:105,998,430...106,010,975
G
Ccdc82
coiled-coil domain containing 82
increases expression
ISO
Vincristine results in increased expression of CCDC82 mRNA
CTD
PMID:23649840
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
G
Cchcr1
coiled-coil alpha-helical rod protein 1
decreases expression
ISO
Vincristine results in decreased expression of CCHCR1 mRNA
CTD
PMID:23649840
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
G
Ccl1
C-C motif chemokine ligand 1
increases expression
ISO
Vincristine results in increased expression of CCL1 mRNA
CTD
PMID:23649840
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO EXP
Vincristine results in increased expression of CCL2 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Vincristine results in increased expression of CCL20 mRNA
CTD
PMID:23649840
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
increases expression
ISO
Vincristine results in increased expression of CCL22 mRNA
CTD
PMID:23649840
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
Vincristine results in increased expression of CCL4 mRNA
CTD
PMID:23649840
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
Vincristine results in increased expression of CCL5 mRNA
CTD
PMID:23649840
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn2
cellular communication network factor 2
decreases response to substance
ISO
CCN2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:24154679
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnb1
cyclin B1
affects response to substance increases expression
ISO
CCNB1 protein affects the susceptibility to Vincristine Vincristine results in increased expression of CCNB1 mRNA
CTD
PMID:22178383 PMID:23649840
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
increases expression
ISO
Vincristine results in increased expression of CCNB2 mRNA
CTD
PMID:23649840
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
decreases expression
ISO
Vincristine results in decreased expression of CCNE1 mRNA
CTD
PMID:23649840
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
decreases expression
ISO
Vincristine results in decreased expression of CCNE2 mRNA
CTD
PMID:23649840
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnl1
cyclin L1
decreases expression
ISO
Vincristine results in decreased expression of CCNL1 mRNA
CTD
PMID:23649840
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Cd109
CD109 molecule
increases expression
ISO
Vincristine results in increased expression of CD109 mRNA
CTD
PMID:23649840
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd14
CD14 molecule
increases expression
EXP
Vincristine results in increased expression of CD14 mRNA
CTD
PMID:20624997
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd200
Cd200 molecule
increases expression
ISO
Vincristine results in increased expression of CD200 mRNA
CTD
PMID:23649840
NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648
G
Cd274
CD274 molecule
increases expression
ISO
Vincristine results in increased expression of CD274 mRNA
CTD
PMID:23649840
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd36
CD36 molecule
increases expression
EXP
Vincristine results in increased expression of CD36 mRNA
CTD
PMID:20624997
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
increases expression
ISO
Vincristine results in increased expression of CD40 mRNA
CTD
PMID:23649840
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
increases expression
ISO
Vincristine results in increased expression of CD44 mRNA
CTD
PMID:23649840
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd48
Cd48 molecule
increases expression
ISO
Vincristine results in increased expression of CD48 mRNA
CTD
PMID:23649840
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
Vincristine results in increased expression of CD55 mRNA
CTD
PMID:23649840
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd69
Cd69 molecule
increases expression
ISO
Vincristine results in increased expression of CD69 mRNA
CTD
PMID:23649840
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cd80
Cd80 molecule
increases expression
ISO
Vincristine results in increased expression of CD80 mRNA
CTD
PMID:23649840
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
increases expression
ISO
Vincristine results in increased expression of CD83 mRNA
CTD
PMID:23649840
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd86
CD86 molecule
increases expression
ISO
Vincristine results in increased expression of CD86 mRNA
CTD
PMID:23649840
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc42ep3
CDC42 effector protein 3
increases expression
ISO
Vincristine results in increased expression of CDC42EP3 mRNA
CTD
PMID:23649840
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
G
Cdc42ep4
CDC42 effector protein 4
increases expression
ISO
Vincristine results in increased expression of CDC42EP4 mRNA
CTD
PMID:23649840
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdc42se1
CDC42 small effector 1
increases expression
ISO
Vincristine results in increased expression of CDC42SE1 mRNA
CTD
PMID:23649840
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc6
cell division cycle 6
decreases expression
ISO
Vincristine results in decreased expression of CDC6 mRNA
CTD
PMID:23649840
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
Vincristine results in decreased expression of CDCA3 mRNA
CTD
PMID:23649840
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
Vincristine results in decreased expression of CDCA7 mRNA
CTD
PMID:23649840
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
G
Cdh1
cadherin 1
increases expression
ISO
Vincristine results in increased expression of CDH1 mRNA
CTD
PMID:23649840
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Vincristine results in decreased expression of CDK1 mRNA
CTD
PMID:23649840
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
Vincristine results in decreased expression of CDK10 mRNA
CTD
PMID:23649840
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk19
cyclin-dependent kinase 19
decreases expression
ISO
Vincristine results in decreased expression of CDK19 mRNA
CTD
PMID:23649840
NCBI chr20:43,770,409...43,910,629
Ensembl chr20:43,770,409...43,910,628
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Vincristine results in decreased expression of CDK2 mRNA
CTD
PMID:23649840
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
EXP ISO
Vincristine results in increased expression of CDKN1A mRNA [XL019 compound co-treated with Vincristine] results in increased expression of CDKN1A protein; Resveratrol inhibits the reaction [Vincristine results in increased expression of CDKN1A mRNA]
CTD
PMID:20624997 PMID:23649840 PMID:26055805 PMID:29187454
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases response to substance
ISO
CDKN2A protein results in increased susceptibility to Vincristine
CTD
PMID:16786135
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
Vincristine results in decreased expression of CDKN2C mRNA
CTD
PMID:23649840
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
Vincristine results in increased expression of CEACAM1 mRNA
CTD
PMID:23649840
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Vincristine results in increased expression of CEBPB mRNA
CTD
PMID:16001973
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Celf1
CUGBP, Elav-like family member 1
decreases expression
ISO
Vincristine results in decreased expression of CELF1 mRNA
CTD
PMID:23649840
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
G
Cenpc
centromere protein C
decreases expression
ISO
Vincristine results in decreased expression of CENPC1 mRNA
CTD
PMID:23649840
NCBI chr14:21,988,067...22,046,732
Ensembl chr14:21,988,144...22,055,476
G
Cenpf
centromere protein F
decreases expression
ISO
Vincristine results in decreased expression of CENPF mRNA
CTD
PMID:23649840
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpi
centromere protein I
decreases expression
ISO
Vincristine results in decreased expression of CENPI mRNA
CTD
PMID:23649840
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
G
Cenpu
centromere protein U
decreases expression
ISO
Vincristine results in decreased expression of CENPU mRNA
CTD
PMID:23649840
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cep135
centrosomal protein 135
increases expression
ISO
Vincristine results in increased expression of CEP135 mRNA
CTD
PMID:23649840
NCBI chr14:31,530,538...31,595,812
Ensembl chr14:31,531,482...31,595,772
G
Ces5a
carboxylesterase 5A
increases expression
ISO
Vincristine results in increased expression of CES5A mRNA
CTD
PMID:23649840
NCBI chr19:11,469,431...11,499,007
Ensembl chr19:11,469,469...11,499,006
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
Vincristine results in increased expression of CFLAR mRNA
CTD
PMID:23649840
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Chd1l
chromodomain helicase DNA binding protein 1-like
increases expression
ISO
Vincristine results in increased expression of CHD1L mRNA
CTD
PMID:23649840
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
G
Chek2
checkpoint kinase 2
decreases expression
ISO
Vincristine results in decreased expression of CHEK2 mRNA
CTD
PMID:23649840
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Chm
CHM Rab escort protein
increases expression
ISO
Vincristine results in increased expression of CHM mRNA
CTD
PMID:23649840
NCBI chr X:78,203,200...78,361,996
Ensembl chr X:78,203,204...78,361,943
G
Chml
CHM like Rab escort protein
decreases expression
ISO
Vincristine results in decreased expression of CHML mRNA
CTD
PMID:23649840
NCBI chr13:87,609,647...87,619,868
Ensembl chr13:87,589,298...87,619,862
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
Vincristine results in decreased expression of CHTF18 mRNA
CTD
PMID:23649840
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Ciapin1
cytokine induced apoptosis inhibitor 1
decreases response to substance
ISO
CIAPIN1 protein results in decreased susceptibility to Vincristine
CTD
PMID:18389626
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
G
Cirbp
cold inducible RNA binding protein
decreases expression
ISO
Vincristine results in decreased expression of CIRBP mRNA
CTD
PMID:23649840
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Clasp2
cytoplasmic linker associated protein 2
increases expression
ISO
Vincristine results in increased expression of CLASP2 mRNA
CTD
PMID:23649840
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
G
Clec2d
C-type lectin domain family 2, member D
decreases expression
ISO
Vincristine results in decreased expression of CLEC2D mRNA
CTD
PMID:23649840
NCBI chr 4:162,216,052...162,239,530
Ensembl chr 4:162,216,572...162,239,527
G
Clic2
chloride intracellular channel 2
increases expression
ISO
Vincristine results in increased expression of CLIC2 mRNA
CTD
PMID:23649840
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
G
Clspn
claspin
decreases expression
ISO
Vincristine results in decreased expression of CLSPN mRNA
CTD
PMID:23649840
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Cnksr2
connector enhancer of kinase suppressor of Ras 2
decreases expression
ISO
Vincristine results in decreased expression of CNKSR2 mRNA
CTD
PMID:23649840
NCBI chr X:36,908,135...37,148,337
Ensembl chr X:36,907,850...37,150,555
G
Cnot3
CCR4-NOT transcription complex, subunit 3
decreases expression
ISO
Vincristine results in decreased expression of CNOT3 mRNA
CTD
PMID:23649840
NCBI chr 1:65,555,924...65,572,167
Ensembl chr 1:65,555,924...65,572,167
G
Cnot6l
CCR4-NOT transcription complex, subunit 6-like
decreases expression
ISO
Vincristine results in decreased expression of CNOT6L mRNA
CTD
PMID:23649840
NCBI chr14:13,410,499...13,502,511
Ensembl chr14:13,411,281...13,498,203
G
Cntln
centlein
decreases expression
ISO
Vincristine results in decreased expression of CNTLN mRNA
CTD
PMID:23649840
NCBI chr 5:99,295,865...99,576,402
Ensembl chr 5:99,296,000...99,576,396
G
Col15a1
collagen type XV alpha 1 chain
decreases response to substance
ISO
COL15A1 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Col1a2
collagen type I alpha 2 chain
increases response to substance
ISO
COL1A2 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases response to substance
ISO
COL3A1 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col5a2
collagen type V alpha 2 chain
decreases response to substance
ISO
COL5A2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Comtd1
catechol-O-methyltransferase domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of COMTD1 mRNA
CTD
PMID:23649840
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
G
Cp
ceruloplasmin
increases expression
EXP
Vincristine results in increased expression of CP mRNA
CTD
PMID:20624997
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
increases expression
ISO
Vincristine results in increased expression of CPEB2 mRNA
CTD
PMID:23649840
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
G
Cpne3
copine 3
decreases expression
ISO
Vincristine results in decreased expression of CPNE3 mRNA
CTD
PMID:23649840
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Cpsf6
cleavage and polyadenylation specific factor 6
decreases expression
ISO
Vincristine results in decreased expression of CPSF6 mRNA
CTD
PMID:23649840
NCBI chr 7:52,956,589...53,001,783
Ensembl chr 7:52,956,589...52,988,122
G
Crebbp
CREB binding protein
increases expression
ISO
Vincristine results in increased expression of CREBBP mRNA
CTD
PMID:23649840
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
Vincristine results in increased expression of CREBRF mRNA
CTD
PMID:23649840
NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999
G
Crebzf
CREB/ATF bZIP transcription factor
decreases expression
ISO
Vincristine results in decreased expression of CREBZF mRNA
CTD
PMID:23649840
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Crtap
cartilage associated protein
decreases expression
ISO
Vincristine results in decreased expression of CRTAP mRNA
CTD
PMID:23649840
NCBI chr 8:114,047,929...114,067,636
Ensembl chr 8:114,047,933...114,067,631
G
Crtc3
CREB regulated transcription coactivator 3
increases expression
ISO
Vincristine results in increased expression of CRTC3 mRNA
CTD
PMID:23649840
NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500
G
Csad
cysteine sulfinic acid decarboxylase
decreases expression
ISO
Vincristine results in decreased expression of CSAD mRNA
CTD
PMID:23649840
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf2
colony stimulating factor 2
increases expression
ISO
Vincristine results in increased expression of CSF2 mRNA
CTD
PMID:23649840
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csnk1a1
casein kinase 1, alpha 1
increases expression
ISO
Vincristine results in increased expression of CSNK1A1 mRNA
CTD
PMID:23649840
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
G
Csnk1g1
casein kinase 1, gamma 1
increases expression
ISO
Vincristine results in increased expression of CSNK1G1 mRNA
CTD
PMID:23649840
NCBI chr 8:66,439,760...66,577,247
Ensembl chr 8:66,439,864...66,572,826
G
Csta
cystatin A
increases expression
ISO
Vincristine results in increased expression of CSTA mRNA
CTD
PMID:23649840
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Cstf1
cleavage stimulation factor subunit 1
decreases expression
ISO
Vincristine results in decreased expression of CSTF1 mRNA
CTD
PMID:23649840
NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300
G
Ctc1
CST telomere replication complex component 1
decreases expression
ISO
Vincristine results in decreased expression of CTC1 mRNA
CTD
PMID:23649840
NCBI chr10:53,714,614...53,735,298
Ensembl chr10:53,714,644...53,735,298
G
Cth
cystathionine gamma-lyase
increases expression
ISO
Vincristine results in increased expression of CTH mRNA
CTD
PMID:23649840
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnnal1
catenin alpha-like 1
decreases expression
ISO
Vincristine results in decreased expression of CTNNAL1 mRNA
CTD
PMID:23649840
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
G
Ctnnb1
catenin beta 1
increases expression decreases response to substance
ISO
Vincristine results in increased expression of CTNNB1 mRNA CTNNB1 results in decreased susceptibility to Vincristine
CTD
PMID:22000491 PMID:23649840
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cul4a
cullin 4A
increases expression
ISO
Vincristine results in increased expression of CUL4A mRNA
CTD
PMID:23649840
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
Vincristine results in increased expression of CXCL10 mRNA
CTD
PMID:23649840
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
ISO
Vincristine results in increased expression of CXCL11 mRNA
CTD
PMID:23649840
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression multiple interactions
ISO
Vincristine results in increased expression of CXCL12 mRNA KN 93 inhibits the reaction [Vincristine results in increased expression of CXCL12 mRNA]
CTD
PMID:34286406
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
increases expression
ISO
Vincristine results in increased expression of CXCL9 mRNA
CTD
PMID:23649840
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyld
CYLD lysine 63 deubiquitinase
increases expression
ISO
Vincristine results in increased expression of CYLD mRNA
CTD
PMID:23649840
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases response to substance
ISO
CYP2C8 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing
ISO
CYP3A4 protein results in increased metabolism of Vincristine
CTD
PMID:19346885
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions increases metabolic processing
ISO
[CYP3A5 gene polymorphism results in increased activity of CYP3A5 protein] which results in increased metabolism of Vincristine CYP3A5 protein results in increased metabolism of Vincristine
CTD
PMID:21225912
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
increases expression
ISO
Vincristine results in increased expression of CYP4F3 mRNA
CTD
PMID:23649840
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cyp4v3
cytochrome P450, family 4, subfamily v, polypeptide 3
decreases expression
ISO
Vincristine results in decreased expression of CYP4V2 mRNA
CTD
PMID:23649840
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
G
Cysltr1
cysteinyl leukotriene receptor 1
decreases expression
ISO
Vincristine results in decreased expression of CYSLTR1 mRNA
CTD
PMID:23649840
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Daam1
dishevelled associated activator of morphogenesis 1
increases expression
ISO
Vincristine results in increased expression of DAAM1 mRNA
CTD
PMID:23649840
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Dcaf8
DDB1 and CUL4 associated factor 8
increases expression
ISO
Vincristine results in increased expression of DCAF8 mRNA
CTD
PMID:23649840
NCBI chr13:84,609,838...84,667,025
Ensembl chr13:84,610,248...84,669,726
G
Dcn
decorin
decreases response to substance
ISO
DCN mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Dcun1d1
defective in cullin neddylation 1 domain containing 1
increases expression
ISO
Vincristine results in increased expression of DCUN1D1 mRNA
CTD
PMID:23649840
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
G
Dcun1d4
defective in cullin neddylation 1 domain containing 4
decreases expression
ISO
Vincristine results in decreased expression of DCUN1D4 mRNA
CTD
PMID:23649840
NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Vincristine results in increased expression of DDIT3 mRNA
CTD
PMID:23649840
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddx50
DExD-box helicase 50
increases expression
ISO
Vincristine results in increased expression of DDX50 mRNA
CTD
PMID:23649840
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Ddx52
DExD-box helicase 52
increases expression
ISO
Vincristine results in increased expression of DDX52 mRNA
CTD
PMID:23649840
NCBI chr10:68,824,594...68,847,400
Ensembl chr10:68,824,645...68,848,266
G
Ddx60
DEXD/H-box helicase 60
increases expression
ISO
Vincristine results in increased expression of DDX60 mRNA
CTD
PMID:23649840
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dennd5a
DENN domain containing 5A
increases expression
ISO
Vincristine results in increased expression of DENND5A mRNA
CTD
PMID:23649840
NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316
G
Dgcr8
DGCR8 microprocessor complex subunit
decreases expression
ISO
Vincristine results in decreased expression of DGCR8 mRNA
CTD
PMID:23649840
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
G
Dhfr
dihydrofolate reductase
decreases expression
ISO
Vincristine results in decreased expression of DHFR mRNA
CTD
PMID:23649840
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dhrs11
dehydrogenase/reductase 11
decreases expression
ISO
Vincristine results in decreased expression of DHRS11 mRNA
CTD
PMID:23649840
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
G
Dhrs2
dehydrogenase/reductase 2
increases expression
ISO
Vincristine results in increased expression of DHRS2 mRNA
CTD
PMID:23649840
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Dhrs7
dehydrogenase/reductase 7
increases expression
ISO
Vincristine results in increased expression of DHRS7 mRNA
CTD
PMID:23649840
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Diablo
diablo, IAP-binding mitochondrial protein
decreases expression
ISO
Vincristine results in decreased expression of DIABLO mRNA
CTD
PMID:23649840
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dido1
death inducer-obliterator 1
decreases expression
ISO
Vincristine results in decreased expression of DIDO1 mRNA
CTD
PMID:23649840
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
G
Dip2a
disco-interacting protein 2 homolog A
increases expression
ISO
Vincristine results in increased expression of DIP2A mRNA
CTD
PMID:23649840
NCBI chr20:12,284,566...12,371,068
Ensembl chr20:12,284,654...12,370,217
G
Dmd
dystrophin
increases expression
ISO
Vincristine results in increased expression of DMD mRNA
CTD
PMID:23649840
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
Vincristine results in decreased expression of DNAJB1 mRNA
CTD
PMID:23649840
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajc7
DnaJ heat shock protein family (Hsp40) member C7
increases expression
ISO
Vincristine results in increased expression of DNAJC7 mRNA
CTD
PMID:23649840
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
G
Dnase1l3
deoxyribonuclease 1L3
decreases expression
ISO
Vincristine results in decreased expression of DNASE1L3 mRNA
CTD
PMID:23649840
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dnmbp
dynamin binding protein
decreases expression
ISO
Vincristine results in decreased expression of DNMBP mRNA
CTD
PMID:23649840
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
Vincristine results in increased expression of DOCK4 mRNA
CTD
PMID:23649840
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dock8
dedicator of cytokinesis 8
decreases expression
ISO
Vincristine results in decreased expression of DOCK8 mRNA
CTD
PMID:23649840
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Dok4
docking protein 4
increases expression
ISO
Vincristine results in increased expression of DOK4 mRNA
CTD
PMID:23649840
NCBI chr19:10,146,520...10,157,187
Ensembl chr19:10,146,474...10,158,203
G
Donson
DNA replication fork stabilization factor DONSON
decreases expression
ISO
Vincristine results in decreased expression of DONSON mRNA
CTD
PMID:23649840
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpp4
dipeptidylpeptidase 4
decreases expression
ISO
Vincristine results in decreased expression of DPP4 mRNA
CTD
PMID:23649840
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpyd
dihydropyrimidine dehydrogenase
increases response to substance
ISO
DPYD gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dram1
DNA-damage regulated autophagy modulator 1
increases expression
ISO
Vincristine results in increased expression of DRAM1 mRNA
CTD
PMID:23649840
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
G
Dtl
denticleless E3 ubiquitin protein ligase homolog
decreases expression
ISO
Vincristine results in decreased expression of DTL mRNA
CTD
PMID:23649840
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Vincristine results in increased expression of DUSP1 mRNA
CTD
PMID:23649840
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Vincristine results in increased expression of DUSP10 mRNA
CTD
PMID:23649840
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
Vincristine results in increased expression of DUSP16 mRNA
CTD
PMID:23649840
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
Vincristine results in increased expression of DUSP2 mRNA
CTD
PMID:23649840
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
Vincristine results in increased expression of DUSP4 mRNA
CTD
PMID:23649840
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dynlt2
dynein light chain Tctex-type 2
decreases expression
ISO
Vincristine results in decreased expression of DYNLT2 mRNA
CTD
PMID:23649840
NCBI chr 1:55,971,285...55,983,249
Ensembl chr 1:55,971,283...55,983,307
G
E2f8
E2F transcription factor 8
decreases expression
ISO
Vincristine results in decreased expression of E2F8 mRNA
CTD
PMID:23649840
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ebf1
EBF transcription factor 1
increases expression
ISO
Vincristine results in increased expression of EBF1 mRNA
CTD
PMID:23649840
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
G
Ednrb
endothelin receptor type B
increases expression
EXP
Vincristine results in increased expression of EDNRB mRNA
CTD
PMID:20624997
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Efna4
ephrin A4
decreases expression
ISO
Vincristine results in decreased expression of EFNA4 mRNA
CTD
PMID:23649840
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
G
Egfl6
EGF-like-domain, multiple 6
decreases response to substance
ISO
EGFL6 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
G
Egr1
early growth response 1
increases expression
ISO
Vincristine results in increased expression of EGR1 mRNA
CTD
PMID:12706485 PMID:23649840
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr3
early growth response 3
increases expression
ISO
Vincristine results in increased expression of EGR3 mRNA
CTD
PMID:23649840
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehbp1l1
EH domain binding protein 1-like 1
decreases expression
ISO
Vincristine results in decreased expression of EHBP1L1 mRNA
CTD
PMID:23649840
NCBI chr 1:202,994,115...203,014,320
Ensembl chr 1:202,994,118...203,014,270
G
Eif1
eukaryotic translation initiation factor 1
decreases expression
ISO
Vincristine results in decreased expression of EIF1 mRNA
CTD
PMID:23649840
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
G
Eif1ad
eukaryotic translation initiation factor 1A domain containing
decreases expression
ISO
Vincristine results in decreased expression of EIF1AD mRNA
CTD
PMID:23649840
NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression multiple interactions
EXP
Vincristine results in increased expression of EIF2AK3 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of EIF2AK3 mRNA]
CTD
PMID:33038355
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
decreases expression
ISO
Vincristine results in decreased expression of EIF3B mRNA
CTD
PMID:23649840
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
ISO
Vincristine results in increased expression of EIF3M mRNA
CTD
PMID:23649840
NCBI chr 3:91,424,754...91,442,358
Ensembl chr 3:91,416,325...91,442,392
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
Vincristine results in increased expression of EIF4A1 mRNA
CTD
PMID:23649840
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4a2
eukaryotic translation initiation factor 4A2
decreases expression
ISO
Vincristine results in decreased expression of EIF4A2 mRNA
CTD
PMID:23649840
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Elf3
E74 like ETS transcription factor 3
increases expression
ISO
Vincristine results in increased expression of ELF3 mRNA
CTD
PMID:23649840
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Elk3
ETS transcription factor ELK3
increases expression
ISO
Vincristine results in increased expression of ELK3 mRNA
CTD
PMID:23649840
NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084
G
Eme2
essential meiotic structure-specific endonuclease subunit 2
decreases expression
ISO
Vincristine results in decreased expression of EME2 mRNA
CTD
PMID:23649840
NCBI chr10:13,913,216...13,915,991
Ensembl chr10:13,913,221...13,915,968
G
Eml6
EMAP like 6
decreases expression
ISO
Vincristine results in decreased expression of EML6 mRNA
CTD
PMID:23649840
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
G
Enox1
ecto-NOX disulfide-thiol exchanger 1
increases expression
ISO
Vincristine results in increased expression of ENOX1 mRNA
CTD
PMID:23649840
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Vincristine results in increased expression of ENPP2 mRNA
CTD
PMID:23649840
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Ensa
endosulfine alpha
decreases expression
ISO
Vincristine results in decreased expression of ENSA mRNA
CTD
PMID:23649840
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
increases expression
ISO
Vincristine results in increased expression of ENTPD2 mRNA
CTD
PMID:23649840
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
G
Eomes
eomesodermin
decreases expression
ISO
Vincristine results in decreased expression of EOMES mRNA
CTD
PMID:23649840
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
G
Epg5
ectopic P-granules 5 autophagy tethering factor
increases expression
ISO
Vincristine results in increased expression of EPG5 mRNA
CTD
PMID:23649840
NCBI chr18:71,403,990...71,502,079
Ensembl chr18:71,404,010...71,501,502
G
Ephb1
Eph receptor B1
decreases expression
ISO
Vincristine results in decreased expression of EPHB1 mRNA
CTD
PMID:23649840
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
G
Ephx1
epoxide hydrolase 1
decreases expression
ISO
Vincristine results in decreased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epm2aip1
EPM2A interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of EPM2AIP1 mRNA
CTD
PMID:23649840
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
G
Epor
erythropoietin receptor
decreases expression
ISO
Vincristine results in decreased expression of EPOR mRNA
CTD
PMID:23649840
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
EXP
Vincristine results in increased expression of EPRS1 mRNA
CTD
PMID:20624997
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Epsti1
epithelial stromal interaction 1
increases expression
ISO
Vincristine results in increased expression of EPSTI1 mRNA
CTD
PMID:23649840
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
G
Erich3
glutamate-rich 3
decreases expression
ISO
Vincristine results in decreased expression of ERICH3 mRNA
CTD
PMID:23649840
NCBI chr 2:243,615,777...243,717,973
Ensembl chr 2:243,615,872...243,715,317
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression multiple interactions
EXP
Vincristine results in increased expression of ERN1 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of ERN1 mRNA]
CTD
PMID:33038355
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
decreases expression
ISO
Vincristine results in decreased expression of ESCO2 mRNA
CTD
PMID:23649840
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esd
esterase D
decreases expression
ISO
Vincristine results in decreased expression of ESD mRNA
CTD
PMID:23649840
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Esm1
endothelial cell-specific molecule 1
decreases expression
EXP
Vincristine results in decreased expression of ESM1 mRNA
CTD
PMID:20624997
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Esr1
estrogen receptor 1
multiple interactions decreases expression
ISO
bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR1 mRNA]; bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR1 protein]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR1 mRNA]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR1 protein]; Vincristine binds to and results in decreased activity of ESR1 protein Vincristine results in decreased expression of ESR1 mRNA; Vincristine results in decreased expression of ESR1 protein
CTD
PMID:25752796 PMID:35263089
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions decreases expression
ISO
bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR2 mRNA]; bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR2 protein]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR2 mRNA]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR2 protein] Vincristine results in decreased expression of ESR2 mRNA; Vincristine results in decreased expression of ESR2 protein
CTD
PMID:35263089
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Evc
EvC ciliary complex subunit 1
increases expression
ISO
Vincristine results in increased expression of EVC mRNA
CTD
PMID:23649840
NCBI chr14:73,456,181...73,498,955
Ensembl chr14:73,456,222...73,498,099
G
Exo1
exonuclease 1
decreases expression
ISO
Vincristine results in decreased expression of EXO1 mRNA
CTD
PMID:23649840
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exog
exo/endonuclease G
decreases expression
ISO
Vincristine results in decreased expression of EXOG mRNA
CTD
PMID:23649840
NCBI chr 8:119,184,974...119,204,819
Ensembl chr 8:119,185,136...119,204,672
G
Ext1
exostosin glycosyltransferase 1
increases expression
ISO
Vincristine results in increased expression of EXT1 mRNA
CTD
PMID:23649840
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
G
F2
coagulation factor II, thrombin
affects expression
ISO
Vincristine affects the expression of F2 protein
CTD
PMID:12542493
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F3
coagulation factor III, tissue factor
increases expression
ISO EXP
Vincristine results in increased expression of F3 mRNA; Vincristine results in increased expression of F3 protein
CTD
PMID:12542493 PMID:20624997
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fam13b
family with sequence similarity 13, member B
increases expression
ISO
Vincristine results in increased expression of FAM13B mRNA
CTD
PMID:23649840
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
G
Fam13c
family with sequence similarity 13, member C
increases expression
ISO
Vincristine results in increased expression of FAM13C mRNA
CTD
PMID:23649840
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam171b
family with sequence similarity 171, member B
decreases expression
ISO
Vincristine results in decreased expression of FAM171B mRNA
CTD
PMID:23649840
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
G
Fam174a
family with sequence similarity 174, member A
increases expression
ISO
Vincristine results in increased expression of FAM174A mRNA
CTD
PMID:23649840
NCBI chr 9:95,742,815...95,761,083
Ensembl chr 9:95,742,927...95,761,081
G
Fam76b
family with sequence similarity 76, member B
decreases expression
ISO
Vincristine results in decreased expression of FAM76B mRNA
CTD
PMID:23649840
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
G
Fam81a
family with sequence similarity 81, member A
decreases expression
ISO
Vincristine results in decreased expression of FAM81A mRNA
CTD
PMID:23649840
NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
Vincristine results in decreased expression of FAM83D mRNA
CTD
PMID:23649840
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fancf
FA complementation group F
decreases expression
ISO
Vincristine results in decreased expression of FANCF mRNA
CTD
PMID:23649840
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
G
Fancg
FA complementation group G
decreases expression
ISO
Vincristine results in decreased expression of FANCG mRNA
CTD
PMID:23649840
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
G
Fas
Fas cell surface death receptor
increases expression
ISO
Vincristine results in increased expression of FAS mRNA
CTD
PMID:23649840
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
increases expression
ISO
Vincristine results in increased expression of FASLG protein
CTD
PMID:11716366
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fastkd2
FAST kinase domains 2
decreases expression
ISO
Vincristine results in decreased expression of FASTKD2 mRNA
CTD
PMID:23649840
NCBI chr 9:65,166,148...65,188,184
Ensembl chr 9:65,168,228...65,188,174
G
Fbxl20
F-box and leucine-rich repeat protein 20
decreases expression
ISO
Vincristine results in decreased expression of FBXL20 mRNA
CTD
PMID:23649840
NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162
G
Fbxl4
F-box and leucine-rich repeat protein 4
decreases expression
ISO
Vincristine results in decreased expression of FBXL4 mRNA
CTD
PMID:23649840
NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443
G
Fbxo33
F-box protein 33
decreases expression
ISO
Vincristine results in decreased expression of FBXO33 mRNA
CTD
PMID:23649840
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
G
Fbxo5
F-box protein 5
decreases expression
ISO
Vincristine results in decreased expression of FBXO5 mRNA
CTD
PMID:23649840
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fbxo9
f-box protein 9
decreases expression
ISO
Vincristine results in decreased expression of FBXO9 mRNA
CTD
PMID:23649840
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Vincristine results in increased expression of FCGR2B mRNA
CTD
PMID:20624997
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
Vincristine results in increased expression of FDFT1 mRNA
CTD
PMID:23649840
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fermt2
FERM domain containing kindlin 2
increases expression
ISO
Vincristine results in increased expression of FERMT2 mRNA
CTD
PMID:23649840
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
G
Ffar2
free fatty acid receptor 2
decreases expression
ISO
Vincristine results in decreased expression of FFAR2 mRNA
CTD
PMID:23649840
NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Vincristine results in decreased expression of FGR mRNA
CTD
PMID:23649840
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Flot2
flotillin 2
decreases expression
ISO
Vincristine results in decreased expression of FLOT2 mRNA
CTD
PMID:23649840
NCBI chr10:62,926,047...62,947,759
Ensembl chr10:62,920,665...62,947,756
G
Flt1
Fms related receptor tyrosine kinase 1
decreases expression
ISO
Vincristine results in decreased expression of FLT1 mRNA
CTD
PMID:23649840
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fmnl3
formin-like 3
increases expression
ISO
Vincristine results in increased expression of FMNL3 mRNA
CTD
PMID:23649840
NCBI chr 7:130,454,270...130,505,626
Ensembl chr 7:130,454,275...130,505,626
G
Fnbp1
formin binding protein 1
increases expression
ISO
Vincristine results in increased expression of FNBP1 mRNA
CTD
PMID:23649840
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
G
Fnbp4
formin binding protein 4
increases expression
ISO
Vincristine results in increased expression of FNBP4 mRNA
CTD
PMID:23649840
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Vincristine results in increased expression of FOS protein
CTD
PMID:18930597
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
ISO
Vincristine results in increased expression of FOSL2 mRNA
CTD
PMID:23649840
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxk2
forkhead box K2
decreases expression
ISO
Vincristine results in decreased expression of FOXK2 mRNA
CTD
PMID:23649840
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
G
Foxo1
forkhead box O1
multiple interactions decreases expression
EXP
Quercetin inhibits the reaction [Vincristine results in decreased expression of FOXO1 mRNA]
CTD
PMID:33038355
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Foxp1
forkhead box P1
increases expression
ISO
Vincristine results in increased expression of FOXP1 mRNA
CTD
PMID:23649840
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Fry
FRY microtubule binding protein
decreases expression
ISO
Vincristine results in decreased expression of FRY mRNA
CTD
PMID:23649840
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
G
Fscn1
fascin actin-bundling protein 1
increases expression
ISO
Vincristine results in increased expression of FSCN1 mRNA
CTD
PMID:23649840
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fsd1l
fibronectin type III and SPRY domain containing 1-like
increases expression
ISO
Vincristine results in increased expression of FSD1L mRNA
CTD
PMID:23649840
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
G
Fubp1
far upstream element binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of FUBP1 mRNA
CTD
PMID:23649840
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fut11
fucosyltransferase 11
decreases expression
ISO
Vincristine results in decreased expression of FUT11 mRNA
CTD
PMID:23649840
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
G
G3bp1
G3BP stress granule assembly factor 1
increases expression
ISO
Vincristine results in increased expression of G3BP1 mRNA
CTD
PMID:23649840
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP ISO
Vincristine results in increased expression of GADD45A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
EXP
Vincristine results in increased expression of GADD45B mRNA
CTD
PMID:20624997
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
EXP
Vincristine results in increased expression of GADD45G mRNA
CTD
PMID:20624997
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Garin1b
golgi associated RAB2 interactor 1B
increases expression
ISO
Vincristine results in increased expression of GARIN1B mRNA
CTD
PMID:23649840
NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
decreases expression
ISO
Vincristine results in decreased expression of GART mRNA
CTD
PMID:23649840
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gas7
growth arrest specific 7
decreases expression
EXP
Vincristine results in decreased expression of GAS7 mRNA
CTD
PMID:20624997
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
G
Gbp1
guanylate binding protein 1
increases expression
ISO
Vincristine results in increased expression of GBP1 mRNA
CTD
PMID:23649840
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp2
guanylate binding protein 2
increases expression
ISO
Vincristine results in increased expression of GBP2 mRNA
CTD
PMID:23649840
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp6
guanylate binding protein family member 6
decreases expression
ISO
Vincristine results in decreased expression of GBP6 mRNA
CTD
PMID:23649840
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine
CTD
PMID:10900222
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions decreases expression
ISO
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine Vincristine results in decreased expression of GCLM mRNA
CTD
PMID:10900222 PMID:23649840
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Vincristine results in increased expression of GDF15 mRNA
CTD
PMID:23649840
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gfap
glial fibrillary acidic protein
increases expression multiple interactions
EXP ISO
Vincristine results in increased expression of GFAP protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein]
CTD
PMID:33038355 PMID:34286406
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfi1
growth factor independent 1 transcriptional repressor
decreases expression
ISO
Vincristine results in decreased expression of GFI1 mRNA
CTD
PMID:23649840
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
G
Gfm1
G elongation factor, mitochondrial 1
increases expression
ISO
Vincristine results in increased expression of GFM1 mRNA
CTD
PMID:23649840
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
G
Gja1
gap junction protein, alpha 1
increases expression multiple interactions
ISO
Vincristine results in increased expression of GJA1 mRNA; Vincristine results in increased expression of GJA1 protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; gap 27 peptide inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; gap 27 peptide inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL1B protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL6 protein]; KN 62 inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; zinc chloride inhibits the reaction [Vincristine results in increased expression of GJA1 protein]
CTD
PMID:34286406
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjc1
gap junction protein, gamma 1
decreases expression
ISO
Vincristine results in decreased expression of GJC1 mRNA
CTD
PMID:23649840
NCBI chr10:87,758,192...87,785,443
Ensembl chr10:87,760,528...87,785,867
G
Gli1
GLI family zinc finger 1
increases response to substance
ISO
GLI1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
Vincristine results in increased expression of GLIPR1 mRNA
CTD
PMID:23649840
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Gmfb
glia maturation factor, beta
increases expression
ISO
Vincristine results in increased expression of GMFB mRNA
CTD
PMID:23649840
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
G
Gmppb
GDP-mannose pyrophosphorylase B
decreases expression
ISO
Vincristine results in decreased expression of GMPPB mRNA
CTD
PMID:23649840
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
G
Gna15
G protein subunit alpha 15
increases expression
ISO
Vincristine results in increased expression of GNA15 mRNA
CTD
PMID:23649840
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
G
Gng2
G protein subunit gamma 2
increases expression
ISO
Vincristine results in increased expression of GNG2 mRNA
CTD
PMID:23649840
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
G
Gon4l
gon-4 like
increases expression
ISO
Vincristine results in increased expression of GON4L mRNA
CTD
PMID:23649840
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
G
Gopc
golgi associated PDZ and coiled-coil motif containing
decreases expression
ISO
Vincristine results in decreased expression of GOPC mRNA
CTD
PMID:23649840
NCBI chr20:31,727,617...31,776,904
Ensembl chr20:31,727,620...31,776,903
G
Gpatch11
G patch domain containing 11
decreases expression
ISO
Vincristine results in decreased expression of GPATCH11 mRNA
CTD
PMID:23649840
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
G
Gpatch2
G patch domain containing 2
increases expression
ISO
Vincristine results in increased expression of GPATCH2 mRNA
CTD
PMID:23649840
NCBI chr13:98,784,993...98,925,696
Ensembl chr13:98,784,969...98,925,661
G
Gpatch2l
G patch domain containing 2-like
increases expression
ISO
Vincristine results in increased expression of GPATCH2L mRNA
CTD
PMID:23649840
NCBI chr 6:105,883,383...105,935,644
Ensembl chr 6:105,883,460...105,934,888
G
Gpbp1l1
GC-rich promoter binding protein 1-like 1
increases expression
ISO
Vincristine results in increased expression of GPBP1L1 mRNA
CTD
PMID:23649840
NCBI chr 5:130,009,768...130,050,636
Ensembl chr 5:130,023,137...130,050,459
G
Gpc3
glypican 3
increases response to substance
ISO
GPC3 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
decreases expression
ISO
Vincristine results in decreased expression of GPD2 mRNA
CTD
PMID:23649840
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpnmb
glycoprotein nmb
increases expression
ISO
Vincristine results in increased expression of GPNMB mRNA
CTD
PMID:23649840
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr132
G protein-coupled receptor 132
increases expression
ISO
Vincristine results in increased expression of GPR132 mRNA
CTD
PMID:23649840
NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:131,924,160...131,942,168
G
Gpr137b
G protein-coupled receptor 137B
increases expression
ISO
Vincristine results in increased expression of GPR137B mRNA
CTD
PMID:23649840
NCBI chr17:86,003,635...86,041,841
Ensembl chr17:85,966,921...86,041,835
G
Gpr180
G protein-coupled receptor 180
decreases expression
ISO
Vincristine results in decreased expression of GPR180 mRNA
CTD
PMID:23649840
NCBI chr15:95,195,782...95,224,955
Ensembl chr15:95,199,777...95,228,373
G
Gpr55
G protein-coupled receptor 55
increases expression
ISO
Vincristine results in increased expression of GPR55 mRNA
CTD
PMID:23649840
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
G
Gpr63
G protein-coupled receptor 63
decreases expression
ISO
Vincristine results in decreased expression of GPR63 mRNA
CTD
PMID:23649840
NCBI chr 5:38,672,548...38,727,224
Ensembl chr 5:38,635,472...38,727,677
G
Gpr84
G protein-coupled receptor 84
increases expression
ISO
Vincristine results in increased expression of GPR84 mRNA
CTD
PMID:23649840
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity
EXP
Quercetin inhibits the reaction [Vincristine results in increased activity of GPT protein]
CTD
PMID:36808657
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gramd2b
GRAM domain containing 2B
increases expression
ISO
Vincristine results in increased expression of GRAMD2B mRNA
CTD
PMID:23649840
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
G
Grap2
GRB2-related adaptor protein 2
decreases expression
ISO
Vincristine results in decreased expression of GRAP2 mRNA
CTD
PMID:23649840
NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
Vincristine results in increased expression of GSPT1 mRNA
CTD
PMID:23649840
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
G
Gstm1
glutathione S-transferase mu 1
affects response to substance decreases response to substance multiple interactions
ISO
GSTM1 gene polymorphism affects the susceptibility to Vincristine GSTM1 protein results in decreased susceptibility to Vincristine Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine]
CTD
PMID:15044619 PMID:15713801
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
decreases response to substance multiple interactions
ISO
GSTP1 protein results in decreased susceptibility to Vincristine GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]
CTD
PMID:10900222
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf3c3
general transcription factor IIIC subunit 3
increases expression
ISO
Vincristine results in increased expression of GTF3C3 mRNA
CTD
PMID:23649840
NCBI chr 9:55,882,252...55,943,037
Ensembl chr 9:55,883,721...55,942,967
G
Gtpbp3
GTP binding protein 3
decreases expression
ISO
Vincristine results in decreased expression of GTPBP3 mRNA
CTD
PMID:23649840
NCBI chr16:18,175,766...18,180,857
Ensembl chr16:18,175,766...18,180,857
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased phosphorylation of H2AX protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased phosphorylation of H2AX protein
CTD
PMID:28669723
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2bc12
H2B clustered histone 12
increases expression
ISO
Vincristine results in increased expression of H2BC12 mRNA
CTD
PMID:23649840
NCBI chr17:42,485,699...42,486,162
G
H2bc3
H2B clustered histone 3
increases expression
ISO
Vincristine results in increased expression of H2BC3 mRNA
CTD
PMID:23649840
NCBI chr17:41,380,056...41,380,686
G
H2bc6
H2B clustered histone 6
increases expression
ISO
Vincristine results in increased expression of H2BC6 mRNA
CTD
PMID:23649840
NCBI chr17:41,520,775...41,521,238
G
Hamp
hepcidin antimicrobial peptide
decreases expression
ISO
Vincristine results in decreased expression of HAMP mRNA
CTD
PMID:25633564
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Haus2
HAUS augmin like complex subunit 2
decreases expression
ISO
Vincristine results in decreased expression of HAUS2 mRNA
CTD
PMID:23649840
NCBI chr 3:107,553,146...107,565,982
Ensembl chr 3:107,553,161...107,565,157
G
Hbb
hemoglobin subunit beta
decreases expression
ISO
Vincristine results in decreased expression of HBB mRNA
CTD
PMID:23649840
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hbb-b1
hemoglobin, beta adult major chain
decreases expression
ISO
Vincristine results in decreased expression of HBD mRNA
CTD
PMID:23649840
NCBI chr 1:158,224,175...158,231,675
Ensembl chr 1:158,120,200...158,252,012
G
Hdac1
histone deacetylase 1
decreases expression
EXP
Vincristine results in decreased expression of HDAC1 protein
CTD
PMID:27474498
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac4
histone deacetylase 4
decreases expression
EXP
Vincristine results in decreased expression of HDAC4 protein
CTD
PMID:27474498
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdac9
histone deacetylase 9
decreases expression
ISO
Vincristine results in decreased expression of HDAC9 mRNA
CTD
PMID:23649840
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Hdhd3
haloacid dehalogenase-like hydrolase domain containing 3
decreases expression
ISO
Vincristine results in decreased expression of HDHD3 mRNA
CTD
PMID:23649840
NCBI chr 5:75,951,308...75,954,775
Ensembl chr 5:75,946,013...75,955,266
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
increases expression
ISO
Vincristine results in increased expression of HECTD4 mRNA
CTD
PMID:23649840
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
G
Hells
helicase, lymphoid specific
decreases expression
ISO
Vincristine results in decreased expression of HELLS mRNA
CTD
PMID:23649840
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Heph
hephaestin
increases expression
ISO
Vincristine results in increased expression of HEPH mRNA
CTD
PMID:23649840
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hhat
hedgehog acyltransferase
increases expression
ISO
Vincristine results in increased expression of HHAT mRNA
CTD
PMID:23649840
NCBI chr13:104,024,507...104,283,580
Ensembl chr13:104,010,916...104,282,893
G
Hic1
HIC ZBTB transcriptional repressor 1
decreases expression
ISO
Vincristine results in decreased expression of HIC1 mRNA
CTD
PMID:23649840
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
G
Hilpda
hypoxia inducible lipid droplet-associated
decreases expression
ISO
Vincristine results in decreased expression of HILPDA mRNA
CTD
PMID:23649840
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hint1
histidine triad nucleotide binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of HINT1 mRNA
CTD
PMID:23649840
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hint3
histidine triad nucleotide binding protein 3
increases expression
ISO
Vincristine results in increased expression of HINT3 mRNA
CTD
PMID:23649840
NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
G
Hist1h2al1
histone cluster 1 H2A family like 1
increases expression
ISO
Vincristine results in increased expression of H2AC6 mRNA
CTD
PMID:23649840
NCBI chr17:42,707,954...42,708,420
G
Hist1h2bc
histone cluster 1, H2bc
increases expression
ISO
Vincristine results in increased expression of H2BC21 mRNA
CTD
PMID:23649840
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
Vincristine results in increased expression of H2BC5 mRNA
CTD
PMID:23649840
NCBI chr17:42,792,887...42,793,268
G
Hist1h2bq
histone cluster 1 H2B family member Q
increases expression
ISO
Vincristine results in increased expression of H2BC7 mRNA
CTD
PMID:23649840
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
G
Hivep3
HIVEP zinc finger 3
increases expression
ISO
Vincristine results in increased expression of HIVEP3 mRNA
CTD
PMID:23649840
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
G
Hlf
HLF transcription factor, PAR bZIP family member
increases expression
ISO
Vincristine results in increased expression of HLF mRNA
CTD
PMID:23649840
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
G
Hmcn1
hemicentin 1
increases response to substance
ISO
HMCN1 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
G
Hmga2
high mobility group AT-hook 2
decreases expression
ISO
Vincristine results in decreased expression of HMGA2 mRNA
CTD
PMID:23649840
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
decreases expression increases secretion decreases response to substance
EXP ISO
Vincristine results in decreased expression of HMGB1 protein Vincristine results in increased secretion of HMGB1 protein HMGB1 protein results in decreased susceptibility to Vincristine
CTD
PMID:27474498 PMID:27807322
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgn5
high mobility group nucleosome binding domain 5
decreases expression
ISO
Vincristine results in decreased expression of HMGN5 mRNA
CTD
PMID:23649840
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
decreases expression decreases activity multiple interactions increases expression
ISO EXP
Vincristine results in decreased expression of HMOX1 mRNA Vincristine results in decreased expression of HMOX1 protein Vincristine results in decreased activity of HMOX1 protein Quercetin inhibits the reaction [Vincristine results in decreased activity of HMOX1 protein]; Quercetin inhibits the reaction [Vincristine results in decreased expression of HMOX1 protein] Vincristine results in increased expression of HMOX1 mRNA
CTD
PMID:20624997 PMID:23649840 PMID:33038355 PMID:36808657
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
ISO
Vincristine results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:23649840
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
decreases expression
ISO
Vincristine results in decreased expression of HNRNPD mRNA
CTD
PMID:23649840
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
decreases expression
ISO
Vincristine results in decreased expression of HNRNPDL mRNA
CTD
PMID:23649840
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
ISO
Vincristine results in decreased expression of HNRNPR mRNA
CTD
PMID:23649840
NCBI chr 5:148,542,999...148,574,888
Ensembl chr 5:148,543,044...148,574,867
G
Hnrnpu
heterogeneous nuclear ribonucleoprotein U
decreases expression
ISO
Vincristine results in decreased expression of HNRNPU mRNA
CTD
PMID:23649840
NCBI chr13:90,069,058...90,086,905
Ensembl chr13:90,074,181...90,086,588
G
Hook1
hook microtubule-tethering protein 1
decreases expression
ISO
Vincristine results in decreased expression of HOOK1 mRNA
CTD
PMID:23649840
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
G
Hook3
hook microtubule-tethering protein 3
decreases expression
ISO
Vincristine results in decreased expression of HOOK3 mRNA
CTD
PMID:23649840
NCBI chr16:65,954,293...66,058,812
Ensembl chr16:65,954,350...66,061,338
G
Hoxb7
homeo box B7
decreases expression
ISO
Vincristine results in decreased expression of HOXB7 mRNA
CTD
PMID:23649840
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
G
Hpdl
4-hydroxyphenylpyruvate dioxygenase-like
decreases expression
ISO
Vincristine results in decreased expression of HPDL mRNA
CTD
PMID:23649840
NCBI chr 5:130,286,627...130,288,233
Ensembl chr 5:130,286,631...130,288,233
G
Hras
HRas proto-oncogene, GTPase
increases expression
ISO
Vincristine results in increased expression of HRAS mRNA
CTD
PMID:16001973
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hs2st1
heparan sulfate 2-O-sulfotransferase 1
decreases expression
ISO
Vincristine results in decreased expression of HS2ST1 mRNA
CTD
PMID:23649840
NCBI chr 2:233,508,018...233,641,769
Ensembl chr 2:233,508,021...233,641,769
G
Hspa14
heat shock protein family A (Hsp70) member 14
decreases expression
ISO
Vincristine results in decreased expression of HSPA14 mRNA
CTD
PMID:23649840
NCBI chr17:74,728,945...74,749,727
Ensembl chr17:74,728,899...74,749,727
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions
EXP
Vincristine results in increased expression of HSPA5 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA]
CTD
PMID:33038355
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspb2
heat shock protein family B (small) member 2
decreases response to substance
ISO
HSPB2 protein results in decreased susceptibility to Vincristine
CTD
PMID:17524270
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
G
Hspd1
heat shock protein family D (Hsp60) member 1
decreases expression
ISO
Vincristine results in decreased expression of HSPD1 mRNA
CTD
PMID:23649840
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions increases expression
EXP
[alpha-phenyl-1-(2-phenylethyl)-4-piperidinemethanol binds to and results in decreased activity of HTR2A protein] which results in decreased susceptibility to Vincristine Vincristine results in increased expression of HTR2A protein
CTD
PMID:18930597
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
decreases expression
ISO
Vincristine results in decreased expression of HYLS1 mRNA
CTD
PMID:23649840
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO EXP
Vincristine results in increased expression of ICAM1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
increases expression
ISO
Vincristine results in increased expression of ICAM4 mRNA
CTD
PMID:23649840
NCBI chr 8:19,566,075...19,567,171
Ensembl chr 8:19,566,075...19,567,171
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
Vincristine results in increased expression of ID2 mRNA
CTD
PMID:23649840
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases response to substance
ISO
ID3 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Ier3
immediate early response 3
increases expression
ISO
Vincristine results in increased expression of IER3 mRNA
CTD
PMID:23649840
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi44
interferon-induced protein 44
increases expression
ISO
Vincristine results in increased expression of IFI44 mRNA
CTD
PMID:23649840
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
Vincristine results in increased expression of IFI44L mRNA
CTD
PMID:23649840
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
increases expression
ISO
Vincristine results in increased expression of IFIH1 mRNA
CTD
PMID:23649840
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
Vincristine results in increased expression of IFIT2 mRNA
CTD
PMID:23649840
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifng
interferon gamma
increases expression
ISO
Vincristine results in increased expression of IFNG mRNA
CTD
PMID:23649840
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd1
interferon-related developmental regulator 1
decreases expression
ISO
Vincristine results in decreased expression of IFRD1 mRNA
CTD
PMID:23649840
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ift20
intraflagellar transport 20
increases expression
ISO
Vincristine results in increased expression of IFT20 mRNA
CTD
PMID:23649840
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
G
Ift25
intraflagellar transport 25
decreases expression
ISO
Vincristine results in decreased expression of IFT25 mRNA
CTD
PMID:23649840
NCBI chr 5:122,035,588...122,062,421
Ensembl chr 5:122,035,581...122,062,421
G
Ift43
intraflagellar transport 43
increases expression
ISO
Vincristine results in increased expression of IFT43 mRNA
CTD
PMID:23649840
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
G
Igf1
insulin-like growth factor 1
multiple interactions decreases response to substance
ISO
Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] IGF1 protein results in decreased susceptibility to Vincristine
CTD
PMID:9452187 PMID:16740780
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ighg1
immunoglobulin heavy constant gamma 1
decreases expression
ISO
Vincristine results in decreased expression of IGHG1 mRNA
CTD
PMID:23649840
Ensembl chr 6:132,389,370...132,393,397
G
Igkc
immunoglobulin kappa constant
decreases expression
ISO
Vincristine results in decreased expression of IGKC mRNA
CTD
PMID:23649840
G
Igkv8-30l1
immunoglobulin kappa chain variable 8-30 like 1
decreases expression
ISO
Vincristine results in decreased expression of IGKV4-1 mRNA
CTD
PMID:23649840
NCBI chr 4:101,838,285...101,839,132
G
Ikzf2
IKAROS family zinc finger 2
decreases expression
ISO
Vincristine results in decreased expression of IKZF2 mRNA
CTD
PMID:23649840
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
G
Il10ra
interleukin 10 receptor subunit alpha
increases expression
ISO
Vincristine results in increased expression of IL10RA mRNA
CTD
PMID:23649840
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il15
interleukin 15
increases expression
ISO
Vincristine results in increased expression of IL15 mRNA
CTD
PMID:23649840
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17rb
interleukin 17 receptor B
decreases expression
ISO
Vincristine results in decreased expression of IL17RB mRNA
CTD
PMID:23649840
NCBI chr16:5,180,431...5,194,125
Ensembl chr16:5,180,432...5,194,125
G
Il1b
interleukin 1 beta
increases expression multiple interactions increases secretion
EXP ISO
Vincristine results in increased expression of IL1B mRNA; Vincristine results in increased expression of IL1B protein gap 27 peptide inhibits the reaction [Vincristine results in increased secretion of IL1B protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL1B protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of IL1B mRNA] coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of IL1B protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of IL1B mRNA]
CTD
PMID:20624997 PMID:29958920 PMID:34286406 PMID:34939713
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO
Vincristine results in increased expression of IL1R1 mRNA
CTD
PMID:23649840
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il2
interleukin 2
multiple interactions increases expression
EXP
tropisetron inhibits the reaction [Vincristine results in increased expression of IL2 protein]
CTD
PMID:24374478
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Vincristine results in increased expression of IL23A mRNA
CTD
PMID:23649840
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il36g
interleukin 36, gamma
increases expression
ISO
Vincristine results in increased expression of IL36G mRNA
CTD
PMID:23649840
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
G
Il6
interleukin 6
affects response to substance multiple interactions increases secretion increases expression
EXP ISO
IL6 protein affects the susceptibility to Vincristine gap 27 peptide inhibits the reaction [Vincristine results in increased secretion of IL6 protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL6 protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of IL6 mRNA] Vincristine results in increased expression of IL6 mRNA; Vincristine results in increased expression of IL6 protein
CTD
PMID:16001973 PMID:18270703 PMID:18652822 PMID:23649840 PMID:34286406
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7
interleukin 7
increases expression
ISO
Vincristine results in increased expression of IL7 mRNA
CTD
PMID:23649840
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
Ildr1
immunoglobulin-like domain containing receptor 1
increases expression
ISO
Vincristine results in increased expression of ILDR1 mRNA
CTD
PMID:23649840
NCBI chr11:64,085,774...64,118,760
Ensembl chr11:64,008,566...64,118,760
G
Ildr2
immunoglobulin-like domain containing receptor 2
decreases expression
ISO
Vincristine results in decreased expression of ILDR2 mRNA
CTD
PMID:23649840
NCBI chr13:78,518,770...78,580,627
Ensembl chr13:78,518,802...78,576,924
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
Vincristine results in decreased expression of IMPA2 mRNA
CTD
PMID:23649840
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ina
internexin neuronal intermediate filament protein, alpha
multiple interactions
ISO
INA affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine]
CTD
PMID:21246521
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Ing2
inhibitor of growth family, member 2
decreases expression
ISO
Vincristine results in decreased expression of ING2 mRNA
CTD
PMID:23649840
NCBI chr16:44,573,592...44,584,180
Ensembl chr16:44,575,597...44,583,482
G
Inha
inhibin subunit alpha
decreases expression
EXP
Vincristine results in decreased expression of INHA mRNA
CTD
PMID:20624997
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Vincristine results in increased expression of INHBE mRNA
CTD
PMID:23649840
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inpp1
inositol polyphosphate-1-phosphatase
increases expression
ISO
Vincristine results in increased expression of INPP1 mRNA
CTD
PMID:23649840
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Inpp4b
inositol polyphosphate-4-phosphatase type II B
increases expression
ISO
Vincristine results in increased expression of INPP4B mRNA
CTD
PMID:23649840
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
G
Ints11
integrator complex subunit 11
decreases expression
ISO
Vincristine results in decreased expression of INTS11 mRNA
CTD
PMID:23649840
NCBI chr 5:166,479,134...166,497,956
Ensembl chr 5:166,479,155...166,497,651
G
Ints5
integrator complex subunit 5
decreases expression
ISO
Vincristine results in decreased expression of INTS5 mRNA
CTD
PMID:23649840
NCBI chr 1:205,788,906...205,793,685
Ensembl chr 1:205,788,906...205,793,685
G
Ipo5
importin 5
decreases expression
ISO
Vincristine results in decreased expression of IPO5 mRNA
CTD
PMID:23649840
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
G
Iqgap2
IQ motif containing GTPase activating protein 2
decreases expression
ISO
Vincristine results in decreased expression of IQGAP2 mRNA
CTD
PMID:23649840
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
G
Irak2
interleukin-1 receptor-associated kinase 2
increases expression
ISO
Vincristine results in increased expression of IRAK2 mRNA
CTD
PMID:23649840
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Ireb2
iron responsive element binding protein 2
increases expression
ISO
Vincristine results in increased expression of IREB2 mRNA
CTD
PMID:23649840
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
G
Irf1
interferon regulatory factor 1
increases expression
ISO
Vincristine results in increased expression of IRF1 mRNA
CTD
PMID:23649840
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
Vincristine results in increased expression of ISG20 mRNA
CTD
PMID:23649840
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
increases expression
ISO
Vincristine results in increased expression of ISLR mRNA
CTD
PMID:23649840
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
G
Itga1
integrin subunit alpha 1
increases response to substance
ISO
ITGA1 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
G
Itga4
integrin subunit alpha 4
decreases expression
ISO
Vincristine results in decreased expression of ITGA4 mRNA
CTD
PMID:23649840
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itgam
integrin subunit alpha M
increases expression
ISO
Vincristine results in increased expression of ITGAM mRNA
CTD
PMID:23649840
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb1bp2
integrin subunit beta 1 binding protein 2
decreases expression
ISO
Vincristine results in decreased expression of ITGB1BP2 mRNA
CTD
PMID:23649840
NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174
G
Itgb7
integrin subunit beta 7
decreases expression
ISO
Vincristine results in decreased expression of ITGB7 mRNA
CTD
PMID:23649840
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
G
Itgb8
integrin subunit beta 8
increases expression
ISO
Vincristine results in increased expression of ITGB8 mRNA
CTD
PMID:23649840
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
G
Itpkb
inositol-trisphosphate 3-kinase B
decreases expression
ISO
Vincristine results in decreased expression of ITPKB mRNA
CTD
PMID:23649840
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
ISO
Vincristine results in increased expression of ITPR1 mRNA
CTD
PMID:23649840
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itprid2
ITPR interacting domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of ITPRID2 mRNA
CTD
PMID:23649840
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Itpripl1
ITPRIP like 1
decreases expression
ISO
Vincristine results in decreased expression of ITPRIPL1 mRNA
CTD
PMID:23649840
NCBI chr 3:114,403,123...114,407,917
Ensembl chr 3:114,402,270...114,414,497
G
Ivl
involucrin
increases expression
ISO
Vincristine results in increased expression of IVL mRNA
CTD
PMID:23649840
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Ivns1abp
influenza virus NS1A binding protein
decreases expression
ISO
Vincristine results in decreased expression of IVNS1ABP mRNA
CTD
PMID:23649840
NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701
G
Jade2
jade family PHD finger 2
increases expression
ISO
Vincristine results in increased expression of JADE2 mRNA
CTD
PMID:23649840
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
G
Jchain
joining chain of multimeric IgA and IgM
decreases expression
ISO
Vincristine results in decreased expression of JCHAIN mRNA
CTD
PMID:23649840
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
G
Jmjd1c
jumonji domain containing 1C
increases expression
ISO
Vincristine results in increased expression of JMJD1C mRNA
CTD
PMID:23649840
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Jpt1
Jupiter microtubule associated homolog 1
decreases expression
ISO
Vincristine results in decreased expression of JPT1 mRNA
CTD
PMID:23649840
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Vincristine results in increased expression of JUN mRNA
CTD
PMID:23649840
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kat2b
lysine acetyltransferase 2B
increases expression
ISO
Vincristine results in increased expression of KAT2B mRNA
CTD
PMID:16001973
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
G
Kcmf1
potassium channel modulatory factor 1
decreases expression
ISO
Vincristine results in decreased expression of KCMF1 mRNA
CTD
PMID:23649840
NCBI chr 4:104,888,452...104,950,234
Ensembl chr 4:104,889,847...104,950,234
G
Kcna5
potassium voltage-gated channel subfamily A member 5
increases response to substance
ISO
KCNA5 protein results in increased susceptibility to Vincristine
CTD
PMID:17428690
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
increases expression
ISO
Vincristine results in increased expression of KCNMB1 mRNA
CTD
PMID:23649840
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
increases expression
ISO
Vincristine results in increased expression of KCNN2 mRNA
CTD
PMID:23649840
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Kdm2b
lysine demethylase 2B
increases expression
ISO
Vincristine results in increased expression of KDM2B mRNA
CTD
PMID:23649840
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Kdsr
3-ketodihydrosphingosine reductase
decreases expression
ISO
Vincristine results in decreased expression of KDSR mRNA
CTD
PMID:23649840
NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
G
Klf12
KLF transcription factor 12
decreases expression
ISO
Vincristine results in decreased expression of KLF12 mRNA
CTD
PMID:23649840
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Klf6
KLF transcription factor 6
increases expression
ISO
Vincristine results in increased expression of KLF6 mRNA
CTD
PMID:23649840
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klhl14
kelch-like family member 14
decreases expression
ISO
Vincristine results in decreased expression of KLHL14 mRNA
CTD
PMID:23649840
NCBI chr18:12,804,253...12,917,828
Ensembl chr18:12,804,253...12,917,828
G
Klhl28
kelch-like family member 28
increases expression
ISO
Vincristine results in increased expression of KLHL28 mRNA
CTD
PMID:23649840
NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164
G
Kmt5b
lysine methyltransferase 5B
increases expression
ISO
Vincristine results in increased expression of KMT5B mRNA
CTD
PMID:23649840
NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Vincristine results in decreased expression of KPNA2 mRNA
CTD
PMID:23649840
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Krt23
keratin 23
increases response to substance
ISO
KRT23 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
G
Krt7
keratin 7
increases expression
ISO
Vincristine results in increased expression of KRT7 mRNA
CTD
PMID:23649840
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Kynu
kynureninase
increases expression
ISO
Vincristine results in increased expression of KYNU mRNA
CTD
PMID:23649840
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lactb2
lactamase, beta 2
decreases expression
ISO
Vincristine results in decreased expression of LACTB2 mRNA
CTD
PMID:23649840
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lama2
laminin subunit alpha 2
increases response to substance
ISO
LAMA2 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lamp3
lysosomal-associated membrane protein 3
increases expression
ISO
Vincristine results in increased expression of LAMP3 mRNA
CTD
PMID:23649840
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Larp1b
La ribonucleoprotein 1B
decreases expression
ISO
Vincristine results in decreased expression of LARP1B mRNA
CTD
PMID:23649840
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Lbh
LBH regulator of WNT signaling pathway
decreases expression
ISO
Vincristine results in decreased expression of LBH mRNA
CTD
PMID:23649840
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
G
Lce1b
late cornified envelope 1B
increases expression
ISO
Vincristine results in increased expression of LCE1B mRNA
CTD
PMID:23649840
NCBI chr 2:178,255,351...178,257,533
Ensembl chr 2:178,256,213...178,257,985
G
Lcor
ligand dependent nuclear receptor corepressor
increases expression
ISO
Vincristine results in increased expression of LCOR mRNA
CTD
PMID:23649840
NCBI chr 1:240,298,565...240,405,627
Ensembl chr 1:240,298,563...240,402,448
G
Lcorl
ligand dependent nuclear receptor corepressor-like
decreases expression
ISO
Vincristine results in decreased expression of LCORL mRNA
CTD
PMID:23649840
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
G
Lcp2
lymphocyte cytosolic protein 2
increases expression
ISO
Vincristine results in increased expression of LCP2 mRNA
CTD
PMID:23649840
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
increases expression
ISO
Vincristine results in increased expression of LDLRAD4 mRNA
CTD
PMID:23649840
NCBI chr18:61,519,253...61,848,403
Ensembl chr18:61,521,428...61,843,238
G
Ldlrap1
low density lipoprotein receptor adaptor protein 1
decreases expression
ISO
Vincristine results in decreased expression of LDLRAP1 mRNA
CTD
PMID:23649840
NCBI chr 5:146,955,607...146,978,601
Ensembl chr 5:146,955,607...146,978,601
G
Leg1
liver enriched gene 1
increases expression
ISO
Vincristine results in increased expression of C6ORF58 mRNA
CTD
PMID:23649840
NCBI chr 1:28,799,902...28,816,230
Ensembl chr 1:28,799,902...28,815,993
G
Leng8
leukocyte receptor cluster member 8
decreases expression
ISO
Vincristine results in decreased expression of LENG8 mRNA
CTD
PMID:23649840
NCBI chr 1:70,040,785...70,052,662
Ensembl chr 1:70,040,785...70,052,488
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Vincristine results in increased expression of LIF mRNA
CTD
PMID:23649840
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
Vincristine results in increased expression of LIMA1 mRNA
CTD
PMID:23649840
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
Vincristine results in increased expression of LIMS1 mRNA
CTD
PMID:23649840
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lmna
lamin A/C
increases expression
ISO
Vincristine results in increased expression of LMNA mRNA
CTD
PMID:23649840
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lnpep
leucyl and cystinyl aminopeptidase
increases expression
ISO
Vincristine results in increased expression of LNPEP mRNA
CTD
PMID:23649840
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
Lrba
LPS responsive beige-like anchor protein
decreases expression
ISO
Vincristine results in decreased expression of LRBA mRNA
CTD
PMID:23649840
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
G
Lrch3
leucine rich repeats and calponin homology domain containing 3
increases expression
ISO
Vincristine results in increased expression of LRCH3 mRNA
CTD
PMID:23649840
NCBI chr11:67,772,499...67,872,269
Ensembl chr11:67,772,506...67,872,264
G
Lrp8
LDL receptor related protein 8
decreases expression
ISO
Vincristine results in decreased expression of LRP8 mRNA
CTD
PMID:23649840
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
Vincristine results in decreased expression of LRRC8C mRNA
CTD
PMID:23649840
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
G
Lrrcc1
leucine rich repeat and coiled-coil centrosomal protein 1
decreases expression
ISO
Vincristine results in decreased expression of LRRCC1 mRNA
CTD
PMID:23649840
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
G
Lrrfip1
LRR binding FLII interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of LRRFIP1 mRNA
CTD
PMID:23649840
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
G
Lta
lymphotoxin alpha
increases expression
ISO
Vincristine results in increased expression of LTA mRNA
CTD
PMID:23649840
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Lto1
LTO1 maturation factor of ABCE1
decreases expression
ISO
Vincristine results in decreased expression of LTO1 mRNA
CTD
PMID:23649840
NCBI chr 1:200,074,247...200,080,951
Ensembl chr 1:200,074,253...200,088,061
G
Lum
lumican
decreases response to substance
ISO
LUM mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Ly96
lymphocyte antigen 96
increases expression
ISO
Vincristine results in increased expression of LY96 mRNA
CTD
PMID:23649840
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lztfl1
leucine zipper transcription factor-like 1
decreases expression
ISO
Vincristine results in decreased expression of LZTFL1 mRNA
CTD
PMID:23649840
NCBI chr 8:123,344,085...123,360,245
Ensembl chr 8:123,344,925...123,360,192
G
Lzts2
leucine zipper tumor suppressor 2
decreases expression
ISO
Vincristine results in decreased expression of LZTS2 mRNA
CTD
PMID:23649840
NCBI chr 1:243,876,665...243,888,489
Ensembl chr 1:243,880,022...243,888,423
G
Macf1
microtubule-actin crosslinking factor 1
increases expression
ISO
Vincristine results in increased expression of MACF1 mRNA
CTD
PMID:23649840
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
G
Macir
macrophage immunometabolism regulator
decreases expression
ISO
Vincristine results in decreased expression of MACIR mRNA
CTD
PMID:23649840
NCBI chr 9:98,420,760...98,440,818
Ensembl chr 9:98,420,376...98,441,733
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Vincristine results in increased expression of MAFF mRNA
CTD
PMID:23649840
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Magt1
magnesium transporter 1
decreases expression
ISO
Vincristine results in decreased expression of MAGT1 mRNA
CTD
PMID:23649840
NCBI chr X:71,038,489...71,079,704
Ensembl chr X:71,038,489...71,079,699
G
Man2a1
mannosidase, alpha, class 2A, member 1
decreases expression
ISO
Vincristine results in decreased expression of MAN2A1 mRNA
CTD
PMID:23649840
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
G
Manea
mannosidase, endo-alpha
decreases expression
ISO
Vincristine results in decreased expression of MANEA mRNA
CTD
PMID:23649840
NCBI chr 5:40,196,373...40,218,540
Ensembl chr 5:40,196,396...40,218,459
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression multiple interactions
ISO EXP
Vincristine results in increased expression of MAP1LC3B mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of MAP1LC3B protein]
CTD
PMID:23649840 PMID:36808657
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
ISO
Vincristine results in decreased expression of MAP3K1 mRNA
CTD
PMID:23649840
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
Vincristine results in decreased expression of MAP3K7 mRNA
CTD
PMID:23649840
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
Vincristine results in increased expression of MAP3K8 mRNA
CTD
PMID:23649840
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
increases expression
ISO
Vincristine results in increased expression of MAP4K4 mRNA
CTD
PMID:23649840
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mapkbp1
mitogen activated protein kinase binding protein 1
increases expression
ISO
Vincristine results in increased expression of MAPKBP1 mRNA
CTD
PMID:23649840
NCBI chr 3:106,947,342...106,998,368
Ensembl chr 3:106,947,827...106,996,199
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
decreases localization multiple interactions
ISO
Vincristine results in decreased localization of MAPRE1 protein olesoxime inhibits the reaction [Vincristine results in decreased localization of MAPRE1 protein]
CTD
PMID:20417191
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
multiple interactions affects localization
ISO
olesoxime inhibits the reaction [Vincristine results in decreased localization of MAPRE3 protein] Vincristine affects the localization of MAPRE3 protein
CTD
PMID:20417191
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Marchf7
membrane associated ring-CH-type finger 7
increases expression
ISO
Vincristine results in increased expression of MARCHF7 mRNA
CTD
PMID:23649840
NCBI chr 3:44,680,229...44,720,172
Ensembl chr 3:44,681,632...44,720,168
G
Marcks
myristoylated alanine rich protein kinase C substrate
increases expression
ISO
Vincristine results in increased expression of MARCKS mRNA
CTD
PMID:23649840
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Mars1
methionyl-tRNA synthetase 1
decreases expression
ISO
Vincristine results in decreased expression of MARS1 mRNA
CTD
PMID:23649840
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
G
Mars2
methionyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
Vincristine results in decreased expression of MARS2 mRNA
CTD
PMID:23649840
NCBI chr 9:56,720,408...56,729,991
Ensembl chr 9:56,720,983...56,723,820
G
Matn2
matrilin 2
decreases response to substance
ISO
MATN2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Matr3
matrin 3
decreases expression
ISO
Vincristine results in decreased expression of MATR3 mRNA
CTD
PMID:23649840
NCBI chr18:27,154,098...27,193,212
Ensembl chr18:27,163,714...27,193,166
G
Max
MYC associated factor X
decreases expression
ISO
Vincristine results in decreased expression of MAX mRNA
CTD
PMID:23649840
NCBI chr 6:95,636,859...95,662,204
Ensembl chr 6:95,636,858...95,662,137
G
Mbd4
methyl-CpG binding domain 4 DNA glycosylase
decreases expression
ISO
Vincristine results in decreased expression of MBD4 mRNA
CTD
PMID:23649840
NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982
G
Mbnl3
muscleblind-like splicing regulator 3
decreases expression
ISO
Vincristine results in decreased expression of MBNL3 mRNA
CTD
PMID:23649840
NCBI chr X:130,641,942...130,737,179
Ensembl chr X:130,648,538...130,737,056
G
Mbtd1
mbt domain containing 1
increases expression
ISO
Vincristine results in increased expression of MBTD1 mRNA
CTD
PMID:23649840
NCBI chr10:78,839,140...78,895,413
Ensembl chr10:78,839,036...78,893,720
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
increases expression
ISO
Vincristine results in increased expression of MCCC2 mRNA
CTD
PMID:23649840
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
Vincristine results in increased expression of MCL1 mRNA
CTD
PMID:23649840
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
Vincristine results in decreased expression of MCM4 mRNA
CTD
PMID:23649840
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcmbp
minichromosome maintenance complex binding protein
increases expression
ISO
Vincristine results in increased expression of MCMBP mRNA
CTD
PMID:23649840
NCBI chr 1:183,270,598...183,316,975
Ensembl chr 1:183,271,980...183,316,975
G
Mcoln2
mucolipin TRP cation channel 2
increases expression
ISO
Vincristine results in increased expression of MCOLN2 mRNA
CTD
PMID:23649840
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
G
Mdm2
MDM2 proto-oncogene
increases expression decreases expression
ISO
Vincristine results in increased expression of MDM2 mRNA Vincristine results in decreased expression of MDM2 mRNA
CTD
PMID:16001973 PMID:23649840
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mdn1
midasin AAA ATPase 1
increases expression
ISO
Vincristine results in increased expression of MDN1 mRNA
CTD
PMID:23649840
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
G
Med29
mediator complex subunit 29
decreases expression
ISO
Vincristine results in decreased expression of MED29 mRNA
CTD
PMID:23649840
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
G
Med31
mediator complex subunit 31
decreases expression
ISO
Vincristine results in decreased expression of MED31 mRNA
CTD
PMID:23649840
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
G
Mettl3
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of METTL3 mRNA
CTD
PMID:23649840
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
G
Mfsd5
major facilitator superfamily domain containing 5
decreases expression
ISO
Vincristine results in decreased expression of MFSD5 mRNA
CTD
PMID:23649840
NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396
G
Mfsd6
major facilitator superfamily domain containing 6
decreases expression
ISO
Vincristine results in decreased expression of MFSD6 mRNA
CTD
PMID:23649840
NCBI chr 9:48,773,171...48,858,471
Ensembl chr 9:48,773,414...48,858,465
G
Mga
MAX dimerization protein MGA
increases expression
ISO
Vincristine results in increased expression of MGA mRNA
CTD
PMID:23649840
NCBI chr 3:106,851,216...106,942,908
Ensembl chr 3:106,851,140...106,941,043
G
Mgat4a
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
decreases expression
ISO
Vincristine results in decreased expression of MGAT4A mRNA
CTD
PMID:23649840
NCBI chr 9:39,673,427...39,786,747
Ensembl chr 9:39,673,430...39,766,890
G
Mgmt
O-6-methylguanine-DNA methyltransferase
multiple interactions
ISO
[MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Vincristine; MGMT affects the susceptibility to [Procarbazine co-treated with Vincristine co-treated with Nitrosourea Compounds]; MGMT protein affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine]
CTD
PMID:11792417 PMID:16033832 PMID:16936459
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mical3
microtubule associated monooxygenase, calponin and LIM domain containing 3
increases expression
ISO
Vincristine results in increased expression of MICAL3 mRNA
CTD
PMID:23649840
NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590
G
Mir132
microRNA 132
increases expression
ISO
Vincristine results in increased expression of MIR132 mRNA
CTD
PMID:32505695
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
G
Mir497
microRNA 497
multiple interactions
ISO
[MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Vincristine
CTD
PMID:21258880
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
G
Mki67
marker of proliferation Ki-67
increases response to substance
ISO
MKI67 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mkln1
muskelin 1
increases expression
ISO
Vincristine results in increased expression of MKLN1 mRNA
CTD
PMID:23649840
NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993
G
Mknk2
MAPK interacting serine/threonine kinase 2
increases expression
ISO
Vincristine results in increased expression of MKNK2 mRNA
CTD
PMID:23649840
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mllt3
MLLT3, super elongation complex subunit
increases expression
ISO
Vincristine results in increased expression of MLLT3 mRNA
CTD
PMID:23649840
NCBI chr 5:102,259,075...102,515,447
Ensembl chr 5:102,260,011...102,515,361
G
Mmd
monocyte to macrophage differentiation-associated
increases expression
ISO
Vincristine results in increased expression of MMD mRNA
CTD
PMID:23649840
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
G
Mnd1
meiotic nuclear divisions 1
decreases expression
ISO
Vincristine results in decreased expression of MND1 mRNA
CTD
PMID:23649840
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mpz
myelin protein zero
increases response to substance
ISO
MPZ gene results in increased susceptibility to Vincristine
CTD
PMID:16676325
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
G
Mr1
major histocompatibility complex, class I-related
increases expression
ISO
Vincristine results in increased expression of MR1 mRNA
CTD
PMID:23649840
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mrpl30
mitochondrial ribosomal protein L30
decreases expression
ISO
Vincristine results in decreased expression of MRPL30 mRNA
CTD
PMID:23649840
NCBI chr 9:40,125,352...40,136,189
Ensembl chr 9:40,125,430...40,137,257
G
Mrpl39
mitochondrial ribosomal protein L39
decreases expression
ISO
Vincristine results in decreased expression of MRPL39 mRNA
CTD
PMID:23649840
NCBI chr11:23,779,655...23,795,146
Ensembl chr11:23,779,662...23,795,125
G
Mrpl50
mitochondrial ribosomal protein L50
decreases expression
ISO
Vincristine results in decreased expression of MRPL50 mRNA
CTD
PMID:23649840
NCBI chr 5:63,867,437...63,872,591
G
Mrps16
mitochondrial ribosomal protein S16
decreases expression
ISO
Vincristine results in decreased expression of MRPS16 mRNA
CTD
PMID:23649840
NCBI chr15:3,918,621...3,921,024
Ensembl chr15:3,918,615...3,921,656
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
increases expression
ISO
Vincristine results in increased expression of ND6 mRNA
CTD
PMID:23649840
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mt2-ps1
metallothionein 2, pseudogene 1
increases expression
ISO
Vincristine results in increased expression of MT1HL1 mRNA
CTD
PMID:23649840
NCBI chr20:3,159,037...3,159,409
Ensembl chr 5:119,728,811...119,730,073
G
Mt2A
metallothionein 2A
increases expression
ISO
Vincristine results in increased expression of MT2A mRNA
CTD
PMID:23649840
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mta3
metastasis associated 1 family, member 3
decreases expression
ISO
Vincristine results in decreased expression of MTA3 mRNA
CTD
PMID:23649840
NCBI chr 6:10,867,028...10,987,221
Ensembl chr 6:10,867,011...10,986,883
G
Mtcp1
mature T-cell proliferation 1
decreases expression
ISO
Vincristine results in decreased expression of MTCP1 mRNA
CTD
PMID:23649840
NCBI chr18:126,189...130,123
G
Mtfr2
mitochondrial fission regulator 2
decreases expression
ISO
Vincristine results in decreased expression of MTFR2 mRNA
CTD
PMID:23649840
NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832
G
Mtg2
mitochondrial ribosome-associated GTPase 2
increases expression
ISO
Vincristine results in increased expression of MTG2 mRNA
CTD
PMID:23649840
NCBI chr 3:167,165,542...167,181,358
Ensembl chr 3:167,165,982...167,181,358
G
Mthfd2l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
decreases expression
ISO
Vincristine results in decreased expression of MTHFD2L mRNA
CTD
PMID:23649840
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
G
Mtrf1l
mitochondrial translation release factor 1 like
decreases expression
ISO
Vincristine results in decreased expression of MTRF1L mRNA
CTD
PMID:23649840
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
G
Mvp
major vault protein
increases expression
ISO
Vincristine results in increased expression of MVP mRNA
CTD
PMID:23649840
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
G
Mxd1
max dimerization protein 1
increases expression
ISO
Vincristine results in increased expression of MXD1 mRNA
CTD
PMID:23649840
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression increases expression
ISO EXP
Vincristine results in decreased expression of MYC mRNA Vincristine results in increased expression of MYC mRNA
CTD
PMID:16001973 PMID:20624997
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
decreases response to substance multiple interactions
ISO
MYCN protein results in decreased susceptibility to Vincristine [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine
CTD
PMID:10348353
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Myh11
myosin heavy chain 11
increases expression
ISO
Vincristine results in increased expression of MYH11 mRNA
CTD
PMID:23649840
NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459
G
Mysm1
myb-like, SWIRM and MPN domains 1
increases expression
ISO
Vincristine results in increased expression of MYSM1 mRNA
CTD
PMID:23649840
NCBI chr 5:109,761,345...109,826,652
Ensembl chr 5:109,776,286...109,819,967
G
Mzb1
marginal zone B and B1 cell-specific protein
decreases expression
ISO
Vincristine results in decreased expression of MZB1 mRNA
CTD
PMID:23649840
NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,239,001...27,241,094
G
N4bp2l2
NEDD4 binding protein 2-like 2
increases expression
ISO
Vincristine results in increased expression of N4BP2L2 mRNA
CTD
PMID:23649840
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Naa25
N(alpha)-acetyltransferase 25, NatB auxiliary subunit
decreases expression
ISO
Vincristine results in decreased expression of NAA25 mRNA
CTD
PMID:23649840
NCBI chr12:35,098,256...35,150,498
Ensembl chr12:35,098,075...35,150,467
G
Naa50
N(alpha)-acetyltransferase 50, NatE catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of NAA50 mRNA
CTD
PMID:23649840
NCBI chr11:56,538,366...56,560,842
Ensembl chr11:56,538,366...56,560,842
G
Nabp1
nucleic acid binding protein 1
increases expression
ISO
Vincristine results in increased expression of NABP1 mRNA
CTD
PMID:23649840
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Naca
nascent polypeptide associated complex subunit alpha
decreases expression
ISO
Vincristine results in decreased expression of NACA mRNA
CTD
PMID:23649840
NCBI chr 7:468,862...481,992
Ensembl chr 7:469,723...481,992
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
Vincristine results in increased expression of NAMPT mRNA
CTD
PMID:23649840
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Napb
NSF attachment protein beta
increases expression
ISO
Vincristine results in increased expression of NAPB mRNA
CTD
PMID:23649840
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
Vincristine results in decreased expression of NASP mRNA
CTD
PMID:23649840
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Nbn
nibrin
increases expression
EXP
Vincristine results in increased expression of NBN mRNA
CTD
PMID:20624997
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Ncbp1
nuclear cap binding protein subunit 1
decreases expression
ISO
Vincristine results in decreased expression of NCBP1 mRNA
CTD
PMID:23649840
NCBI chr 5:60,416,023...60,449,004
Ensembl chr 5:60,415,982...60,449,089
G
Nceh1
neutral cholesterol ester hydrolase 1
increases expression
ISO
Vincristine results in increased expression of NCEH1 mRNA
CTD
PMID:23649840
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
G
Ncf2
neutrophil cytosolic factor 2
increases expression
ISO
Vincristine results in increased expression of NCF2 mRNA
CTD
PMID:23649840
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ncoa7
nuclear receptor coactivator 7
increases expression
ISO
Vincristine results in increased expression of NCOA7 mRNA
CTD
PMID:23649840
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
G
Nde1
nudE neurodevelopment protein 1
increases expression
ISO
Vincristine results in increased expression of NDE1 mRNA
CTD
PMID:23649840
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Ndufb4
NADH:ubiquinone oxidoreductase subunit B4
decreases expression
ISO
Vincristine results in decreased expression of NDUFB4 mRNA
CTD
PMID:23649840
NCBI chr11:63,063,723...63,070,426
Ensembl chr11:63,063,795...63,070,425
G
Nefl
neurofilament light chain
increases expression multiple interactions
EXP
Vincristine results in increased expression of NEFL protein coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of NEFL protein]
CTD
PMID:34939713
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
increases expression
ISO
Vincristine results in increased expression of NEURL3 mRNA
CTD
PMID:23649840
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
Vincristine results in increased expression of NFAT5 mRNA
CTD
PMID:23649840
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nfatc2
nuclear factor of activated T-cells 2
increases response to substance
ISO
NFATC2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325
G
Nfe2l1
NFE2 like bZIP transcription factor 1
increases expression
ISO
Vincristine results in increased expression of NFE2L1 mRNA
CTD
PMID:23649840
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of NFE2L2 mRNA; Vincristine results in decreased expression of NFE2L2 protein coenzyme Q10 inhibits the reaction [Vincristine results in decreased expression of NFE2L2 mRNA]; Quercetin inhibits the reaction [Vincristine results in decreased expression of NFE2L2 protein]
CTD
PMID:33038355 PMID:34939713 PMID:36808657
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfe2l3
NFE2 like bZIP transcription factor 3
decreases expression
ISO
Vincristine results in decreased expression of NFE2L3 mRNA
CTD
PMID:23649840
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
G
Ngf
nerve growth factor
multiple interactions decreases response to substance
EXP
Bicuculline inhibits the reaction [Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Bicuculline inhibits the reaction [Thiopental inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]; Thiopental inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein] NGF protein results in decreased susceptibility to Vincristine; Vincristine results in decreased susceptibility to NGF protein
CTD
PMID:9524088 PMID:9622663 PMID:10553948 PMID:11991087
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nhsl1
NHS-like 1
increases expression
ISO
Vincristine results in increased expression of NHSL1 mRNA
CTD
PMID:23649840
NCBI chr 1:12,956,525...13,188,580
Ensembl chr 1:12,956,021...13,187,547
G
Ninj1
ninjurin 1
increases expression
ISO
Vincristine results in increased expression of NINJ1 mRNA
CTD
PMID:23649840
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nisch
nischarin
decreases expression
ISO
Vincristine results in decreased expression of NISCH mRNA
CTD
PMID:23649840
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to Vincristine
CTD
PMID:18463239
NCBI chr 8:98,892,168...99,003,912
Ensembl chr 8:98,873,398...99,020,645
G
Nmrk2
nicotinamide riboside kinase 2
decreases response to substance
ISO
ITGB1BP3 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:8,514,855...8,517,916
Ensembl chr 7:8,514,927...8,517,922
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Vincristine results in decreased expression of NNT mRNA
CTD
PMID:23649840
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nol12
nucleolar protein 12
decreases expression
ISO
Vincristine results in decreased expression of NOL12 mRNA
CTD
PMID:23649840
NCBI chr 7:110,493,294...110,498,908
Ensembl chr 7:110,493,246...110,498,907
G
Nol4l
nucleolar protein 4-like
increases expression
ISO
Vincristine results in increased expression of NOL4L mRNA
CTD
PMID:23649840
NCBI chr 3:141,884,840...142,007,668
Ensembl chr 3:141,884,840...142,008,976
G
Nos1
nitric oxide synthase 1
decreases expression
ISO
Vincristine results in decreased expression of NOS1 protein
CTD
PMID:16098672
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Npl
N-acetylneuraminate pyruvate lyase
increases expression
ISO
Vincristine results in increased expression of NPL mRNA
CTD
PMID:23649840
NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases activity multiple interactions
EXP
Vincristine results in decreased activity of NQO1 protein Quercetin inhibits the reaction [Vincristine results in decreased activity of NQO1 protein]
CTD
PMID:33038355
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
Vincristine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases activity
ISO
[Vincristine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; NR1I2 protein promotes the reaction [Vincristine results in increased expression of ABCB1 protein]
CTD
PMID:20041327
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
decreases expression
ISO
Vincristine results in decreased expression of NR2F2 mRNA
CTD
PMID:23649840
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
increases expression
ISO
Vincristine results in increased expression of NR5A2 mRNA
CTD
PMID:23649840
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
Vincristine results in decreased expression of NREP mRNA
CTD
PMID:23649840
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrn1
neuritin 1
decreases expression
ISO
Vincristine results in decreased expression of NRN1 mRNA
CTD
PMID:23649840
NCBI chr17:28,129,969...28,138,898
Ensembl chr17:28,129,977...28,138,896
G
Nsmce4a
NSE4 homolog A, SMC5-SMC6 complex component
decreases expression
ISO
Vincristine results in decreased expression of NSMCE4A mRNA
CTD
PMID:23649840
NCBI chr 1:185,102,075...185,109,166
Ensembl chr 1:185,094,360...185,109,166
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Vincristine results in increased expression of NT5E mRNA
CTD
PMID:23649840
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nudt7
nudix hydrolase 7
decreases expression
ISO
Vincristine results in decreased expression of NUDT7 mRNA
CTD
PMID:23649840
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
G
Nuf2
NUF2 component of NDC80 kinetochore complex
increases expression
ISO
Vincristine results in increased expression of NUF2 mRNA
CTD
PMID:23649840
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Numb
NUMB, endocytic adaptor protein
increases expression
ISO
Vincristine results in increased expression of NUMB mRNA
CTD
PMID:23649840
NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354
G
Nup153
nucleoporin 153
increases expression
ISO
Vincristine results in increased expression of NUP153 mRNA
CTD
PMID:23649840
NCBI chr17:17,972,217...18,024,876
Ensembl chr17:17,972,217...18,024,876
G
Nxt1
nuclear transport factor 2-like export factor 1
decreases expression
ISO
Vincristine results in decreased expression of NXT1 mRNA
CTD
PMID:23649840
NCBI chr 3:136,108,975...136,111,897
Ensembl chr 3:136,108,862...136,111,907
G
Oga
O-GlcNAcase
increases expression
ISO
Vincristine results in increased expression of OGA mRNA
CTD
PMID:23649840
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
G
Ogg1
8-oxoguanine DNA glycosylase
decreases expression
ISO
Vincristine results in decreased expression of OGG1 mRNA
CTD
PMID:23649840
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
ISO
Vincristine results in decreased expression of OGT mRNA
CTD
PMID:23649840
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Olah
oleoyl-ACP hydrolase
increases expression
ISO
Vincristine results in increased expression of OLAH mRNA
CTD
PMID:23649840
NCBI chr17:74,877,651...74,902,517
Ensembl chr17:74,877,655...74,902,518
G
Orai1
ORAI calcium release-activated calcium modulator 1
decreases expression
ISO
Vincristine results in decreased expression of ORAI1 mRNA
CTD
PMID:23649840
NCBI chr12:33,533,151...33,548,361
Ensembl chr12:33,534,344...33,548,405
G
Otp
orthopedia homeobox
increases expression
ISO
Vincristine results in increased expression of OTP mRNA
CTD
PMID:23649840
NCBI chr 2:26,108,158...26,116,359
Ensembl chr 2:26,108,163...26,116,359
G
Oxtr
oxytocin receptor
affects response to substance
ISO
OXTR protein affects the susceptibility to Vincristine
CTD
PMID:33429010
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
G
P2rx5
purinergic receptor P2X 5
decreases expression
ISO
Vincristine results in decreased expression of P2RX5 mRNA
CTD
PMID:23649840
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
G
P2rx7
purinergic receptor P2X 7
multiple interactions
EXP
[(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) binds to and results in decreased activity of P2RX7 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:16982702
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
Vincristine results in decreased expression of P4HA1 mRNA
CTD
PMID:23649840
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Pabpc1l
poly(A) binding protein, cytoplasmic 1-like
decreases expression
ISO
Vincristine results in decreased expression of PABPC1L mRNA
CTD
PMID:23649840
NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
G
Pabpn1
poly(A) binding protein, nuclear 1
decreases expression
ISO
Vincristine results in decreased expression of PABPN1 mRNA
CTD
PMID:23649840
NCBI chr15:28,368,100...28,372,712
Ensembl chr15:28,368,100...28,372,703
G
Paip1
poly(A) binding protein interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of PAIP1 mRNA
CTD
PMID:23649840
NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241
G
Pank2
pantothenate kinase 2
decreases expression
ISO
Vincristine results in decreased expression of PANK2 mRNA
CTD
PMID:23649840
NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320
G
Paqr4
progestin and adipoQ receptor family member 4
decreases expression
ISO
Vincristine results in decreased expression of PAQR4 mRNA
CTD
PMID:23649840
NCBI chr10:12,758,970...12,762,649
Ensembl chr10:12,758,972...12,762,584
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased cleavage of PARP1 protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased cleavage of PARP1 protein
CTD
PMID:28669723
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp2
poly (ADP-ribose) polymerase 2
decreases expression
ISO
Vincristine results in decreased expression of PARP2 mRNA
CTD
PMID:23649840
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
G
Parp9
poly (ADP-ribose) polymerase family, member 9
increases expression
ISO
Vincristine results in increased expression of PARP9 mRNA
CTD
PMID:23649840
NCBI chr11:64,780,977...64,814,995
Ensembl chr11:64,780,981...64,815,455
G
Patl1
PAT1 homolog 1, processing body mRNA decay factor
decreases expression
ISO
Vincristine results in decreased expression of PATL1 mRNA
CTD
PMID:23649840
NCBI chr 1:208,831,115...208,862,904
Ensembl chr 1:208,831,115...208,862,857
G
Pbxip1
PBX homeobox interacting protein 1
increases expression
ISO
Vincristine results in increased expression of PBXIP1 mRNA
CTD
PMID:23649840
NCBI chr 2:174,856,339...174,868,922
Ensembl chr 2:174,856,397...174,868,919
G
Pced1b
PC-esterase domain containing 1B
decreases expression
ISO
Vincristine results in decreased expression of PCED1B mRNA
CTD
PMID:23649840
NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:128,391,319...128,528,231
G
Pcf11
PCF11 cleavage and polyadenylation factor subunit
decreases expression
ISO
Vincristine results in decreased expression of PCF11 mRNA
CTD
PMID:23649840
NCBI chr 1:146,694,045...146,724,030
Ensembl chr 1:146,697,646...146,724,124
G
Pcgf2
polycomb group ring finger 2
decreases expression
ISO
Vincristine results in decreased expression of PCGF2 mRNA
CTD
PMID:23649840
NCBI chr10:82,682,563...82,694,563
Ensembl chr10:82,683,553...82,693,406
G
Pcnx1
pecanex 1
increases expression
ISO
Vincristine results in increased expression of PCNX1 mRNA
CTD
PMID:23649840
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
G
Pcnx2
pecanex 2
increases expression
ISO
Vincristine results in increased expression of PCNX2 mRNA
CTD
PMID:23649840
NCBI chr19:53,718,920...53,869,559
Ensembl chr19:53,718,655...53,871,364
G
Pcsk7
proprotein convertase subtilisin/kexin type 7
increases expression
ISO
Vincristine results in increased expression of PCSK7 mRNA
CTD
PMID:23649840
NCBI chr 8:46,202,079...46,224,699
Ensembl chr 8:46,202,131...46,224,705
G
Pdcd5
programmed cell death 5
decreases expression
ISO
Vincristine results in decreased expression of PDCD5 mRNA
CTD
PMID:23649840
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pde4b
phosphodiesterase 4B
increases expression
ISO
Vincristine results in increased expression of PDE4B mRNA
CTD
PMID:23649840
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases expression
ISO
Vincristine results in decreased expression of PDK1 mRNA
CTD
PMID:23649840
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdk3
pyruvate dehydrogenase kinase 3
decreases expression
ISO
Vincristine results in decreased expression of PDK3 mRNA
CTD
PMID:23649840
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:58,486,554...58,553,557
G
Pds5b
PDS5 cohesin associated factor B
increases expression
ISO
Vincristine results in increased expression of PDS5B mRNA
CTD
PMID:23649840
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
Vincristine results in increased expression of PEA15 mRNA
CTD
PMID:23649840
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Peli1
pellino E3 ubiquitin protein ligase 1
decreases expression
ISO
Vincristine results in decreased expression of PELI1 mRNA
CTD
PMID:23649840
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
G
Pex11b
peroxisomal biogenesis factor 11 beta
decreases expression
ISO
Vincristine results in decreased expression of PEX11B mRNA
CTD
PMID:23649840
NCBI chr 2:184,172,041...184,180,972
Ensembl chr 2:184,172,004...184,181,495
G
Pex13
peroxisomal biogenesis factor 13
decreases expression
ISO
Vincristine results in decreased expression of PEX13 mRNA
CTD
PMID:23649840
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
G
Pfas
phosphoribosylformylglycinamidine synthase
decreases expression
ISO
Vincristine results in decreased expression of PFAS mRNA
CTD
PMID:23649840
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
decreases expression
ISO
Vincristine results in decreased expression of PFKFB4 mRNA
CTD
PMID:23649840
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
Vincristine results in decreased expression of PGM1 mRNA
CTD
PMID:23649840
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
Vincristine results in decreased expression of PGP mRNA
CTD
PMID:23649840
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Phf11
PHD finger protein 11
increases expression
ISO
Vincristine results in increased expression of PHF11 mRNA
CTD
PMID:23649840
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
G
Phf6
PHD finger protein 6
decreases expression
ISO
Vincristine results in decreased expression of PHF6 mRNA
CTD
PMID:23649840
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
G
Phtf2
putative homeodomain transcription factor 2
decreases expression
ISO
Vincristine results in decreased expression of PHTF2 mRNA
CTD
PMID:23649840
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
increases expression
ISO
Vincristine results in increased expression of PIK3C2A mRNA
CTD
PMID:23649840
NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases phosphorylation multiple interactions
ISO
Vincristine results in decreased phosphorylation of PIK3R1 protein 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]; bisphenol A inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]; perfluorooctanoic acid inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]
CTD
PMID:36181250
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
Vincristine results in decreased expression of PIK3R2 mRNA
CTD
PMID:23649840
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
Vincristine results in increased expression of PILRA mRNA
CTD
PMID:23649840
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
G
Pim2
Pim-2 proto-oncogene, serine/threonine kinase
increases expression
ISO
Vincristine results in increased expression of PIM2 mRNA
CTD
PMID:23649840
NCBI chr X:14,617,582...14,622,851
Ensembl chr X:14,617,582...14,622,851
G
Pitpnb
phosphatidylinositol transfer protein, beta
decreases expression
ISO
Vincristine results in decreased expression of PITPNB mRNA
CTD
PMID:23649840
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
G
Pkig
cAMP-dependent protein kinase inhibitor gamma
increases expression
ISO
Vincristine results in increased expression of PKIG mRNA
CTD
PMID:23649840
NCBI chr 3:152,330,477...152,398,085
Ensembl chr 3:152,366,041...152,398,082
G
Pla1a
phospholipase A1 member A
increases expression
ISO
Vincristine results in increased expression of PLA1A mRNA
CTD
PMID:23649840
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Pla2g4c
phospholipase A2 group IVC
increases expression
ISO
Vincristine results in increased expression of PLA2G4C mRNA
CTD
PMID:23649840
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
G
Plat
plasminogen activator, tissue type
increases expression
EXP
Vincristine results in increased expression of PLAT mRNA
CTD
PMID:20624997
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Vincristine results in increased expression of PLAUR mRNA
CTD
PMID:20624997
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of PLCXD1 mRNA
CTD
PMID:23649840
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Plek
pleckstrin
increases expression
ISO
Vincristine results in increased expression of PLEK mRNA
CTD
PMID:23649840
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Plekha2
pleckstrin homology domain containing A2
decreases expression
ISO
Vincristine results in decreased expression of PLEKHA2 mRNA
CTD
PMID:23649840
NCBI chr16:66,938,684...67,000,661
Ensembl chr16:66,939,109...66,999,395
G
Plekhg1
pleckstrin homology and RhoGEF domain containing G1
increases expression
ISO
Vincristine results in increased expression of PLEKHG1 mRNA
CTD
PMID:23649840
NCBI chr 1:40,348,684...40,434,063
Ensembl chr 1:40,311,221...40,434,063
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
Vincristine results in increased expression of PLPP3 mRNA
CTD
PMID:23649840
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Pm20d2
peptidase M20 domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of PM20D2 mRNA
CTD
PMID:23649840
NCBI chr 5:47,566,059...47,586,334
Ensembl chr 5:47,566,072...47,586,212
G
Pmp22
peripheral myelin protein 22
increases response to substance
ISO
PMP22 gene mutant form results in increased susceptibility to Vincristine
CTD
PMID:12427913
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
Vincristine results in decreased expression of PMS1 mRNA
CTD
PMID:23649840
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pnisr
PNN interacting serine and arginine rich protein
decreases expression
ISO
Vincristine results in decreased expression of PNISR mRNA
CTD
PMID:23649840
NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
G
Pnoc
prepronociceptin
decreases expression
ISO
Vincristine results in decreased expression of PNOC mRNA
CTD
PMID:23649840
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Poglut1
protein O-glucosyltransferase 1
increases expression
ISO
Vincristine results in increased expression of POGLUT1 mRNA
CTD
PMID:23649840
NCBI chr11:62,198,600...62,226,446
Ensembl chr11:62,198,513...62,226,434
G
Pogz
pogo transposable element derived with ZNF domain
increases expression
ISO
Vincristine results in increased expression of POGZ mRNA
CTD
PMID:23649840
NCBI chr 2:182,394,269...182,440,711
Ensembl chr 2:182,380,768...182,440,707
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of POLA1 mRNA
CTD
PMID:23649840
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pold3
DNA polymerase delta 3, accessory subunit
decreases expression
ISO
Vincristine results in decreased expression of POLD3 mRNA
CTD
PMID:23649840
NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665
G
Polq
DNA polymerase theta
increases expression
ISO
Vincristine results in increased expression of POLQ mRNA
CTD
PMID:23649840
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
G
Polr1b
RNA polymerase I subunit B
decreases expression
ISO
Vincristine results in decreased expression of POLR1B mRNA
CTD
PMID:23649840
NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379
G
Polr1h
RNA polymerase I subunit H
decreases response to substance multiple interactions
ISO
POLR1H protein results in decreased susceptibility to Vincristine Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]
CTD
PMID:14726695
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
G
Postn
periostin
decreases response to substance
ISO
POSTN mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Pou2af1
POU class 2 homeobox associating factor 1
decreases expression
ISO
Vincristine results in decreased expression of POU2AF1 mRNA
CTD
PMID:23649840
NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:51,474,015...51,548,819
G
Pou2f1
POU class 2 homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of POU2F1 mRNA
CTD
PMID:23649840
NCBI chr13:78,120,617...78,263,306
Ensembl chr13:78,130,685...78,263,363
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of PPARGC1A protein Quercetin inhibits the reaction [Vincristine results in decreased expression of PPARGC1A protein]
CTD
PMID:36808657
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppm1a
protein phosphatase, Mg2+/Mn2+ dependent, 1A
increases expression
ISO
Vincristine results in increased expression of PPM1A mRNA
CTD
PMID:23649840
NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
Vincristine results in increased expression of PPP1R10 mRNA
CTD
PMID:23649840
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
EXP ISO
Vincristine results in increased expression of PPP1R15A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
increases response to substance
ISO
PPP1R1B protein results in increased susceptibility to Vincristine
CTD
PMID:17470401
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Ppp1r3e
protein phosphatase 1, regulatory subunit 3E
decreases expression
ISO
Vincristine results in decreased expression of PPP1R3E mRNA
CTD
PMID:23649840
NCBI chr15:28,348,443...28,349,603
Ensembl chr15:28,347,854...28,349,603
G
Ppp4r3b
protein phosphatase 4, regulatory subunit 3B
decreases expression
ISO
Vincristine results in decreased expression of PPP4R3B mRNA
CTD
PMID:23649840
NCBI chr14:102,917,043...102,965,210
Ensembl chr14:102,917,443...103,068,192
G
Prc1
protein regulator of cytokinesis 1
increases expression
ISO
Vincristine results in increased expression of PRC1 mRNA
CTD
PMID:17374387
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prim1
DNA primase subunit 1
decreases expression
ISO
Vincristine results in decreased expression of PRIM1 mRNA
CTD
PMID:23649840
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prkcd
protein kinase C, delta
affects localization
ISO
Vincristine affects the localization of PRKCD protein
CTD
PMID:9852137
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkce
protein kinase C, epsilon
increases response to substance
EXP
PRKCE protein results in increased susceptibility to Vincristine
CTD
PMID:12809704
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
increases expression
ISO
Vincristine results in increased expression of PRKDC mRNA
CTD
PMID:23649840
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Prlr
prolactin receptor
increases expression
ISO
Vincristine results in increased expression of PRLR mRNA
CTD
PMID:23649840
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prnp
prion protein
decreases response to substance
ISO
PRNP protein results in decreased susceptibility to Vincristine
CTD
PMID:15386405
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Prpf4b
pre-mRNA processing factor 4B
decreases expression
ISO
Vincristine results in decreased expression of PRP4K mRNA
CTD
PMID:23649840
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
G
Prr12
proline rich 12
decreases expression
ISO
Vincristine results in decreased expression of PRR12 mRNA
CTD
PMID:23649840
NCBI chr 1:95,510,015...95,534,002
Ensembl chr 1:95,509,931...95,533,652
G
Prr3
proline rich 3
decreases expression
ISO
Vincristine results in decreased expression of PRR3 mRNA
CTD
PMID:23649840
NCBI chr20:2,792,868...2,799,865
Ensembl chr20:2,792,860...2,799,865
G
Prrg4
proline rich and Gla domain 4
increases expression
ISO
Vincristine results in increased expression of PRRG4 mRNA
CTD
PMID:23649840
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
Vincristine results in increased expression of PSD3 mRNA
CTD
PMID:23649840
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psme4
proteasome activator subunit 4
increases expression
ISO
Vincristine results in increased expression of PSME4 mRNA
CTD
PMID:23649840
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Psmg4
proteasome assembly chaperone 4
increases expression
ISO
Vincristine results in increased expression of PSMG4 mRNA
CTD
PMID:23649840
NCBI chr17:30,710,682...30,718,035
Ensembl chr17:30,710,682...30,718,082
G
Pspc1
paraspeckle component 1
decreases expression
ISO
Vincristine results in decreased expression of PSPC1 mRNA
CTD
PMID:23649840
NCBI chr15:30,828,617...30,911,315
Ensembl chr15:30,828,626...30,911,202
G
Ptafr
platelet-activating factor receptor
increases expression
ISO
Vincristine results in increased expression of PTAFR mRNA
CTD
PMID:23649840
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptger4
prostaglandin E receptor 4
increases expression
ISO
Vincristine results in increased expression of PTGER4 mRNA
CTD
PMID:23649840
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgr2
prostaglandin reductase 2
decreases expression
ISO
Vincristine results in decreased expression of PTGR2 mRNA
CTD
PMID:23649840
NCBI chr 6:103,931,367...103,963,113
Ensembl chr 6:103,931,409...103,963,111
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
Vincristine results in increased expression of PTGS2 mRNA; Vincristine results in increased expression of PTGS2 protein KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 protein]
CTD
PMID:34286406
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
increases phosphorylation
ISO
Vincristine results in increased phosphorylation of PTK2B protein
CTD
PMID:11478917
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
decreases expression
ISO
Vincristine results in decreased expression of PTPN11 mRNA
CTD
PMID:23649840
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
increases expression
ISO
Vincristine results in increased expression of PTPN13 mRNA
CTD
PMID:23649840
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Ptpn3
protein tyrosine phosphatase, non-receptor type 3
increases expression
ISO
Vincristine results in increased expression of PTPN3 mRNA
CTD
PMID:23649840
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
G
Ptprk
protein tyrosine phosphatase, receptor type, K
increases expression
ISO
Vincristine results in increased expression of PTPRK mRNA
CTD
PMID:23649840
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
G
Ptpro
protein tyrosine phosphatase, receptor type, O
increases expression
ISO
Vincristine results in increased expression of PTPRO mRNA
CTD
PMID:23649840
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Ptprr
protein tyrosine phosphatase, receptor type, R
increases expression
ISO
Vincristine results in increased expression of PTPRR mRNA
CTD
PMID:23649840
NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603
G
Pvrig
PVR related immunoglobulin domain containing
decreases expression
ISO
Vincristine results in decreased expression of PVRIG mRNA
CTD
PMID:23649840
NCBI chr12:17,363,721...17,365,577
Ensembl chr12:17,364,080...17,365,280
G
Pxt1
peroxisomal testis enriched protein 1
increases expression
ISO
Vincristine results in increased expression of PXT1 mRNA
CTD
PMID:23649840
NCBI chr20:7,002,270...7,005,296
Ensembl chr20:7,002,271...7,006,780
G
Qrich1
glutamine-rich 1
increases phosphorylation
ISO
Vincristine results in increased phosphorylation of QRICH1 protein
CTD
PMID:17510977
NCBI chr 8:109,216,900...109,256,472
Ensembl chr 8:109,217,376...109,261,359
G
Rab11fip1
RAB11 family interacting protein 1
increases expression
ISO
Vincristine results in increased expression of RAB11FIP1 mRNA
CTD
PMID:23649840
NCBI chr16:64,886,902...64,917,491
Ensembl chr16:64,884,676...64,917,491
G
Rab11fip3
RAB11 family interacting protein 3
increases expression
ISO
Vincristine results in increased expression of RAB11FIP3 mRNA
CTD
PMID:23649840
NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
G
Rab12
RAB12, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB12 mRNA
CTD
PMID:23649840
NCBI chr 9:106,480,301...106,506,895
Ensembl chr 9:106,480,301...106,506,910
G
Rab20
RAB20, member RAS oncogene family
decreases expression
ISO
Vincristine results in decreased expression of RAB20 mRNA
CTD
PMID:23649840
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
G
Rab21
RAB21, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB21 mRNA
CTD
PMID:23649840
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
G
Rab29
RAB29, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB29 mRNA
CTD
PMID:23649840
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
G
Rab8b
RAB8B, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB8B mRNA
CTD
PMID:23649840
NCBI chr 8:67,458,921...67,536,466
Ensembl chr 8:67,458,923...67,536,384
G
Rab9a
RAB9A, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB9A mRNA
CTD
PMID:23649840
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
decreases expression
ISO
Vincristine results in decreased expression of RABGGTB mRNA
CTD
PMID:23649840
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rabif
RAB interacting factor
decreases expression
ISO
Vincristine results in decreased expression of RABIF mRNA
CTD
PMID:23649840
NCBI chr13:45,936,371...45,948,929
Ensembl chr13:45,936,369...45,949,775
G
Rac2
Rac family small GTPase 2
affects response to substance
ISO
RAC2 protein affects the susceptibility to Vincristine
CTD
PMID:19783987
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rack1
receptor for activated C kinase 1
decreases expression
ISO
Vincristine results in decreased expression of RACK1 mRNA
CTD
PMID:23649840
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Rad54l
RAD54 like
decreases expression
ISO
Vincristine results in decreased expression of RAD54L mRNA
CTD
PMID:23649840
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Ralgdsl1
ral guanine nucleotide dissociation stimulator like 1
increases expression
ISO
Vincristine results in increased expression of RGL1 mRNA
CTD
PMID:23649840
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
G
Rasef
RAS and EF hand domain containing
increases expression
ISO
Vincristine results in increased expression of RASEF mRNA
CTD
PMID:23649840
NCBI chr 5:87,548,908...87,619,286
Ensembl chr 5:87,548,908...87,619,031
G
Rassf1
Ras association domain family member 1
increases expression
EXP
Vincristine results in increased expression of RASSF1 mRNA
CTD
PMID:20624997
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rassf4
Ras association domain family member 4
increases expression
ISO
Vincristine results in increased expression of RASSF4 mRNA
CTD
PMID:23649840
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased phosphorylation of RB1 protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased phosphorylation of RB1 protein; [XL019 compound co-treated with Vincristine] results in increased expression of and results in increased phosphorylation of RB1 protein modified form
CTD
PMID:28669723 PMID:29187454
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
increases expression
ISO
Vincristine results in increased expression of RBBP4 mRNA
CTD
PMID:23649840
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
Vincristine results in decreased expression of RBBP8 mRNA
CTD
PMID:23649840
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
Vincristine results in decreased expression of RBL1 mRNA
CTD
PMID:23649840
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
Vincristine results in decreased expression of RBM12 mRNA
CTD
PMID:23649840
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915 Ensembl chr 3:144,611,623...144,629,915
G
Rbm15
RNA binding motif protein 15
decreases expression
ISO
Vincristine results in decreased expression of RBM15 mRNA
CTD
PMID:23649840
NCBI chr 2:194,945,974...194,954,498
Ensembl chr 2:194,945,974...194,954,703
G
Rbm17
RNA binding motif protein 17
decreases response to substance
ISO
RBM17 protein results in decreased susceptibility to Vincristine
CTD
PMID:16061639
NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014
G
Rbm18
RNA binding motif protein 18
increases expression
ISO
Vincristine results in increased expression of RBM18 mRNA
CTD
PMID:23649840
NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178
G
Rbm25
RNA binding motif protein 25
decreases expression
ISO
Vincristine results in decreased expression of RBM25 mRNA
CTD
PMID:23649840
NCBI chr 6:103,271,775...103,319,090
Ensembl chr 6:103,271,801...103,317,854
G
Rbm4b
RNA binding motif protein 4B
decreases expression
ISO
Vincristine results in decreased expression of RBM4B mRNA
CTD
PMID:23649840
NCBI chr 1:202,047,934...202,058,025
Ensembl chr 1:202,047,927...202,058,020
G
Rbm5
RNA binding motif protein 5
decreases expression
ISO
Vincristine results in decreased expression of RBM5 mRNA
CTD
PMID:23649840
NCBI chr 8:108,420,220...108,449,481
Ensembl chr 8:108,420,222...108,449,430
G
Rbm6
RNA binding motif protein 6
decreases expression
ISO
Vincristine results in decreased expression of RBM6 mRNA
CTD
PMID:23649840
NCBI chr 8:108,452,687...108,552,783
Ensembl chr 8:108,452,687...108,552,771
G
Rbm8a
RNA binding motif protein 8A
decreases expression
ISO
Vincristine results in decreased expression of RBM8A mRNA
CTD
PMID:23649840
NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959
G
Rcc1l
RCC1 like
increases expression
ISO
Vincristine results in increased expression of RCC1L mRNA
CTD
PMID:23649840
NCBI chr12:22,543,125...22,574,042
Ensembl chr12:22,543,734...22,574,036
G
Recql4
RecQ like helicase 4
decreases expression
ISO
Vincristine results in decreased expression of RECQL4 mRNA
CTD
PMID:23649840
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Rel
REL proto-oncogene, NF-kB subunit
increases expression
ISO
Vincristine results in increased expression of REL mRNA
CTD
PMID:23649840
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression increases phosphorylation
EXP ISO
coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of RELA protein]; Sumatriptan inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein] KN 93 inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein]
CTD
PMID:29958920 PMID:34286406 PMID:34939713
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reps1
RALBP1 associated Eps domain containing 1
increases expression
ISO
Vincristine results in increased expression of REPS1 mRNA
CTD
PMID:23649840
NCBI chr 1:12,697,742...12,775,562
Ensembl chr 1:12,697,747...12,775,561
G
Rev1
REV1, DNA directed polymerase
decreases expression
ISO
Vincristine results in decreased expression of REV1 mRNA
CTD
PMID:23649840
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
G
Rffl
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
increases expression
ISO
Vincristine results in increased expression of RFFL mRNA
CTD
PMID:23649840
NCBI chr10:67,740,711...67,803,669
Ensembl chr10:67,740,712...67,824,434
G
Rftn1
raftlin lipid raft linker 1
increases expression
ISO
Vincristine results in increased expression of RFTN1 mRNA
CTD
PMID:23649840
NCBI chr 9:10,804,611...11,002,084
Ensembl chr 9:10,804,611...11,002,084
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
Vincristine results in increased expression of RGS1 mRNA
CTD
PMID:23649840
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rgs10
regulator of G-protein signaling 10
increases response to substance
ISO
RGS10 protein results in increased susceptibility to Vincristine
CTD
PMID:21044322
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Vincristine results in increased expression of RGS16 mRNA
CTD
PMID:23649840
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs17
regulator of G-protein signaling 17
increases response to substance
ISO
RGS17 protein results in increased susceptibility to Vincristine
CTD
PMID:21044322
NCBI chr 1:42,222,248...42,324,625
Ensembl chr 1:42,227,070...42,324,609
G
Rhof
ras homolog family member F, filopodia associated
increases expression
ISO
Vincristine results in increased expression of RHOF mRNA
CTD
PMID:23649840
NCBI chr12:33,422,375...33,446,689
Ensembl chr12:33,431,280...33,446,703
G
Rhoq
ras homolog family member Q
increases expression
ISO
Vincristine results in increased expression of RHOQ mRNA
CTD
PMID:23649840
NCBI chr 6:7,613,632...7,652,047
G
Rif1
replication timing regulatory factor 1
decreases expression
ISO
Vincristine results in decreased expression of RIF1 mRNA
CTD
PMID:23649840
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
Vincristine results in increased expression of RIPK2 mRNA
CTD
PMID:23649840
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rnase6
ribonuclease A family member 6
decreases expression
ISO
Vincristine results in decreased expression of RNASE6 mRNA
CTD
PMID:23649840
NCBI chr15:24,354,305...24,357,289
Ensembl chr15:24,354,303...24,357,328
G
Rnf144a
ring finger protein 144A
decreases expression
ISO
Vincristine results in decreased expression of RNF144A mRNA
CTD
PMID:23649840
NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012
G
Rnf19b
ring finger protein 19B
increases expression
ISO
Vincristine results in increased expression of RNF19B mRNA
CTD
PMID:23649840
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rnf213
ring finger protein 213
decreases expression
ISO
Vincristine results in decreased expression of RNF213 mRNA
CTD
PMID:23649840
NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918
G
Rnf34
ring finger protein 34
increases expression
ISO
Vincristine results in increased expression of RNF34 mRNA
CTD
PMID:23649840
NCBI chr12:33,703,655...33,724,606
Ensembl chr12:33,703,673...33,724,586
G
Rora
RAR-related orphan receptor A
increases expression
ISO
Vincristine results in increased expression of RORA mRNA
CTD
PMID:23649840
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpain
RPA interacting protein
decreases expression
ISO
Vincristine results in decreased expression of RPAIN mRNA
CTD
PMID:23649840
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
G
Rpl10
ribosomal protein L10
decreases expression
ISO
Vincristine results in decreased expression of RPL10 mRNA
CTD
PMID:23649840
NCBI chr X:152,054,562...152,056,769
Ensembl chr X:152,054,452...152,056,761
G
Rpl13
ribosomal protein L13
decreases expression
ISO
Vincristine results in decreased expression of RPL13 mRNA
CTD
PMID:23649840
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
G
Rpl17
ribosomal protein L17
decreases expression
ISO
Vincristine results in decreased expression of RPL17 mRNA
CTD
PMID:23649840
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253
G
Rpl31
ribosomal protein L31
decreases expression
ISO
Vincristine results in decreased expression of RPL31 mRNA
CTD
PMID:23649840
NCBI chr 9:41,647,397...41,651,441
Ensembl chr 9:41,647,426...41,662,129
G
Rpl37a
ribosomal protein L37A
decreases expression
ISO
Vincristine results in decreased expression of RPL37A mRNA
CTD
PMID:23649840
NCBI chr 9:74,298,843...74,300,926
G
Rpl5
ribosomal protein L5
decreases expression
ISO
Vincristine results in decreased expression of RPL5 mRNA
CTD
PMID:23649840
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rpl6
ribosomal protein L6
decreases response to substance
ISO
RPL6 protein results in decreased susceptibility to Vincristine
CTD
PMID:15846068
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
G
Rpl7
ribosomal protein L7
decreases expression
ISO
Vincristine results in decreased expression of RPL7 mRNA
CTD
PMID:23649840
NCBI chr 5:3,217,184...3,220,192
G
Rprd1a
regulation of nuclear pre-mRNA domain containing 1A
decreases expression
ISO
Vincristine results in decreased expression of RPRD1A mRNA
CTD
PMID:23649840
NCBI chr18:15,791,418...15,839,338
Ensembl chr18:15,791,418...15,839,338
G
Rps24
ribosomal protein S24
decreases expression
ISO
Vincristine results in decreased expression of RPS24 mRNA
CTD
PMID:23649840
NCBI chr16:89,538...94,267
Ensembl chr16:89,604...94,279
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
Vincristine results in increased expression of RPS27L mRNA
CTD
PMID:23649840
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rragc
Ras-related GTP binding C
increases expression
ISO
Vincristine results in increased expression of RRAGC mRNA
CTD
PMID:23649840
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
Vincristine results in decreased expression of RRM2 mRNA
CTD
PMID:23649840
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrp7a
ribosomal RNA processing 7 homolog A
decreases expression
ISO
Vincristine results in decreased expression of RRP7A mRNA
CTD
PMID:23649840
NCBI chr 7:114,262,929...114,272,817
Ensembl chr 7:114,256,472...114,272,817
G
Rskr
ribosomal protein S6 kinase related
decreases expression
ISO
Vincristine results in decreased expression of RSKR mRNA
CTD
PMID:23649840
NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,156,044...63,191,141
G
Rsrp1
arginine and serine rich protein 1
decreases expression
ISO
Vincristine results in decreased expression of RSRP1 mRNA
CTD
PMID:23649840
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Runx3
RUNX family transcription factor 3
increases response to substance
ISO
RUNX3 protein results in increased susceptibility to Vincristine
CTD
PMID:15756676
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
S100a4
S100 calcium-binding protein A4
increases expression
ISO
Vincristine results in increased expression of S100A4 mRNA
CTD
PMID:23649840
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a8
S100 calcium binding protein A8
increases expression
ISO EXP
Vincristine results in increased expression of S100A8 mRNA
CTD
PMID:20624997 PMID:21971985
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Vincristine results in increased expression of S100A9 mRNA
CTD
PMID:20624997
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
decreases expression
ISO
Vincristine results in decreased expression of SAMHD1 mRNA
CTD
PMID:23649840
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
increases expression
ISO
Vincristine results in increased expression of SAMSN1 mRNA
CTD
PMID:23649840
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
G
Sarm1
sterile alpha and TIR motif containing 1
increases expression multiple interactions
EXP
Vincristine results in increased expression of SARM1 mRNA coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of SARM1 mRNA]
CTD
PMID:34939713
NCBI chr10:63,369,456...63,393,016
Ensembl chr10:63,369,456...63,392,822
G
Sash3
SAM and SH3 domain containing 3
increases expression
ISO
Vincristine results in increased expression of SASH3 mRNA
CTD
PMID:23649840
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Vincristine results in increased expression of SAT1 mRNA
CTD
PMID:23649840
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sbf2
SET binding factor 2
increases expression
ISO
Vincristine results in increased expression of SBF2 mRNA
CTD
PMID:23649840
NCBI chr 1:164,352,892...164,719,883
Ensembl chr 1:164,353,444...164,719,807
G
Sbno1
strawberry notch homolog 1
increases expression
ISO
Vincristine results in increased expression of SBNO1 mRNA
CTD
PMID:23649840
NCBI chr12:32,175,176...32,234,200
Ensembl chr12:32,185,485...32,230,158
G
Scaf11
SR-related CTD-associated factor 11
increases expression
ISO
Vincristine results in increased expression of SCAF11 mRNA
CTD
PMID:23649840
NCBI chr 7:127,571,678...127,624,089
Ensembl chr 7:127,574,463...127,624,101
G
Scamp2
secretory carrier membrane protein 2
decreases expression
ISO
Vincristine results in decreased expression of SCAMP2 mRNA
CTD
PMID:23649840
NCBI chr 8:57,965,612...57,992,248
Ensembl chr 8:57,965,631...57,992,646
G
Sclt1
sodium channel and clathrin linker 1
increases expression
ISO
Vincristine results in increased expression of SCLT1 mRNA
CTD
PMID:23649840
NCBI chr 2:124,605,445...124,763,964
Ensembl chr 2:124,605,658...124,764,065
G
Scly
selenocysteine lyase
decreases expression
ISO
Vincristine results in decreased expression of SCLY mRNA
CTD
PMID:23649840
NCBI chr 9:91,890,269...91,910,947
Ensembl chr 9:91,890,306...91,910,941
G
Sdcbp
syndecan binding protein
increases expression
ISO
Vincristine results in increased expression of SDCBP mRNA
CTD
PMID:23649840
NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
G
Sec31b
SEC31 homolog B, COPII coat complex component
decreases expression
ISO
Vincristine results in decreased expression of SEC31B mRNA
CTD
PMID:23649840
NCBI chr 1:243,376,283...243,404,557
Ensembl chr 1:243,378,456...243,404,557
G
Sec62
SEC62 homolog, preprotein translocation factor
decreases expression
ISO
Vincristine results in decreased expression of SEC62 mRNA
CTD
PMID:23649840
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
G
Sele
selectin E
increases expression
EXP
Vincristine results in increased expression of SELE mRNA
CTD
PMID:20624997
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenoh
selenoprotein H
decreases expression
ISO
Vincristine results in decreased expression of SELENOH mRNA
CTD
PMID:23649840
NCBI chr 3:69,751,850...69,753,417
Ensembl chr 3:69,752,757...69,753,417
G
Senp1
SUMO specific peptidase 1
decreases expression
ISO
Vincristine results in decreased expression of SENP1 mRNA
CTD
PMID:23649840
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Septin6
septin 6
decreases expression
ISO
Vincristine results in decreased expression of SEPTIN6 mRNA
CTD
PMID:23649840
NCBI chr X:116,153,255...116,230,334
Ensembl chr X:116,153,255...116,230,115
G
Serinc5
serine incorporator 5
increases expression
ISO
Vincristine results in increased expression of SERINC5 mRNA
CTD
PMID:23649840
NCBI chr 2:23,846,899...23,950,346
Ensembl chr 2:23,846,900...23,950,346
G
Serpinb10
serpin family B member 10
increases expression
ISO
Vincristine results in increased expression of SERPINB10 mRNA
CTD
PMID:23649840
NCBI chr13:23,553,348...23,571,182
Ensembl chr13:23,553,430...23,571,182
G
Serpinb2
serpin family B member 2
increases expression
ISO
Vincristine results in increased expression of SERPINB2 mRNA
CTD
PMID:23649840
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Serpinb8
serpin family B member 8
increases expression
ISO
Vincristine results in increased expression of SERPINB8 mRNA
CTD
PMID:23649840
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
increases expression increases response to substance
EXP ISO
Vincristine results in increased expression of SERPINE1 mRNA SERPINE1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20624997 PMID:21245421
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sertad3
SERTA domain containing 3
decreases expression
ISO
Vincristine results in decreased expression of SERTAD3 mRNA
CTD
PMID:23649840
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
G
Sesn1
sestrin 1
increases expression
EXP
Vincristine results in increased expression of SESN1 mRNA
CTD
PMID:20624997
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
increases expression
ISO
Vincristine results in increased expression of SESN2 mRNA
CTD
PMID:23649840
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Setbp1
SET binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of SETBP1 mRNA
CTD
PMID:23649840
NCBI chr18:72,190,542...72,551,272
Ensembl chr18:72,191,035...72,552,556
G
Setd1b
SET domain containing 1B, histone lysine methyltransferase
decreases expression
ISO
Vincristine results in decreased expression of SETD1B mRNA
CTD
PMID:23649840
NCBI chr12:33,395,963...33,421,671
Ensembl chr12:33,396,120...33,426,934
G
Setd6
SET domain containing 6, protein lysine methyltransferase
decreases expression
ISO
Vincristine results in decreased expression of SETD6 mRNA
CTD
PMID:23649840
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
G
Sfxn3
sideroflexin 3
increases expression
ISO
Vincristine results in increased expression of SFXN3 mRNA
CTD
PMID:23649840
NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
Vincristine results in increased expression of SGK1 mRNA
CTD
PMID:23649840
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sh3yl1
SH3 and SYLF domain containing 1
increases expression
ISO
Vincristine results in increased expression of SH3YL1 mRNA
CTD
PMID:23649840
NCBI chr 6:47,522,098...47,565,858
Ensembl chr 6:47,522,091...47,565,858
G
Shisa8
shisa family member 8
decreases expression
ISO
Vincristine results in decreased expression of SHISA8 mRNA
CTD
PMID:23649840
NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression
ISO
Vincristine results in decreased expression of SIAH1 mRNA
CTD
PMID:23649840
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Siah2
siah E3 ubiquitin protein ligase 2
increases expression
ISO
Vincristine results in increased expression of SIAH2 mRNA
CTD
PMID:23649840
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Sidt2
SID1 transmembrane family, member 2
increases expression
ISO
Vincristine results in increased expression of SIDT2 mRNA
CTD
PMID:23649840
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
G
Sirt1
sirtuin 1
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of SIRT1 protein Quercetin inhibits the reaction [Vincristine results in decreased expression of SIRT1 protein]
CTD
PMID:36808657
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Siva1
SIVA1, apoptosis-inducing factor
decreases expression
ISO
Vincristine results in decreased expression of SIVA1 mRNA
CTD
PMID:23649840
NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690
G
Six1
SIX homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of SIX1 mRNA
CTD
PMID:23649840
NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975
G
Skil
SKI-like proto-oncogene
increases expression
ISO
Vincristine results in increased expression of SKIL mRNA
CTD
PMID:23649840
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Skp2
S-phase kinase associated protein 2
decreases expression
ISO
Vincristine results in decreased expression of SKP2 mRNA
CTD
PMID:23649840
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
Vincristine results in increased expression of SLAMF1 mRNA
CTD
PMID:23649840
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
G
Slamf7
SLAM family member 7
increases expression
ISO
Vincristine results in increased expression of SLAMF7 mRNA
CTD
PMID:23649840
NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105
G
Slc10a2
solute carrier family 10 member 2
increases response to substance
ISO
SLC10A2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc15a4
solute carrier family 15 member 4
decreases expression
ISO
Vincristine results in decreased expression of SLC15A4 mRNA
CTD
PMID:23649840
NCBI chr12:29,048,634...29,082,480
Ensembl chr12:29,063,015...29,082,480
G
Slc16a14
solute carrier family 16, member 14
decreases expression
ISO
Vincristine results in decreased expression of SLC16A14 mRNA
CTD
PMID:23649840
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC20A1 mRNA
CTD
PMID:23649840
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a23
solute carrier family 22, member 23
increases expression
ISO
Vincristine results in increased expression of SLC22A23 mRNA
CTD
PMID:23649840
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC25A1 mRNA
CTD
PMID:23649840
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a11
solute carrier family 25 member 11
decreases expression
ISO
Vincristine results in decreased expression of SLC25A11 mRNA
CTD
PMID:23649840
NCBI chr10:55,357,590...55,360,441
Ensembl chr10:55,357,597...55,360,410
G
Slc25a37
solute carrier family 25 member 37
decreases expression
ISO
Vincristine results in decreased expression of SLC25A37 mRNA
CTD
PMID:23649840
NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC29A1 mRNA
CTD
PMID:23649840
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc29a2
solute carrier family 29 member 2
decreases expression
ISO
Vincristine results in decreased expression of SLC29A2 mRNA
CTD
PMID:23649840
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Slc2a1
solute carrier family 2 member 1
decreases response to substance
ISO
SLC2A1 protein results in decreased susceptibility to Vincristine
CTD
PMID:17520257
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc44a5
solute carrier family 44, member 5
increases expression
ISO
Vincristine results in increased expression of SLC44A5 mRNA
CTD
PMID:23649840
NCBI chr 2:242,911,050...243,208,018
Ensembl chr 2:242,911,325...243,206,404
G
Slc4a7
solute carrier family 4 member 7
decreases expression
ISO
Vincristine results in decreased expression of SLC4A7 mRNA
CTD
PMID:23649840
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Vincristine results in increased expression of SLC7A11 mRNA
CTD
PMID:23649840
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc9a9
solute carrier family 9 member A9
increases expression
ISO
Vincristine results in increased expression of SLC9A9 mRNA
CTD
PMID:23649840
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
G
Slco4c1
solute carrier organic anion transporter family, member 4C1
decreases expression
ISO
Vincristine results in decreased expression of SLCO4C1 mRNA
CTD
PMID:23649840
NCBI chr 9:97,177,497...97,229,161
Ensembl chr 9:97,178,861...97,229,715
G
Smad1
SMAD family member 1
increases expression
ISO
Vincristine results in increased expression of SMAD1 mRNA
CTD
PMID:23649840
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad2
SMAD family member 2
decreases expression
ISO
Vincristine results in decreased expression of SMAD2 mRNA
CTD
PMID:23649840
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad4
SMAD family member 4
increases expression
ISO
Vincristine results in increased expression of SMAD4 mRNA
CTD
PMID:23649840
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
Vincristine results in decreased expression of SMC6 mRNA
CTD
PMID:23649840
NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
G
Snapc3
small nuclear RNA activating complex, polypeptide 3
decreases expression
ISO
Vincristine results in decreased expression of SNAPC3 mRNA
CTD
PMID:23649840
NCBI chr 5:97,817,827...97,868,494
Ensembl chr 5:97,817,947...97,844,650
G
Snn
stannin
increases expression
ISO
Vincristine results in increased expression of SNN mRNA
CTD
PMID:23649840
NCBI chr10:4,572,933...4,581,606
Ensembl chr10:4,572,376...4,584,021
G
Snord104
small nucleolar RNA, C/D box 104
decreases expression
ISO
Vincristine results in decreased expression of SNORD104 mRNA
CTD
PMID:23649840
NCBI chr10:91,435,313...91,435,382
Ensembl chr10:91,435,313...91,435,382
G
Snrnp200
small nuclear ribonucleoprotein U5 subunit 200
increases expression
ISO
Vincristine results in increased expression of SNRNP200 mRNA
CTD
PMID:23649840
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
G
Snrpa1
small nuclear ribonucleoprotein polypeptide A'
increases expression
ISO
Vincristine results in increased expression of SNRPA1 mRNA
CTD
PMID:23649840
NCBI chr 1:119,641,402...119,654,653
Ensembl chr 1:119,638,481...119,654,653
G
Snrpn
small nuclear ribonucleoprotein polypeptide N
decreases expression
ISO
Vincristine results in decreased expression of SNRPN mRNA
CTD
PMID:23649840
NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:111,101,329...111,123,634
G
Snu13
small nuclear ribonucleoprotein 13
decreases expression
ISO
Vincristine results in decreased expression of SNU13 mRNA
CTD
PMID:23649840
NCBI chr 7:113,565,293...113,570,887
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
G
Snx11
sorting nexin 11
increases expression
ISO
Vincristine results in increased expression of SNX11 mRNA
CTD
PMID:23649840
NCBI chr10:81,742,020...81,752,778
Ensembl chr10:81,742,024...81,752,712
G
Snx25
sorting nexin 25
decreases expression
ISO
Vincristine results in decreased expression of SNX25 mRNA
CTD
PMID:23649840
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
G
Snx4
sorting nexin 4
decreases expression
ISO
Vincristine results in decreased expression of SNX4 mRNA
CTD
PMID:23649840
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Snx5
sorting nexin 5
decreases expression
ISO
Vincristine results in decreased expression of SNX5 mRNA
CTD
PMID:23649840
NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
Vincristine results in decreased expression of SOBP mRNA
CTD
PMID:23649840
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
Vincristine results in increased expression of SOCS3 mRNA
CTD
PMID:23649840
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
bisindolylmaleimide I inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; calphostin C inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; Cycloheximide promotes the reaction [Vincristine results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]
CTD
PMID:9852137
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Son
SON DNA and RNA binding protein
decreases expression
ISO
Vincristine results in decreased expression of SON mRNA
CTD
PMID:23649840
NCBI chr11:30,850,890...30,923,167
Ensembl chr11:30,892,005...30,923,167
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
increases expression
ISO
Vincristine results in increased expression of SOS1 mRNA
CTD
PMID:16001973
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Sp1
Sp1 transcription factor
decreases expression
ISO
Vincristine results in decreased expression of SP1 mRNA
CTD
PMID:23649840
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sp100
SP100 nuclear antigen
increases expression
ISO
Vincristine results in increased expression of SP100 mRNA
CTD
PMID:23649840
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
G
Sp4
Sp4 transcription factor
decreases expression
ISO
Vincristine results in decreased expression of SP4 mRNA
CTD
PMID:23649840
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Spart
spartin
decreases expression
ISO
Vincristine results in decreased expression of SPART mRNA
CTD
PMID:23649840
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
G
Spic
Spi-C transcription factor
increases expression
ISO
Vincristine results in increased expression of SPIC mRNA
CTD
PMID:23649840
NCBI chr 7:23,069,815...23,077,517
Ensembl chr 7:23,069,821...23,077,548
G
Spin4
spindlin family, member 4
decreases expression
ISO
Vincristine results in decreased expression of SPIN4 mRNA
CTD
PMID:23649840
NCBI chr X:59,888,728...59,892,817
Ensembl chr X:59,891,581...59,892,330
G
Spon1
spondin 1
increases expression
EXP
Vincristine results in increased expression of SPON1 mRNA
CTD
PMID:20624997
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spred1
sprouty-related, EVH1 domain containing 1
increases expression
ISO
Vincristine results in increased expression of SPRED1 mRNA
CTD
PMID:23649840
NCBI chr 3:103,983,120...104,050,321
Ensembl chr 3:103,983,072...104,049,718
G
Spry1
sprouty RTK signaling antagonist 1
decreases expression
ISO
Vincristine results in decreased expression of SPRY1 mRNA
CTD
PMID:23649840
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
G
Sqstm1
sequestosome 1
multiple interactions increases expression
ISO
[cotylenin A co-treated with Vincristine] results in increased degradation of SQSTM1 protein Vincristine results in increased expression of SQSTM1 mRNA
CTD
PMID:23649840 PMID:25672400
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
Vincristine results in decreased expression of SREBF1 mRNA
CTD
PMID:23649840
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srek1
splicing regulatory glutamic acid and lysine rich protein 1
decreases expression
ISO
Vincristine results in decreased expression of SREK1 mRNA
CTD
PMID:23649840
NCBI chr 2:34,849,548...34,885,120
Ensembl chr 2:34,852,458...34,884,972
G
Srgn
serglycin
increases expression
ISO
Vincristine results in increased expression of SRGN mRNA
CTD
PMID:23649840
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Sri
sorcin
decreases response to substance
ISO
SRI protein results in decreased susceptibility to Vincristine
CTD
PMID:18423116
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
G
Srm
spermidine synthase
decreases expression
ISO
Vincristine results in decreased expression of SRM mRNA
CTD
PMID:23649840
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
Vincristine results in decreased expression of SRSF3 mRNA
CTD
PMID:23649840
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srsf7
serine and arginine rich splicing factor 7
decreases expression
ISO
Vincristine results in decreased expression of SRSF7 mRNA
CTD
PMID:23649840
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Ssbp1
single stranded DNA binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of SSBP1 mRNA
CTD
PMID:23649840
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
G
Sstr2
somatostatin receptor 2
increases expression
ISO
Vincristine results in increased expression of SSTR2 mRNA
CTD
PMID:23649840
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
G
Stag1
STAG1 cohesin complex component
increases expression
ISO
Vincristine results in increased expression of STAG1 mRNA
CTD
PMID:23649840
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
G
Stambpl1
STAM binding protein-like 1
decreases expression
ISO
Vincristine results in decreased expression of STAMBPL1 mRNA
CTD
PMID:23649840
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
G
Stat1
signal transducer and activator of transcription 1
increases expression
ISO
Vincristine results in increased expression of STAT1 mRNA
CTD
PMID:16001973
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions increases expression
EXP
Quercetin inhibits the reaction [Vincristine results in increased expression of STAT3 protein]
CTD
PMID:36808657
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stip1
stress-induced phosphoprotein 1
decreases expression
ISO
Vincristine results in decreased expression of STIP1 mRNA
CTD
PMID:23649840
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Stk4
serine/threonine kinase 4
increases expression
ISO
Vincristine results in increased expression of STK4 mRNA
CTD
PMID:23649840
NCBI chr 3:152,745,958...152,827,747
Ensembl chr 3:152,745,681...152,827,744
G
Strip2
striatin interacting protein 2
decreases expression
ISO
Vincristine results in decreased expression of STRIP2 mRNA
CTD
PMID:23649840
NCBI chr 4:58,536,034...58,578,279
Ensembl chr 4:58,536,055...58,578,291
G
Sts
steroid sulfatase
decreases expression
ISO
Vincristine results in decreased expression of STS mRNA
CTD
PMID:23649840
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Stx12
syntaxin 12
increases expression
ISO
Vincristine results in increased expression of STX12 mRNA
CTD
PMID:23649840
NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
ISO
Vincristine results in increased expression of SUN2 mRNA
CTD
PMID:23649840
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt20h
SPT20 homolog, SAGA complex component
increases expression
ISO
Vincristine results in increased expression of SUPT20H mRNA
CTD
PMID:23649840
NCBI chr 2:138,897,316...138,930,493
Ensembl chr 2:138,897,416...138,930,495
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
increases expression
ISO
Vincristine results in increased expression of SUZ12 mRNA
CTD
PMID:23649840
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Syf2
SYF2 pre-mRNA-splicing factor
increases expression
ISO
Vincristine results in increased expression of SYF2 mRNA
CTD
PMID:23649840
NCBI chr 5:147,156,492...147,164,416
Ensembl chr 5:147,156,480...147,164,414
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Vincristine results in decreased expression of SYNCRIP mRNA
CTD
PMID:23649840
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
Vincristine results in decreased expression of SYNE2 mRNA
CTD
PMID:23649840
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Sypl2
synaptophysin-like 2
increases expression
ISO
Vincristine results in increased expression of SYPL2 mRNA
CTD
PMID:23649840
NCBI chr 2:195,849,062...195,863,794
Ensembl chr 2:195,849,062...195,863,794
G
Sytl3
synaptotagmin-like 3
increases expression
ISO
Vincristine results in increased expression of SYTL3 mRNA
CTD
PMID:23649840
NCBI chr 1:46,896,308...46,967,461
Ensembl chr 1:46,911,217...46,967,460
G
Taf15
TATA-box binding protein associated factor 15
increases expression
ISO
Vincristine results in increased expression of TAF15 mRNA
CTD
PMID:23649840
NCBI chr10:68,272,921...68,304,951
Ensembl chr10:68,272,969...68,304,949
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
decreases expression
ISO
Vincristine results in decreased expression of TAF1D mRNA
CTD
PMID:23649840
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Taf5l1
TATA-box binding protein associated factor 5 like 1
decreases expression
ISO
Vincristine results in decreased expression of TAF5L mRNA
CTD
PMID:23649840
NCBI chr19:51,991,704...52,011,001
Ensembl chr19:51,991,708...52,011,295
G
Tank
TRAF family member-associated NFKB activator
decreases expression increases expression
ISO
Vincristine results in decreased expression of TANK mRNA Vincristine results in increased expression of TANK mRNA
CTD
PMID:23649840
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
Vincristine results in increased expression of TAP1 mRNA
CTD
PMID:23649840
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tasor2
transcription activation suppressor family member 2
increases expression
ISO
Vincristine results in increased expression of TASOR2 mRNA
CTD
PMID:23649840
NCBI chr17:66,583,554...66,650,127
Ensembl chr17:66,594,908...66,649,135
G
Tbc1d12
TBC1 domain family, member 12
decreases expression
ISO
Vincristine results in decreased expression of TBC1D12 mRNA
CTD
PMID:23649840
NCBI chr 1:236,603,597...236,685,859
Ensembl chr 1:236,603,607...236,685,859
G
Tbc1d4
TBC1 domain family, member 4
increases expression
ISO
Vincristine results in increased expression of TBC1D4 mRNA
CTD
PMID:23649840
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tbc1d8b
TBC1 domain family member 8B
decreases expression
ISO
Vincristine results in decreased expression of TBC1D8B mRNA
CTD
PMID:23649840
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbx22
T-box transcription factor 22
increases expression
ISO
Vincristine results in increased expression of TBX22 mRNA
CTD
PMID:23649840
NCBI chr X:72,723,619...72,774,647
Ensembl chr X:72,723,617...72,774,647
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
Vincristine results in decreased expression of TCAF1 mRNA
CTD
PMID:23649840
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tcea2
transcription elongation factor A2
increases expression
ISO
Vincristine results in increased expression of TCEA2 mRNA
CTD
PMID:23649840
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
G
Tcf19
transcription factor 19
decreases expression
ISO
Vincristine results in decreased expression of TCF19 mRNA
CTD
PMID:23649840
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
ISO
Vincristine results in decreased expression of TCIRG1 mRNA
CTD
PMID:23649840
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
G
Tdrd9
tudor domain containing 9
increases expression
ISO
Vincristine results in increased expression of TDRD9 mRNA
CTD
PMID:23649840
NCBI chr 6:131,029,644...131,145,076
Ensembl chr 6:131,029,652...131,144,651
G
Tenm2
teneurin transmembrane protein 2
increases expression
ISO
Vincristine results in increased expression of TENM2 mRNA
CTD
PMID:23649840
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
G
Tent2
terminal nucleotidyltransferase 2
increases expression
ISO
Vincristine results in increased expression of TENT2 mRNA
CTD
PMID:23649840
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Tent5c
terminal nucleotidyltransferase 5C
decreases expression
ISO
Vincristine results in decreased expression of TENT5C mRNA
CTD
PMID:23649840
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
G
Tfap2a
transcription factor AP-2 alpha
decreases expression
ISO
Vincristine results in decreased expression of TFAP2A mRNA
CTD
PMID:23649840
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tfpi
tissue factor pathway inhibitor
increases expression
ISO
Vincristine results in increased expression of TFPI mRNA
CTD
PMID:23649840
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgds
TDP-glucose 4,6-dehydratase
increases expression
ISO
Vincristine results in increased expression of TGDS mRNA
CTD
PMID:23649840
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
G
Tgfbi
transforming growth factor, beta induced
decreases response to substance
ISO
TGFBI mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
G
Tgfbr3
transforming growth factor beta receptor 3
decreases expression
ISO
Vincristine results in decreased expression of TGFBR3 mRNA
CTD
PMID:23649840
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
G
Thada
THADA, armadillo repeat containing
increases expression
ISO
Vincristine results in increased expression of THADA mRNA
CTD
PMID:23649840
NCBI chr 6:10,183,942...10,488,007
Ensembl chr 6:10,183,982...10,487,159
G
Thbd
thrombomodulin
decreases response to substance
ISO
THBD protein results in decreased susceptibility to Vincristine
CTD
PMID:27474498
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
EXP
Vincristine results in increased expression of THBS1 mRNA
CTD
PMID:20624997
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Them6
thioesterase superfamily member 6
decreases expression
ISO
Vincristine results in decreased expression of THEM6 mRNA
CTD
PMID:23649840
NCBI chr 7:106,606,570...106,609,747
Ensembl chr 7:106,606,570...106,609,746
G
Themis2
thymocyte selection associated family member 2
increases expression
ISO
Vincristine results in increased expression of THEMIS2 mRNA
CTD
PMID:23649840
NCBI chr 5:144,991,110...145,006,362
Ensembl chr 5:144,991,112...145,006,400
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Vincristine binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tigar
TP53 induced glycolysis regulatory phosphatase
increases expression
ISO
Vincristine results in increased expression of TIGAR mRNA
CTD
PMID:23649840
NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:159,927,139...159,946,029
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP ISO
Vincristine results in increased expression of TIMP1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tinag
tubulointerstitial nephritis antigen
decreases expression
ISO
Vincristine results in decreased expression of TINAG mRNA
CTD
PMID:23649840
NCBI chr 8:77,800,031...77,885,077
Ensembl chr 8:77,800,032...77,885,077
G
Tirap
TIR domain containing adaptor protein
decreases expression
ISO
Vincristine results in decreased expression of TIRAP mRNA
CTD
PMID:23649840
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tlcd1
TLC domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of TLCD1 mRNA
CTD
PMID:23649840
NCBI chr10:63,074,469...63,076,502
Ensembl chr10:63,074,469...63,076,501
G
Tlr10
toll-like receptor 10
decreases expression
ISO
Vincristine results in decreased expression of TLR10 mRNA
CTD
PMID:23649840
NCBI chr14:43,400,843...43,414,056
Ensembl chr14:43,406,217...43,413,917
G
Tm2d1
TM2 domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of TM2D1 mRNA
CTD
PMID:23649840
NCBI chr 5:113,020,793...113,062,134
Ensembl chr 5:113,020,760...113,050,933
G
Tmcc3
transmembrane and coiled-coil domain family 3
increases expression
ISO
Vincristine results in increased expression of TMCC3 mRNA
CTD
PMID:23649840
NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926
G
Tmco6
transmembrane and coiled-coil domains 6
decreases expression
ISO
Vincristine results in decreased expression of TMCO6 mRNA
CTD
PMID:23649840
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
G
Tmem106c
transmembrane protein 106C
decreases expression
ISO
Vincristine results in decreased expression of TMEM106C mRNA
CTD
PMID:23649840
NCBI chr 7:129,088,468...129,094,128
Ensembl chr 7:129,088,498...129,094,130
G
Tmem107
transmembrane protein 107
decreases expression
ISO
Vincristine results in decreased expression of TMEM107 mRNA
CTD
PMID:23649840
NCBI chr10:53,772,153...53,774,685
Ensembl chr10:53,771,784...53,774,676
G
Tmem163
transmembrane protein 163
increases expression
ISO
Vincristine results in increased expression of TMEM163 mRNA
CTD
PMID:23649840
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
G
Tmem177
transmembrane protein 177
decreases expression
ISO
Vincristine results in decreased expression of TMEM177 mRNA
CTD
PMID:23649840
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
Vincristine results in decreased expression of TMEM200A mRNA
CTD
PMID:23649840
NCBI chr 1:19,323,646...19,408,324
Ensembl chr 1:19,323,829...19,406,453
G
Tmem223
transmembrane protein 223
decreases expression
ISO
Vincristine results in decreased expression of TMEM223 mRNA
CTD
PMID:23649840
NCBI chr 1:205,668,716...205,670,077
Ensembl chr 1:205,662,063...205,670,056
G
Tmem267
transmembrane protein 267
increases expression
ISO
Vincristine results in increased expression of TMEM267 mRNA
CTD
PMID:23649840
NCBI chr 2:51,580,210...51,588,937
Ensembl chr 2:51,581,252...51,587,636
G
Tmem38a
transmembrane protein 38a
decreases expression
ISO
Vincristine results in decreased expression of TMEM38A mRNA
CTD
PMID:23649840
NCBI chr16:17,258,160...17,274,204
Ensembl chr16:17,258,164...17,273,415
G
Tmem43
transmembrane protein 43
increases expression
ISO
Vincristine results in increased expression of TMEM43 mRNA
CTD
PMID:23649840
NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825
G
Tmem80
transmembrane protein 80
decreases expression
ISO
Vincristine results in decreased expression of TMEM80 mRNA
CTD
PMID:23649840
NCBI chr 1:196,435,999...196,444,368
Ensembl chr 1:196,436,003...196,444,367 Ensembl chr 1:196,436,003...196,444,367
G
Tmf1
TATA element modulatory factor 1
increases expression
ISO
Vincristine results in increased expression of TMF1 mRNA
CTD
PMID:23649840
NCBI chr 4:129,759,952...129,785,705
Ensembl chr 4:129,763,114...129,785,629
G
Tmx4
thioredoxin-related transmembrane protein 4
decreases expression
ISO
Vincristine results in decreased expression of TMX4 mRNA
CTD
PMID:23649840
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP ISO
coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of TNF protein]; Pregabalin inhibits the reaction [Vincristine results in increased expression of TNF protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of TNF mRNA]; tetrahydrocurcumin inhibits the reaction [Vincristine results in increased expression of TNF protein]; Tropisetron inhibits the reaction [Vincristine results in increased expression of TNF protein] KN 93 inhibits the reaction [Vincristine results in increased expression of TNF mRNA] Vincristine results in increased expression of TNF mRNA; Vincristine results in increased expression of TNF protein
CTD
PMID:23649840 PMID:24374478 PMID:26102012 PMID:29958920 PMID:34286406 PMID:34939713 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Vincristine results in increased expression of TNFAIP3 mRNA
CTD
PMID:23649840
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Vincristine results in increased expression of TNFAIP6 mRNA
CTD
PMID:23649840
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfaip8l1
TNF alpha induced protein 8 like 1
increases expression
ISO
Vincristine results in increased expression of TNFAIP8L1 mRNA
CTD
PMID:23649840
NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254
G
Tnfrsf17
TNF receptor superfamily member 17
decreases expression
ISO
Vincristine results in decreased expression of TNFRSF17 mRNA
CTD
PMID:23649840
NCBI chr10:4,301,023...4,306,889
Ensembl chr10:4,301,038...4,306,788
G
Tnfrsf19
TNF receptor superfamily member 19
decreases expression
ISO
Vincristine results in decreased expression of TNFRSF19 mRNA
CTD
PMID:23649840
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
Vincristine results in increased expression of TNFRSF9 mRNA
CTD
PMID:23649840
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
Vincristine results in increased expression of TNFSF10 mRNA
CTD
PMID:23649840
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf4
TNF superfamily member 4
increases expression
ISO
Vincristine results in increased expression of TNFSF4 mRNA
CTD
PMID:23649840
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
Vincristine results in increased expression of TNFSF9 mRNA
CTD
PMID:23649840
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tnip2
TNFAIP3 interacting protein 2
increases expression
ISO
Vincristine results in increased expression of TNIP2 mRNA
CTD
PMID:23649840
NCBI chr14:76,228,350...76,245,553
Ensembl chr14:76,228,371...76,275,265
G
Tnni3
troponin I3, cardiac type
increases expression
EXP
Vincristine results in increased expression of TNNI3 protein
CTD
PMID:20624997
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Tnnt2
troponin T2, cardiac type
multiple interactions
EXP
Vincristine inhibits the reaction [Isoproterenol results in increased secretion of TNNT2 protein]
CTD
PMID:25537132
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tomm70
translocase of outer mitochondrial membrane 70
decreases expression
ISO
Vincristine results in decreased expression of TOMM70 mRNA
CTD
PMID:23649840
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
Vincristine results in decreased expression of TOP2A mRNA
CTD
PMID:23649840
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of TOPBP1 mRNA
CTD
PMID:23649840
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tp53
tumor protein p53
increases response to substance increases glutathionylation increases expression multiple interactions increases activity
ISO
TP53 protein results in increased susceptibility to Vincristine Vincristine results in increased glutathionylation of TP53 protein Vincristine results in increased expression of TP53 protein [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of TP53 protein Vincristine results in increased activity of TP53 protein
CTD
PMID:9815696 PMID:12082016 PMID:14704126 PMID:15131059 PMID:17555331 PMID:22010212 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
Vincristine results in increased expression of TP53I3 mRNA
CTD
PMID:23649840
NCBI chr 6:27,818,327...27,825,753
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
Vincristine results in increased expression of TP53INP1 mRNA
CTD
PMID:23649840
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpcn2
two pore segment channel 2
increases expression
ISO
Vincristine results in increased expression of TPCN2 mRNA
CTD
PMID:23649840
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Tpd52
tumor protein D52
decreases expression
ISO
Vincristine results in decreased expression of TPD52 mRNA
CTD
PMID:23649840
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
G
Tpd52l1
TPD52 like 1
increases expression
EXP
Vincristine results in increased expression of TPD52L1 mRNA
CTD
PMID:20624997
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Tpi1
triosephosphate isomerase 1
affects response to substance
ISO
TPI1 protein affects the susceptibility to Vincristine
CTD
PMID:18309519
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tpm4
tropomyosin 4
increases expression
ISO
Vincristine results in increased expression of TPM4 mRNA
CTD
PMID:23649840
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tprg1l
tumor protein p63 regulated 1-like
increases expression
ISO
Vincristine results in increased expression of TPRG1L mRNA
CTD
PMID:23649840
NCBI chr 5:164,722,151...164,725,358
Ensembl chr 5:164,710,285...164,725,425
G
Tra2a
transformer 2 alpha
increases expression
ISO
Vincristine results in increased expression of TRA2A mRNA
CTD
PMID:23649840
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
Vincristine results in increased expression of TRAF1 mRNA
CTD
PMID:23649840
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf3ip3
TRAF3 interacting protein 3
decreases expression
ISO
Vincristine results in decreased expression of TRAF3IP3 mRNA
CTD
PMID:23649840
NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673
G
Trappc10
trafficking protein particle complex subunit 10
increases expression
ISO
Vincristine results in increased expression of TRAPPC10 mRNA
CTD
PMID:23649840
NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074
G
Trex1
three prime repair exonuclease 1
decreases expression
ISO
Vincristine results in decreased expression of TREX1 mRNA
CTD
PMID:23649840
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
G
Trib1
tribbles pseudokinase 1
decreases expression
ISO
Vincristine results in decreased expression of TRIB1 mRNA
CTD
PMID:23649840
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trim13
tripartite motif-containing 13
decreases expression
ISO
Vincristine results in decreased expression of TRIM13 mRNA
CTD
PMID:23649840
NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677
G
Trim29
tripartite motif-containing 29
increases expression
ISO
Vincristine results in increased expression of TRIM29 mRNA
CTD
PMID:23649840
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim45
tripartite motif-containing 45
decreases expression
ISO
Vincristine results in decreased expression of TRIM45 mRNA
CTD
PMID:23649840
NCBI chr 2:188,349,979...188,359,205
Ensembl chr 2:188,349,744...188,359,204
G
Trio
trio Rho guanine nucleotide exchange factor
increases expression
ISO
Vincristine results in increased expression of TRIO mRNA
CTD
PMID:23649840
NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:78,505,070...78,803,135
G
Trir
telomerase RNA component interacting RNase
decreases expression
ISO
Vincristine results in decreased expression of TRIR mRNA
CTD
PMID:23649840
NCBI chr19:23,125,083...23,128,502
Ensembl chr19:23,125,083...23,128,510
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
decreases expression
ISO
Vincristine results in decreased expression of TRPV1 protein
CTD
PMID:38458354
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
increases expression
ISO
Vincristine results in increased expression of TRPV2 mRNA
CTD
PMID:23649840
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
increases response to substance
EXP
TRPV4 protein results in increased susceptibility to Vincristine
CTD
PMID:18234883
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Tsc22d1
TSC22 domain family, member 1
decreases expression
ISO
Vincristine results in decreased expression of TSC22D1 mRNA
CTD
PMID:23649840
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tsen15
tRNA splicing endonuclease subunit 15
decreases expression
ISO
Vincristine results in decreased expression of TSEN15 mRNA
CTD
PMID:23649840
NCBI chr13:64,490,216...64,505,591
Ensembl chr13:64,490,218...64,505,617
G
Tsg101
tumor susceptibility 101
affects response to substance
ISO
TSG101 affects the susceptibility to Vincristine
CTD
PMID:15044860
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of TSHZ1 mRNA
CTD
PMID:23649840
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
Vincristine results in decreased expression of TTC3 mRNA
CTD
PMID:23649840
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Ttc9c
tetratricopeptide repeat domain 9C
increases expression decreases expression
ISO
Vincristine results in increased expression of TTC9C mRNA Vincristine results in decreased expression of TTC9C mRNA
CTD
PMID:23649840
NCBI chr 1:205,701,768...205,712,782
Ensembl chr 1:205,701,768...205,712,773
G
Ttyh2
tweety family member 2
increases expression
ISO
Vincristine results in increased expression of TTYH2 mRNA
CTD
PMID:23649840
NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBA1B mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1c
tubulin, alpha 1C
decreases expression
ISO
Vincristine results in decreased expression of TUBA1C mRNA
CTD
PMID:23649840
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba3b
tubulin, alpha 3B
decreases expression
ISO
Vincristine results in decreased expression of TUBA3D mRNA
CTD
PMID:23649840
NCBI chr 4:178,588,779...178,594,328
Ensembl chr 4:178,588,779...178,594,326
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP ISO
Vincristine results in decreased expression of TUBA4A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Vincristine results in decreased expression of TUBB3 mRNA
CTD
PMID:23649840
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBB4B mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBB mRNA Vincristine results in decreased expression of TUBB5 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubg1
tubulin, gamma 1
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBG1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Tubgcp5
tubulin gamma complex component 5
decreases expression
ISO
Vincristine results in decreased expression of TUBGCP5 mRNA
CTD
PMID:23649840
NCBI chr 1:106,636,526...106,672,175
Ensembl chr 1:106,636,526...106,672,175
G
Tulp4
TUB like protein 4
increases expression
ISO
Vincristine results in increased expression of TULP4 mRNA
CTD
PMID:23649840
NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688
G
Twf1
twinfilin actin-binding protein 1
affects response to substance
ISO
TWF1 protein affects the susceptibility to Vincristine
CTD
PMID:19783987
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Txnip
thioredoxin interacting protein
increases expression
ISO
Vincristine results in increased expression of TXNIP mRNA
CTD
PMID:23649840
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Tymp
thymidine phosphorylase
multiple interactions
ISO
TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]
CTD
PMID:15907805
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Tyms
thymidylate synthetase
affects response to substance
ISO
TYMS gene polymorphism affects the susceptibility to Vincristine
CTD
PMID:15713801
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
U2surp
U2 snRNP-associated SURP domain containing
increases expression
ISO
Vincristine results in increased expression of U2SURP mRNA
CTD
PMID:23649840
NCBI chr 8:96,018,932...96,075,795
Ensembl chr 8:96,022,957...96,075,691
G
Ubald2
UBA-like domain containing 2
increases expression
ISO
Vincristine results in increased expression of UBALD2 mRNA
CTD
PMID:23649840
NCBI chr10:101,662,507...101,667,089
Ensembl chr10:101,658,127...101,667,061
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
Vincristine results in decreased expression of UBAP2 mRNA
CTD
PMID:23649840
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ubc
ubiquitin C
decreases expression
ISO
Vincristine results in decreased expression of UBC mRNA
CTD
PMID:23649840
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Vincristine results in decreased expression of UBE2C mRNA
CTD
PMID:23649840
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2g1
ubiquitin-conjugating enzyme E2G 1
decreases expression
ISO
Vincristine results in decreased expression of UBE2G1 mRNA
CTD
PMID:23649840
NCBI chr10:57,225,963...57,306,748
Ensembl chr10:57,225,952...57,308,568
G
Ube2i
ubiquitin-conjugating enzyme E2I
decreases expression
ISO
Vincristine results in decreased expression of UBE2I mRNA
CTD
PMID:23649840
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2j1
ubiquitin-conjugating enzyme E2, J1
decreases expression
ISO
Vincristine results in decreased expression of UBE2J1 mRNA
CTD
PMID:23649840
NCBI chr 5:47,422,476...47,441,476
Ensembl chr 5:47,422,587...47,441,461
G
Ubr2
ubiquitin protein ligase E3 component n-recognin 2
increases expression
ISO
Vincristine results in increased expression of UBR2 mRNA
CTD
PMID:23649840
NCBI chr 9:13,982,427...14,062,315
Ensembl chr 9:13,982,329...14,062,139
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
increases expression
ISO
Vincristine results in increased expression of UBR4 mRNA
CTD
PMID:23649840
NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Vincristine results in increased expression of UCHL1 protein
CTD
PMID:16797537
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Vincristine results in decreased expression of UCP2 mRNA
CTD
PMID:23649840
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugcg
UDP-glucose ceramide glucosyltransferase
increases expression
ISO
Vincristine results in increased expression of UGCG mRNA
CTD
PMID:23649840
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
increases expression
ISO
Vincristine results in increased expression of UGGT2 mRNA
CTD
PMID:23649840
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
G
Unc119
unc-119 lipid binding chaperone
increases expression
ISO
Vincristine results in increased expression of UNC119 mRNA
CTD
PMID:23649840
NCBI chr10:63,237,862...63,243,339
Ensembl chr10:63,237,903...63,243,339
G
Upb1
beta-ureidopropionase 1
increases expression
ISO
Vincristine results in increased expression of UPB1 mRNA
CTD
PMID:23649840
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Urod
uroporphyrinogen decarboxylase
decreases expression
ISO
Vincristine results in decreased expression of UROD mRNA
CTD
PMID:23649840
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:130,455,217...130,468,808
G
Usp12
ubiquitin specific peptidase 12
increases expression
ISO
Vincristine results in increased expression of USP12 mRNA
CTD
PMID:23649840
NCBI chr12:8,309,845...8,363,686
Ensembl chr12:8,309,750...8,363,656
G
Usp25
ubiquitin specific peptidase 25
decreases expression
ISO
Vincristine results in decreased expression of USP25 mRNA
CTD
PMID:23649840
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Usp34
ubiquitin specific peptidase 34
increases expression
ISO
Vincristine results in increased expression of USP34 mRNA
CTD
PMID:23649840
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp37
ubiquitin specific peptidase 37
decreases expression
ISO
Vincristine results in decreased expression of USP37 mRNA
CTD
PMID:23649840
NCBI chr 9:76,018,863...76,118,732
Ensembl chr 9:76,018,991...76,084,044
G
Vamp2
vesicle-associated membrane protein 2
decreases expression
ISO
Vincristine results in decreased expression of VAMP2 mRNA
CTD
PMID:23649840
NCBI chr10:53,793,581...53,797,815
Ensembl chr10:53,793,923...53,797,809
G
Vasp
vasodilator-stimulated phosphoprotein
increases expression
ISO
Vincristine results in increased expression of VASP mRNA
CTD
PMID:23649840
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO EXP
Vincristine results in increased expression of VCAM1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdr
vitamin D receptor
affects response to substance
ISO
VDR gene polymorphism affects the susceptibility to Vincristine
CTD
PMID:15713801
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
decreases expression
EXP
Vincristine results in decreased expression of VEGFA mRNA
CTD
PMID:20624997
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vezf1
vascular endothelial zinc finger 1
decreases expression
ISO
Vincristine results in decreased expression of VEZF1 mRNA
CTD
PMID:23649840
NCBI chr10:72,859,669...72,876,111
Ensembl chr10:72,859,877...72,876,111
G
Vit
vitrin
increases response to substance
ISO
VIT mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 6:16,445,966...16,565,644
Ensembl chr 6:16,445,955...16,565,665
G
Vps13a
vacuolar protein sorting 13 homolog A
decreases expression
ISO
Vincristine results in decreased expression of VPS13A mRNA
CTD
PMID:23649840
NCBI chr 1:213,901,999...214,128,638
Ensembl chr 1:213,901,999...214,128,555
G
Vps13d
vacuolar protein sorting 13 homolog D
increases expression
ISO
Vincristine results in increased expression of VPS13D mRNA
CTD
PMID:23649840
NCBI chr 5:156,830,509...157,055,895
Ensembl chr 5:156,830,512...157,055,891
G
Vps25
vacuolar protein sorting 25 homolog
decreases expression
ISO
Vincristine results in decreased expression of VPS25 mRNA
CTD
PMID:23649840
NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,188,812...86,231,829
G
Vps53
VPS53 subunit of GARP complex
increases expression
ISO
Vincristine results in increased expression of VPS53 mRNA
CTD
PMID:23649840
NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676
G
Vps72
vacuolar protein sorting 72 homolog
decreases expression
ISO
Vincristine results in decreased expression of VPS72 mRNA
CTD
PMID:23649840
NCBI chr 2:182,678,594...182,690,185
Ensembl chr 2:182,678,609...182,690,182
G
Vti1a
vesicle transport through interaction with t-SNAREs 1A
decreases expression
ISO
Vincristine results in decreased expression of VTI1A mRNA
CTD
PMID:23649840
NCBI chr 1:254,356,343...254,661,854
Ensembl chr 1:254,356,429...254,661,852
G
Vwf
von Willebrand factor
increases expression
EXP
Vincristine results in increased expression of VWF mRNA
CTD
PMID:20624997
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of WDHD1 mRNA
CTD
PMID:23649840
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Wdr17
WD repeat domain 17
decreases expression
ISO
Vincristine results in decreased expression of WDR17 mRNA
CTD
PMID:23649840
NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
G
Wdr33
WD repeat domain 33
decreases expression
ISO
Vincristine results in decreased expression of WDR33 mRNA
CTD
PMID:23649840
NCBI chr18:23,432,233...23,535,460
Ensembl chr18:23,432,191...23,468,597
G
Wdr72
WD repeat domain 72
decreases expression
ISO
Vincristine results in decreased expression of WDR72 mRNA
CTD
PMID:23649840
NCBI chr 8:74,838,338...75,020,938
Ensembl chr 8:74,838,318...75,018,229
G
Wdr76
WD repeat domain 76
decreases expression
ISO
Vincristine results in decreased expression of WDR76 mRNA
CTD
PMID:23649840
NCBI chr 3:108,456,784...108,491,528
Ensembl chr 3:108,456,815...108,490,840
G
Wdr90
WD repeat domain 90
decreases expression
ISO
Vincristine results in decreased expression of WDR90 mRNA
CTD
PMID:23649840
NCBI chr10:14,864,672...14,881,285
Ensembl chr10:14,864,670...14,881,292
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
Vincristine results in decreased expression of WEE1 mRNA
CTD
PMID:23649840
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wnk1
WNK lysine deficient protein kinase 1
increases expression
ISO
Vincristine results in increased expression of WNK1 mRNA
CTD
PMID:23649840
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Wsb1
WD repeat and SOCS box-containing 1
decreases expression
ISO
Vincristine results in decreased expression of WSB1 mRNA
CTD
PMID:23649840
NCBI chr10:64,202,761...64,219,039
Ensembl chr10:64,202,763...64,219,019
G
Xirp2
xin actin-binding repeat containing 2
decreases expression
ISO
Vincristine results in decreased expression of XIRP2 mRNA
CTD
PMID:23649840
NCBI chr 3:52,126,213...52,213,094
Ensembl chr 3:51,870,092...52,213,091
G
Xpnpep3
X-prolyl aminopeptidase 3
increases expression
ISO
Vincristine results in increased expression of XPNPEP3 mRNA
CTD
PMID:23649840
NCBI chr 7:112,926,154...112,978,793
Ensembl chr 7:112,926,248...112,974,878
G
Ypel5
yippee-like 5
increases expression
ISO
Vincristine results in increased expression of YPEL5 mRNA
CTD
PMID:23649840
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Ythdc2
YTH N6-methyladenosine RNA binding protein C2
decreases expression
ISO
Vincristine results in decreased expression of YTHDC2 mRNA
CTD
PMID:23649840
NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
G
Ythdf3
YTH N6-methyladenosine RNA binding protein F3
increases expression
ISO
Vincristine results in increased expression of YTHDF3 mRNA
CTD
PMID:23649840
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
G
Zbtb10
zinc finger and BTB domain containing 10
increases expression
ISO
Vincristine results in increased expression of ZBTB10 mRNA
CTD
PMID:23649840
NCBI chr 2:92,475,254...92,509,892
Ensembl chr 2:92,479,014...92,512,515
G
Zbtb14
zinc finger and BTB domain containing 14
decreases expression
ISO
Vincristine results in decreased expression of ZBTB14 mRNA
CTD
PMID:23649840
NCBI chr 9:109,333,440...109,338,646
Ensembl chr 9:109,331,028...109,338,632
G
Zbtb24
zinc finger and BTB domain containing 24
decreases expression
ISO
Vincristine results in decreased expression of ZBTB24 mRNA
CTD
PMID:23649840
NCBI chr20:44,943,302...44,965,329
Ensembl chr20:44,947,297...44,963,963
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
Vincristine results in increased expression of ZC3H12A mRNA
CTD
PMID:23649840
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zcchc2
zinc finger CCHC-type containing 2
decreases expression
ISO
Vincristine results in decreased expression of ZCCHC2 mRNA
CTD
PMID:23649840
NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,119,568...22,166,373
G
Zfp207
zinc finger protein 207
decreases expression increases expression
ISO
Vincristine results in decreased expression of ZNF207 mRNA Vincristine results in increased expression of ZNF207 mRNA
CTD
PMID:23649840
NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386
G
Zfp395
zinc finger protein 395
decreases expression
ISO
Vincristine results in decreased expression of ZNF395 mRNA
CTD
PMID:23649840
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp503
zinc finger protein 503
decreases expression
ISO
Vincristine results in decreased expression of ZNF503 mRNA
CTD
PMID:23649840
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848
G
Zfp638
zinc finger protein 638
increases expression
ISO
Vincristine results in increased expression of ZNF638 mRNA
CTD
PMID:23649840
NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845
G
Zfp652
zinc finger protein 652
decreases expression
ISO
Vincristine results in decreased expression of ZNF652 mRNA
CTD
PMID:23649840
NCBI chr10:80,626,555...80,706,397
Ensembl chr10:80,649,400...80,698,674
G
Zfp672
zinc finger protein 672
decreases expression
ISO
Vincristine results in decreased expression of ZNF672 mRNA
CTD
PMID:23649840
NCBI chr10:42,496,558...42,512,134
Ensembl chr10:42,495,476...42,504,852
G
Zfp691
zinc finger protein 691
decreases expression
ISO
Vincristine results in decreased expression of ZNF691 mRNA
CTD
PMID:23649840
NCBI chr 5:132,780,259...132,784,954
Ensembl chr 5:132,780,181...132,785,000
G
Zfp692
zinc finger protein 692
decreases expression
ISO
Vincristine results in decreased expression of ZNF692 mRNA
CTD
PMID:23649840
NCBI chr10:42,484,576...42,496,573
Ensembl chr10:42,488,588...42,496,018
G
Zfp709
zinc finger protein 709
decreases expression
ISO
Vincristine results in decreased expression of ZNF443 mRNA
CTD
PMID:23649840
NCBI chr16:17,907,599...17,920,047
Ensembl chr16:17,909,641...17,919,700
G
Zfp830
zinc finger protein 830
decreases expression
ISO
Vincristine results in decreased expression of ZNF830 mRNA
CTD
PMID:23649840
NCBI chr10:67,701,340...67,702,804
Ensembl chr10:67,701,073...67,704,523
G
Zfyve16
zinc finger FYVE-type containing 16
increases expression
ISO
Vincristine results in increased expression of ZFYVE16 mRNA
CTD
PMID:23649840
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
Vincristine results in increased expression of ZMAT3 mRNA
CTD
PMID:23649840
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Zmiz2
zinc finger, MIZ-type containing 2
increases expression
ISO
Vincristine results in increased expression of ZMIZ2 mRNA
CTD
PMID:23649840
NCBI chr14:81,251,391...81,267,936
Ensembl chr14:81,251,417...81,267,936
G
Zmynd8
zinc finger, MYND-type containing 8
increases expression
ISO
Vincristine results in increased expression of ZMYND8 mRNA
CTD
PMID:23649840
NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463
G
Znfx1
zinc finger, NFX1-type containing 1
increases expression
ISO
Vincristine results in increased expression of ZNFX1 mRNA
CTD
PMID:23649840
NCBI chr 3:155,764,073...155,791,777
Ensembl chr 3:155,764,980...155,821,242
G
Znrf2
zinc and ring finger 2
decreases expression
ISO
Vincristine results in decreased expression of ZNRF2 mRNA
CTD
PMID:23649840
NCBI chr 4:83,950,406...84,032,676
Ensembl chr 4:83,949,309...84,027,818
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions decreases expression
ISO
Tamoxifen promotes the reaction [Vindesine results in decreased expression of BAX mRNA]
CTD
PMID:19757172
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression
ISO
Tamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA]
CTD
PMID:19757172
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Ngf
nerve growth factor
decreases response to substance
EXP
Vindesine results in decreased susceptibility to NGF protein
CTD
PMID:9524088
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Casp3
caspase 3
multiple interactions
ISO
[pifithrin co-treated with vinorelbine] results in increased cleavage of and results in increased activity of CASP3 protein [Cisplatin co-treated with vinorelbine] results in increased activity of CASP3 protein
CTD
PMID:18516295 PMID:21544650
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of CASP7 mRNA
CTD
PMID:21544650
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cd40lg
CD40 ligand
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of CD40LG mRNA
CTD
PMID:21544650
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
vinorelbine results in decreased expression of CDKN2A protein
CTD
PMID:17904787
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Epcam
epithelial cell adhesion molecule
multiple interactions increases expression
ISO
[vinorelbine co-treated with Cisplatin] results in increased expression of EPCAM protein vinorelbine results in increased expression of EPCAM protein
CTD
PMID:12695858
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in increased expression of FAS protein
CTD
PMID:21544650
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of FASL mRNA
CTD
PMID:21544650
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Il10
interleukin 10
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of IL10 mRNA
CTD
PMID:21544650
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il7
interleukin 7
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in increased expression of IL7 protein
CTD
PMID:21544650
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
Krt18
keratin 18
increases expression increases metabolic processing
ISO
vinorelbine results in increased expression of KRT18 protein vinorelbine results in increased metabolism of KRT18 protein
CTD
PMID:16685278
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Lhx4
LIM homeobox 4
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of LHX4 mRNA
CTD
PMID:21544650
NCBI chr13:67,877,109...67,917,219
Ensembl chr13:67,877,109...67,927,003
G
Npm1
nucleophosmin 1
decreases response to substance
ISO
NPM1 protein results in decreased susceptibility to vinorelbine
CTD
PMID:24736981
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
vinorelbine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Pak5
p21 (RAC1) activated kinase 5
multiple interactions
ISO
[Cisplatin co-treated with Vinorelbine] results in decreased expression of PAK5 mRNA
CTD
PMID:21544650
NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
decreases expression
ISO
vinorelbine results in decreased expression of PROC protein
CTD
PMID:10475134
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
vinorelbine results in decreased expression of PTGS2 protein
CTD
PMID:17904787
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rbm17
RNA binding motif protein 17
decreases response to substance
ISO
RBM17 protein results in decreased susceptibility to vinorelbine
CTD
PMID:16061639
NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014
G
Slc29a1
solute carrier family 29 member 1
affects response to substance
ISO
SLC29A1 protein affects the susceptibility to vinorelbine
CTD
PMID:18452103
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Tgfb1
transforming growth factor, beta 1
decreases activity
ISO
Vinorelbine results in decreased activity of TGFB1 protein
CTD
PMID:31652400
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of TNF mRNA
CTD
PMID:21544650
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Traf1
TNF receptor-associated factor 1
multiple interactions
ISO
[Cisplatin co-treated with vinorelbine] results in decreased expression of TRAF1 mRNA
CTD
PMID:21544650
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
Yohimbine analog results in increased expression of ABCB1 mRNA
CTD
PMID:7476894
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ABCB4 mRNA
CTD
PMID:28843594
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ABCC2 mRNA
CTD
PMID:28843594
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ABCC3 mRNA
CTD
PMID:28843594
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Actg1
actin, gamma 1
increases expression
EXP
Yohimbine results in increased expression of ACTG1 mRNA
CTD
PMID:21983523
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Adam9
ADAM metallopeptidase domain 9
decreases expression
EXP
Yohimbine results in decreased expression of ADAM9 mRNA
CTD
PMID:21983523
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
increases expression
EXP
Yohimbine results in increased expression of ADAMTS4 mRNA
CTD
PMID:21983523
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adra2a
adrenoceptor alpha 2A
multiple interactions
ISO EXP
Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] Yohimbine binds to and results in decreased activity of ADRA2A protein
CTD
PMID:8397342 PMID:10742289 PMID:17666864
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Adrb1
adrenoceptor beta 1
multiple interactions
EXP
[Imipramine co-treated with Yohimbine] results in decreased activity of ADRB1 protein
CTD
PMID:2868116
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Aldoc
aldolase, fructose-bisphosphate C
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of ALDOA mRNA
CTD
PMID:28843594
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Avpr1a
arginine vasopressin receptor 1A
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of AVPR1A mRNA
CTD
PMID:28843594
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
G
Bhmt
betaine-homocysteine S-methyltransferase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of BHMT mRNA
CTD
PMID:28843594
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Calu
calumenin
increases expression
EXP
Yohimbine results in increased expression of CALU mRNA
CTD
PMID:21983523
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Cat
catalase
multiple interactions
EXP
Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in decreased activity of CAT protein]
CTD
PMID:27028940
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccng1
cyclin G1
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CCNG1 mRNA
CTD
PMID:28843594
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Cd36
CD36 molecule
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CD36 mRNA
CTD
PMID:28843594
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdc14b
cell division cycle 14B
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CDC14B mRNA
CTD
PMID:28843594
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
G
Cemip2
cell migration inducing hyaluronidase 2
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CEMIP2 mRNA
CTD
PMID:28843594
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
G
Clic1
chloride intracellular channel 1
decreases expression
EXP
Yohimbine results in decreased expression of CLIC1 mRNA
CTD
PMID:21983523
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Col2a1
collagen type II alpha 1 chain
multiple interactions
EXP
Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in decreased activity of CAT protein]; Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of PTGS2 protein]; Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of RELA protein]; Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of TNF protein]
CTD
PMID:27028940
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Crh
corticotropin releasing hormone
multiple interactions
EXP
Yohimbine affects the reaction [Norepinephrine affects the expression of and affects the secretion of CRH protein]; Yohimbine inhibits the reaction [Nitroprusside results in increased expression of and results in increased secretion of CRH protein]
CTD
PMID:3497798
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of CXCL12 mRNA
CTD
PMID:28843594
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA
CTD
PMID:28843594
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing affects response to substance
ISO
CYP2D6 gene polymorphism affects the metabolism of Yohimbine CYP2D6 protein affects the susceptibility to Yohimbine
CTD
PMID:15289791 PMID:34027562
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions affects metabolic processing
ISO
Yohimbine analog inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] CYP3A4 gene polymorphism affects the metabolism of Yohimbine
CTD
PMID:15289791 PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Fasn
fatty acid synthase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of FASN mRNA
CTD
PMID:28843594
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA
CTD
PMID:28843594
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GSR mRNA
CTD
PMID:28843594
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
[Yohimbine co-treated with Cocaine] affects the reaction [HTR2A protein results in increased susceptibility to 4-iodo-2,5-dimethoxyphenylisopropylamine]
CTD
PMID:8392199
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Lpl
lipoprotein lipase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA
CTD
PMID:28843594
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lss
lanosterol synthase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] affects the expression of LSS mRNA
CTD
PMID:28843594
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Maoa
monoamine oxidase A
decreases activity
ISO
Yohimbine results in decreased activity of MAOA protein
CTD
PMID:28302559
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Mir101a
microRNA 101a
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of MIR101A mRNA
CTD
PMID:28843594
NCBI chr 5:115,966,332...115,966,406
Ensembl chr 5:115,966,328...115,966,410
G
Mir122
microRNA 122
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] affects the expression of MIR122 mRNA
CTD
PMID:28843594
NCBI chr18:58,758,703...58,758,787
G
Mir192
microRNA 192
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of MIR192 mRNA
CTD
PMID:28843594
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
G
Mlxipl
MLX interacting protein-like
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA
CTD
PMID:28843594
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
G
Myct1
myc target 1
increases expression
EXP
Yohimbine results in increased expression of MYCT1 mRNA
CTD
PMID:21983523
NCBI chr 1:42,018,137...42,029,410
Ensembl chr 1:42,018,137...42,029,410
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
Yohimbine results in increased expression of NFKBIZ mRNA
CTD
PMID:21983523
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein]; Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:17637181
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npy
neuropeptide Y
multiple interactions
EXP
Yohimbine inhibits the reaction [Clonidine results in decreased expression of NPY mRNA]
CTD
PMID:1878751
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of NQO1 mRNA
CTD
PMID:28843594
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrip3
nuclear receptor interacting protein 3
increases expression
EXP
Yohimbine results in increased expression of NRIP3 mRNA
CTD
PMID:21983523
NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600
G
Pla2g12a
phospholipase A2, group XIIA
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA
CTD
PMID:28843594
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Pomc
proopiomelanocortin
multiple interactions
EXP
Yohimbine inhibits the reaction [Ethanol results in increased secretion of POMC protein]
CTD
PMID:22236039
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
increases expression
ISO
Yohimbine results in increased expression of PRL protein
CTD
PMID:3153710
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of PTGS2 protein]; Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein]; Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:17637181 PMID:27028940
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of RELA protein]
CTD
PMID:27028940
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
multiple interactions increases expression
EXP
Chlorisondamine inhibits the reaction [Yohimbine results in increased expression of REN protein]; Indomethacin inhibits the reaction [Yohimbine results in increased expression of REN protein]; Meclofenamic Acid inhibits the reaction [Yohimbine results in increased expression of REN protein]; Propranolol inhibits the reaction [Yohimbine results in increased expression of REN protein]
CTD
PMID:6323192
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Scd
stearoyl-CoA desaturase
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of SCD1 mRNA
CTD
PMID:28843594
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Thrsp
thyroid hormone responsive
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in decreased expression of THRSP mRNA
CTD
PMID:28843594
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Yohimbine inhibits the reaction [[COL2A1 protein co-treated with Adjuvants, Immunologic co-treated with Freund's Adjuvant] results in increased expression of TNF protein]
CTD
PMID:27028940
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txnrd1
thioredoxin reductase 1
multiple interactions
ISO
[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of TXNRD1 mRNA
CTD
PMID:28843594
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all